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 ABSTRACT 
Lindsay B. Case: Spatiotemporal coordination of the actin cytoskeleton  
and integrin adhesion during cell migration 
(Under the direction of Dr. Clare Waterman) 
 
Integrin-based adhesions mediate critical interactions between the cell and its external 
environment.  Integrins assemble into macromolecular “focal adhesions” (FAs) that contain hundreds of 
proteins and indirectly connect integrin cytoplasmic tails to the actin cytoskeleton.  Forces transmitted 
across FAs drive tissue morphogenesis, cell movement, and extracellular matrix (ECM) remodeling.  
During cell migration, actin polymerization drives protrusion of the leading edge and integrins mediate 
adhesion to the ECM.  However, efficient movement requires that these distinct processes are 
spatiotemporally coordinated.  Here we provide evidence that Arp2/3-mediated actin polymerization can 
stimulate integrin adhesion throughout the cell surface, while vinculin activation is spatiotemporally 
controlled by the macromolecular FA architecture to engage actin retrograde flow to growing FAs.  
We have identified and characterized “adhesive F-actin waves,” a novel integrin-mediated 
adhesion complex coupled to ventral actin polymerization.  Integrins engage the ECM downstream of 
Arp2/3-mediated ventral F-actin waves in a variety of mammalian cell types.  These adhesive F-actin 
waves require a cycle of integrin engagement and disengagement to the extracellular matrix for their 
formation and propagation, and exhibit morphometry and a hierarchical assembly and disassembly 
mechanism distinct from other integrin-containing structures.  These results suggest that Arp2/3 activity, 
rather than the specific lamellipodium structure, is important for initiating integrin adhesion.   
Vinculin is recruited to FAs as they grow and compositionally mature to engage actin retrograde 
flow and mechanically reinforce the integrin-actin linkage.  Vinculin has many binding partners at FAs, 
and its interactions are regulated by an auto-inhibitory, high-affinity intramolecular interaction.  To study 
the spatiotemporal regulation of vinculin activation and vinculin function, we used superresolution 
microscopy to assay vinculin nanoscale organization and a FRET biosensor to assay vinculin 
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conformation.  We found that movement up the laminar FA structure during FA maturation facilitates 
vinculin activation and mechanical reinforcement of FAs.  Inactive vinculin is recruited to the lower integrin 
signaling layer by binding to phospho-paxillin.  Talin and actin binding activates vinculin, and talin targets 
active vinculin to the higher FA layers where vinculin can engage actin retrograde flow.  Thus, specific 
protein interactions occur within distinct FA nano-domains to regulate vinculin recruitment, activation, and 
function in during FA maturation.       
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 CHAPTER 1: INTRODUCTION 
INTEGRATION OF ACTIN DYNAMICS AND CELL ADHESION BY A THREE-DIMENSIONAL, 
MECHANOSENSATIVE MOLECULAR CLUTCH 
1.1 Summary 
Cell migration is important during embryonic development
1,2
, the immune response, and wound 
healing
3
, and the misregulation of cell migration can lead to inflammation and cancer metastasis
4
.  Cell 
migration involves coordinated edge protrusion and adhesion to the extracellular matrix (ECM), usually in 
response to external chemical or physical guidance cues
5
.  In order to move, cells must be able to apply 
forces to deform the extracellular environment and generate traction.  The actin cytoskeleton is the major 
source of internally generated force that regulates cell shape and drives cell migration
6
.  Actin 
polymerization against the plasma membrane and myosin-II contraction of F-actin filaments generate a 
net rearward “retrograde flow” of the F-actin network relative to the direction of cell movement, but how 
does the cell convert rearward actin flow into forward cell movement?  The molecular clutch hypothesis 
postulates that macromolecular focal adhesions (FAs) act as a clutch by mediating transient, indirect 
interactions between the retrograde moving actin cytoskeleton and ECM-bound integrins (Fig.1.1). Here 
we describe how forces originating in the actin cytoskeleton are transmitted to the ECM to generate the 
rearward traction forces that propel forward cell movement.  We outline the growing body of evidence that 
force transduction is regulated by a three-dimensional molecular clutch consisting of the FA molecules 
talin and vinculin.  We discuss how forces transmitted by the clutch impact the molecules within FAs and 
allow individual FAs to act as mechanosensors. Finally, we speculate about the generality of the 
molecular clutch concept in driving dynamic cell interactions with other cells or their environment in critical 
physiological processes including the immune response, vascular function, and epithelial morphogenesis. 
1.2 The molecular clutch hypothesis: a brief history 
Cell movement has captivated scientists since the invention of the light microscope,
7
 and 
microscopy continues to provide insight into the molecular regulation of the migration of mammalian cells.   
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Figure 1.1.  The molecular 
clutch hypothesis 
(a) New actin monomers (light blue) are incorporated onto the barbed end of a pre-existing actin filament 
(dark blue) facing the leading edge of the lamellipodia. Transmembrane integrin dimers (red) are bound to 
the extracellular matrix (ECM, gray).  (b) If the clutch is not engaged to connect actin to the ECM, then 
actin polymerization results in rapid retrograde cytoskeletal flow, no net leading edge protrusion, and no 
traction force on the ECM.  (c) If the clutch is engaged (yellow), the forces generated by polymerization of 
the actin cytoskeleton are physically transmitted to the ECM, resulting in slowing of retrograde flow, 
traction force on the ECM,  and a net edge protrusion. 
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In the early 1960s, Abercrombie proposed that protruding and ruffling membrane at the front of migrating 
chick fibroblasts was the main “locomotory organ” of the fibroblast
8
, and this leading edge was observed 
to undergo cycles of protrusion and retraction to result in net forward movement
9
.  Abercrombie and 
Harris observed that marker particles derived from ink or resin moved centripetally from the leading edge 
along both the dorsal and ventral cell membranes at a constant rate and rearward direction relative to the 
direction of leading edge protrusion
10,11
.  These first observations of “retrograde flow” were proposed to 
be related to forward edge protrusion and rearward traction forces, although the flow of particles was 
initially thought to be due to a moving plasma membrane
10–12
.  However, it was later proposed by Wolpert 
and Allison that this rearward particle movement could be due to the movement of the filamentous 
network inside of the cell pulling proteins in a fluid plasma membrane
12
.  Small and Abercrombie used 
electron microscopy to show that the leading edge is full of filamentous actin that is organized into the 
structurally distinct lamellipodia and lamella, and that actin within the lamellipodia is polarized with the 
growing barbed end facing the cell edge
13,14
.  In 1985, Wang performed seminal FRAP experiments of 
fluorescently-labeled actin to demonstrate that actin monomers were incorporated at the leading edge of 
the lamellipodia and then underwent a rearward movement away from the edge
15
.  Forscher also 
observed retrograde actin flow in neuronal growth cones and showed that retrograde actin flow was 
dependent on both actin polymerization and myosin-II contractility
16,17
.  Theriot and Mitchinson 
demonstrated that actin polymerization in the lamellipodia was directly coupled to forward cell 
movement
18
, and retrograde flow was observed to be inversely related to cell speed
15,17,19,20
.  In 1988 
Mitchison and Kirschner proposed that a “”molecular clutch” connected the retrograde moving actin 
cytoskeleton to extracellular matrix receptors in the plasma membrane, allowing tension to be exerted on 
the substrate
21
.   
In the subsequent decades, the evidence supporting this molecular clutch hypothesis has grown; 
however, the basic principles remain unchanged (Fig. 1.1).  Actin is rapidly polymerized in the 
lamellipodia, and actin polymerization and myosin-II contraction drive the net rearward retrograde 
movement of the actin network.  Macromolecular focal adhesions (FAs) act as a regulatable molecular 
clutch by mediating transient, indirect interactions between the retrograde moving actin cytoskeleton and 
ECM-bound integrins.  When the clutch is “engaged,” the actin cytoskeleton is bound through focal 
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adhesion proteins to integrins, and thus retrograde flow slows down and forces from the actin 
cytoskeleton are propagated to the substrate, resulting in rearward traction and forward membrane 
protrusion.  However, disengagement or slippage of the clutch results in faster retrograde flow, decreased 
traction forces, and cessation of membrane protrusion 
1.3 Forces generated in the actin cytoskeleton drive actin retrograde flow 
The retrograde movement of the actin cytoskeleton is the basis of the molecular clutch 
hypothesis.  In adherent, migrating cells, the actin cytoskeleton is organized into two structurally and 
functionally distinct regions: the lamellipodium and the lamellum
13,22,23
.  Rapid Arp2/3-mediated F-actin 
polymerization at the tip of the lamellipodium generates a pushing force against the plasma membrane 
and has been proposed to drive protrusion via a Brownian ratchet mechanism 
24–26
.  F-actin 
polymerization against the membrane also results in a counter-force that pushes the entire F-actin 
network rearward, and the majority of F-actin is depolymerized at the base of the lamellipodium 
15,16,22,27
.  
Therefore, although new actin monomers are continuously incorporated at the lamellipodium tip, the 
lamellipodial actin network exhibits treadmilling behavior and undergoes “retrograde flow” of ~0.5 
micron/min
22
.  The lamellum is located behind the lamellipodium (i.e. closer to the cell body) and contains 
many distinct F-actin structures including dorsal stress fibers, transverse arcs, and ventral stress fibers
28–
30
.  In the lamellum, myosin-II assembles into mini-filaments and contracts actin bundles to generate 
forces that reorganize actin, disassemble actin, and drive a slower retrograde flow of ~0.25 micron/min 
22,28,31,32
.  Thus, actin polymerization drives rapid retrograde flow in the lamellipodia, while myosin 
contraction drives slower retrograde flow in the lamella.   
1.4 FAs are a three-dimensional macromolecular complex that physically connect the actin 
cytoskeleton to the ECM  
There is evidence in diverse cell types that actin retrograde flow speed is inversely correlated to 
edge protrusion
17,18,22,33
, suggesting that actin retrograde flow provides the force for forward cell 
movement.  However, in order for actin retrograde flow to drive cell movement, the forces generated in 
the actin cytoskeleton must be transmitted to the ECM.  Therefore, it is important to understand how the 
actin cytoskeleton is physically linked to the extracellular environment.  FAs are integrin-based adhesion 
structures that physically connect the actin cytoskeleton to the ECM 
34–36
 via a macromolecular complex.  
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Integrins are transmembrane heterodimers that can interact with different extracellular ligands such as 
fibronectin, collagen, and laminin
37,38
.  Integrins have a large extracellular domain and a small cytoplasmic 
tail, and they must undergo a dramatic conformational change to become “activated” and competent to 
tightly bind ligand
38–40
.  The β-integrin cytoplasmic tail binds several proteins including talin, α-actinin, and 
kindlin, but neither α-integrin or β-integrin can directly interact with actin 
41–45
.  Therefore, the connection 
between integrins and actin must be indirectly mediated by the assembly of the macromolecular FA 
structure.  FAs can contain hundreds of different proteins including scaffolding proteins, structural 
proteins, kinases, and phosphatases, and their composition changes in response to diverse stimuli
46–49
.  
FAs form in the protruding lamellipodia as small puncta containing integrin, FAK, and paxillin 
50–52
.  While 
most of these “nascent” FAs have a lifetime of ~1 min, a subset of FAs are stabilized and undergo 
“maturation” when they reach the lamella
51
.  FA maturation requires stress fiber assembly and myosin-II 
activity
51,53,54
 as FAs elongate along an actin/α-actinin template in the direction of retrograde flow
51
 and 
undergo dramatic compositional changes
47
.   
Although many proteins localize to FAs, these proteins are not homogenously distributed in the 
three-dimensional FA structure.  Recent advances in light microscopy have allowed for the determination 
of protein localization in FAs at the nanoscale level, and has revealed that mature FAs are vertically 
stratified along the axis perpendicular to the ventral plasma membrane (Fig. 1.2)
55–58
.  Paxillin and FAK 
associate with integrin cytoplasmic tails within ~30nm of the plasma membrane (i.e. low in the FA).  In 
contrast, actin and the actin-associated proteins zyxin, vasp and α-actinin localize >50nm above the 
plasma membrane (i.e. high in the FA).  Talin is a large protein that that forms the primary link between 
integrin and actin
59
.  The talin head, which binds β-integrin tails, co-localizes with paxillin and FAK near 
the plasma membrane, while the talin tail, which binds actin, localizes ~30nm higher
42,57,60,61
.  Vinculin 
colocalizes with the talin rod in the intermediary layer
57
.  This conserved layered organization of FA 
proteins is observed in diverse cell types, suggesting that it arises from the self-assembly of protein-
protein interactions at FAs.   
Proteins are also organized along the length of individual FAs (i.e. the axis parallel to the ventral 
plasma membrane, Fig. 1.2).  FAs grow in the direction of actin retrograde flow, so mature FAs are 
oriented with their long axis perpendicular to the leading edge
50
.  We will refer to the tip of the FA nearest  
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Figure 1.2.  Nano-scale architecture of the focal adhesion clutch 
Focal adhesions are three-dimensionally organized into “nano-domains” with unique protein composition 
and mechanical signature.  The distal tip of the FA facing the leading edge is where lamellipodial dendritic 
actin interacts with the FA, and contains an enrichment of phosphorylated paxillin, rapid retrograde flow 
and high traction forces.  The proximal tip of the FA interacts with the actin stress fiber and is enriched 
with the actin binding proteins -actinin, zyxin and VASP, and is characterized by slow retrograde flow 
and low traction forces.  Additionally, proteins are stratified in the axis perpendicular to the cell plasmsa 
membrane (PM).  Paxillin, FAK and the talin head domain are co-localized with integrin cytoplasmic tails 
near the plasma membrane in the integrin signaling layer.  Actin and actin-binding proteins are localized 
>50nm above the plasma membrane in the actin regulatory layer.  Talin and vinculin reside in the force 
transduction layer that spans between the integrin signaling and actin regulatory layers.  Talin is oriented 
with the N-terminus near the plasma membrane and the C-terminus ~30nm higher and extended towards 
the FA proximal tip.   
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the leading edge as the “distal tip”, while the tip closer to the cell body is the “proximal tip”.  Actin stress 
fibers attach at the proximal tip of FAs, so actin-associated proteins are also concentrated at the proximal 
tip 
50,57,62,63
.  In contrast, FAK-dependent phosphorylation of paxillin is highest at the distal tip of FAs, 
providing a mechanism for proteins to be concentrated in this region
64
.  Talin molecules have been shown 
to be organized along the long axis of the FA such that the talin head is localized closer to the distal tip of 
the adhesion while the talin tail is stretched rearward in the direction of F-actin flow 
65
.  It’s likely that other 
proteins are also organized along the long axis of the FA by actin retrograde flow.       
Although FAs have a conserved nanoscale architecture, proteins within FAs are highly dynamic.  
Inactive integrins can freely diffuse in the plasma membrane at FAs, and activation triggers integrin 
immobilization 
66,67
.  Most FA proteins, including paxillin, vinculin, α-actinin, talin, kindlin, FAK, zyxin, 
VASP, and ILK, rapidly exchange with the cytoplasmic pool (i.e. FRAP t1/2 measured to be less than 30 
seconds) 
62,68–70
.  Additionally, FRAP recovery at FAs is rarely approximated by a single exponential 
curve, suggesting that there are subpopulations of molecules within the FA with different dynamics.  
Indeed, both paxillin and vinculin have been measured to have at least four distinct sub-populations in the 
FA and surrounding cytoplasm, and paxillin and vinculin have different dynamics at the distal and 
proximal tip of the FA 
62
.  Thus, even when a FA appears stable for tens of minutes, the molecules within 
the adhesion are rapidly turning over.  Furthermore, the types of interactions occuring within the FA can 
change over time.  Fluorescence fluctuation correlation methods suggest that talin-vinculin complexes 
form prior to the integrin-talin complex in nascent FAs, while -actinin clusters periodically enter nascent 
FAs and transiently interact with integrins
71
.   Fluoresecence cross-correlation spectroscopy studies have 
suggested that molecules can enter and leave the stable FA as preformed cytoplasmic complexes 
corresponding to the different FA-layers.  For example, paxillin and FAK co-localize in FA near the plasma 
membrane and diffuse together in the cytoplasm 
72
.  Thus, it’s possible that the self-organization of 
protein-protein interactions dictating FA architecture may initiate from interactions in the cytoplasm. 
1.5 The actin cytoskeleton is a master regulator of FAs 
The molecular clutch hypothesis proposes that the forces generated in the actin cytoskeleton are 
transmitted across FAs to generate rearward traction forces against the substrate
53,73–75
.  Furthermore, 
actin polymerization and integrin adhesion are spatiotemporally coordinated, and the actin cytoskeleton is 
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a master regulator of FAs.  Actin polymerization, F-actin structural organization, and myosin-II contractility 
all contribute to the regulation of FAs in lamellipodia and lamella.   
Actin retrograde flow has been proposed to directly contribute to integrin activation.  The lateral 
force of retrograde flow potentially helps to drive integrin activation by separating α- and β- integrin 
cytoplasmic tails 
76
.  Integrin activation can be initiated by binding of cytoplasmic proteins, such as talin, to 
the integrin tails (“inside-out” activation) or by binding of integrins to their extracellular ligand (“outside-in” 
activation)
40,77–79
.  Integrin activation involves a dramatic conformational change between a low-affinity 
conformation with the extracellular domain folded close to the plasma membrane and a high-affinity 
conformation with the extracellular domain extended away from the plasma membrane
40,79,80
.  However, 
both inside-out and outside-in integrin activation correspond to a lateral separation of the α- and β-integrin 
cytoplasmic tails that can be measured by a loss in intermolecular FRET
81
.  Furthermore, introducing an 
artificial 14nm separation between the α5 and β1 cytoplasmic domains is sufficient to induce high-affinity 
binding to fibronectin in vitro, and molecular dynamics simulations suggest that the lateral force of actin 
retrograde flow could pull the tail away from the α tail to stabilize integrin heterodimers in an open, high-
affinity conformation
39,76
.  This force-dependent model of integrin activation predicts integrin cytoplasmic 
tails would open in the direction of retrograde flow, resulting in a polarized population of active integrins in 
FAs.   
Actin polymerization also controls the formation of initial macromolecular nascent FAs.  FA 
formation and stability in the lamellipodia requires active actin polymerization 
51,75
, and loss of Arp2/3 
activity reduces FA assembly and results in disorganized, abnormal adhesions that do not support 
migration up a surface-bound gradient of ECM 
82,83
.  Therefore, Arp2/3 activity is thought to be required 
for proper FA formation in the lamellipodium.  The FA proteins FAK and vinculin have both been shown to 
bind directly to the Arp2/3 complex, suggesting a direct molecular link between Arp2/3 and FAs
84,85
.  
Although there is evidence that Arp2/3 activity could regulate adhesion formation through specific 
molecular interactions and indirect physical mechanisms, more research is needed to understand how 
Arp2/3 regulates nascent FA assembly.   
Actin also regulates the growth and maturation of FAs.  While most nascent FAs disassemble at 
the base of the lamellipodium, a subset of FAs stabilize and undergo a maturation process at the 
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lamellipodium-lamellum border 
51,86
.  Thus, a row of maturing FAs spatially defines the lamellipodium-
lamellum border and contributes to the abrupt slowing of actin retrograde flow speeds in the lamella 
22,73,75
.  During maturation, FAs undergo a compositional change as they grow and elongate in the 
direction of retrograde flow 
47,50,51,54,87
.   FAs grow at a rate proportional to actin flow, independent of 
specific molecular perturbations; thus, faster retrograde flow results in faster FA elongation
88
.  This 
suggests that FA growth, and therefore local integrin activation, is limited by the distance of actin 
retrograde movement, in agreement with the later force model of integrin activation
76
.  FA maturation 
requires tension to be applied across FAs, either from intracellular myosin contractility or extracellular 
pulling 
89–94
, and FA size correlates to the amount of applied force 
74
.  During FA maturation, α-actinin is 
recruited to cross-link actin filaments
51
.  Mature FAs remain attached to actin stress fibers throughout their 
lifetime, and the maintenance of mature FAs requires association with contractile F-actin bundles 
28,54,95
.  
Disruption of mDia2-generated dorsal stress fibers leads to abnormal FA morphology and dynamics,
28,96
 
and several additional formin family members have been found in biochemically isolated FAs 
47
.  While 
actin regulates FAs both in the lamellipodia and the lamella, further work is needed to clarify the role of 
specific actin nucleators and F-actin structures in regulating the different stages of FA assembly, growth 
and disassembly.   
1.6 Forces at FAs can regulate protein-protein interactions and protein activity 
 Forces generated in the actin cytoskeleton are transmitted across the macromolecular FA to 
generate traction on the extracellular substrate.  Individual FAs have been measured to apply traction 
forces ranging from less than 1kPa to greater than 10kPa (1-10nN/µm
2
), although this is the cumulative 
forces distributed across many molecules in the FA
74,97
.  The development of fluorescence- based 
molecular tension sensors are allowing the direct measurement of forces applied across individual 
molecules
98–100
.  The tension across individual vinculin molecules is estimated to be ~2.5pN when 
measured with a FRET biosensor
98
.  Single-molecule integrin tension sensors based on FRET
100
 or 
quenching
99
 measured ~1-10 pN of tension across individual integrins at FAs.  However, both vinculin 
and integrin molecules were observed to experience a dynamic range of tensions at FAs.  Many other 
molecules, including talin and p130Cas, are thought to bear tension at FAs, although additional tools are 
needed to directly measure tension in other proteins of interest
65,101
.   
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Proteins have evolved diverse mechanisms to respond to tension, and forces transmitted across 
FAs not only generate traction for cell migration but can also significantly alter protein localization and 
activity at FAs.  Some molecules form catch-bonds, characterized by an increase in the dissociation 
lifetime upon increasing tensile force.  For example, the lifetime of α5β1 integrin-fibronectin bonds is 
significantly prolonged when 10-30pN of force is applied 
102
.  Thus, increasing forces will stabilize the 
integrin-fibronectin interaction.  Other proteins, such as talin, undergo a force-dependent extension
103
.  
Although talin contains many vinculin binding sites (VBS) buried within the native structure, an 
unstretched talin molecule contains a single available VBS 
103
.  However, application of 2pN of force 
unmasks cryptic VBS allowing for the recruitment of additional vinculin molecules 
103
.  Talin extension 
occurs at forces >5pN, and binding of vinculin to talin prevents refolding of the talin rod in vitro 
104
.  
However, at >25pN force, vinculin dissociates from talin 
104
.  Force can also directly alter protein activity.  
The application of a 1-3pN pulling force to the formin mDia2 bound to the end of an actin filament results 
in a significant increase in the actin polymerization rate 
105,106
.     
1.7 Talin and vinculin regulate a mechanosensative FA clutch 
If FAs are a molecular clutch, actin retrograde flow will be specifically engaged to the ECM at 
FAs.  Thus, a key prediction of the molecular clutch hypothesis is that actin flow slows down locally at FAs 
as traction forces increase.  Indeed, actin retrograde flow speeds have been experimentally observed to 
decrease at FAs, 
53,67,75,88,107
 and traction forces are observed to be highest at FAs
53,74,108
.  Since actin 
does not directly interact with integrins, actin retrograde flow must be transmitted across a molecular 
“transmission interface” of actin and integrin binding proteins.  Many molecules in FAs, including integrins, 
paxillin, FAK, -actinin, talin, and vinculin, have been observed to undergo retrograde flow at rates equal 
to or slower than the local actin retrograde flow 
53,67,75,88,107,109
, suggesting that retrograde flow is 
transmitted across many of the molecules within FAs.  
Molecules that directly bind integrins and/or actin are thought to be responsible for regulating 
force transmission across FAs by modulating the efficiency of the integrin-actin connection.  When actin is 
tightly associated with integrins, there will be maximum force transmission at FAs.  However, if there is 
“slippage” between the actin retrograde flow and the ECM, less force is expected to be transmitted 
53,110–
112
.  There is growing evidence that talin, vinculin, and -actinin can directly engage actin retrograde flow 
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to increase force transmission at FAs.  Talin is one of the few molecules that can bind directly to both  
integrin tails and F-actin 
42,60
, and when talin is depleted cells have decreased traction forces and fail to 
stiffen in response to tension 
113,114
.  Additionally, talin depletion causes slippage between actin 
retrograde flow and the ECM, resulting in a much wider region of fast lamellipodial actin retrograde flow 
114,115
.  Vinculin binds simultaneously to talin and F-actin, and helps to mechanically reinforce the talin-
actin linkage
116,117
.  When vinculin is depleted cells have decreased traction forces, a widened 
lamellipodia, and faster retrograde flow rates 
88,97,117,118
.  Additionally, vinculin must interact with both talin 
and actin to restore WT retrograde flow and traction forces, suggesting that the talin-vinculin-actin linkage 
directly regulates FA clutch engagement
88,117
.  Thus, recruitment of talin and vinculin to FAs engages 
actin retrograde flow and increases tractions forces on the ECM.  The talin-vinculin interaction is highly 
sensitive to changes in force
103,104
, suggesting that clutch engagement has a positive feedback effect.  As 
force transmission increases across talin, additional vinculin molecules are recruited to bind actin, slow 
retrograde flow, and increase force transmission.  -actinin, which can bind integrin and actin, is also 
required for maximum force transmission across 3 integrins, and -actinin recruitment correlates with 
force generation
119
, suggesting that -actinin could regulate the molecular clutch in addition to cross-
linking actin.   
Since the FA clutch can be dynamically regulated, force transmission could be variable over time 
110
.  Furthermore, the amount of clutch engagement is predicted to be dependent on the stiffness of the 
substrate
110
.  Modeling predicts that if the cell is unable to significantly deform a stiff substrate, then there 
will be stochastic, weak clutch engagement and constant, low traction forces
110
.  However, on a softer 
substrate, cooperative engagement of many clutch molecules within FA can occur.  As more molecules 
bind actin and integrins, retrograde flow slows and traction forces increase until the entire 
macromolecular clutch breaks under the increased tension.  Thus, on softer substrates cells are predicted 
to exhibit a “tugging” behaviour, with the position of peak traction and the magnitude of traction across 
individual FAs fluctuating over time
97,110
.  Indeed, high-resolution traction force microscopy has shown 
that traction forces fluctuate by several thousand Pa within individual FAs, and a single FA can undergo 
several transitions between low and high traction regimes each minute
97
.  Furthermore, the ability for cells 
to fluctuate between low and high forces requires vinculin, supporting the important role of vinculin in 
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regulating the FA clutch 
97
.  FA “tugging” is mechanosensative, as it only occurs on soft substrates.  On 
stiff substrates individual FAs have stable, low traction forces, while on softer substrates individual FAs 
have fluctuating traction forces
97
.  Fluctuating traction forces are required for cells to differentiate between 
soft and stiff substrates as they migrate
97
.  Thus, individual FAs dynamically sample substrate stiffness by 
applying fluctuating pulling forces and act as mechanosensors to guide cell migration 
97,110
.  
1.8 The three-dimensional molecular clutch 
The three-dimensional organization of proteins in FAs likely imposes physical limitations on the 
molecular clutch.  Since actin flows directionally from the distal tip to the proximal tip of FAs, forces 
applied to molecules within FAs are biased in this direction.  As a result, molecules can become aligned 
within the FA.  For example, talin molecules are oriented with the actin-binding tail domain higher and 
further from the leading edge than the integrin-binding head
57,65
.  Actin retrograde flow likely polarizes 
other molecules, such as integrins, and results in FA elongation away from the leading edge during 
maturation.  There is also growing evidence that the clutch is differentially engaged along the length of 
the FA, as both actin retrograde flow speeds and traction forces are highest at the distal tip of mature 
FA
53,97
.   
Since more than 50nm separates the actin cytoskeleton from integrin cytoplasmic tails, forces 
must be transmitted vertically down the FA.  Forces are likely highest near the actin cytoskeleton and 
dissipate as they propagate toward the ECM, suggesting there would be differences in the retrograde flow 
of proteins in the different FA layers.  Indeed, α-actinin has a fast retrograde flow speed of ~2.5um/min 
and co-localizes with actin >60nm above the plasma membrane
57,107
.  In contrast, paxillin and integrin, 
which localize close to the plasma membrane, have retrograde flow speeds below 0.1um/min.  Talin and 
vinculin, which localize in an intermediary layer between the plasma membrane and the actin 
cytoskeleton, have flow speeds between 0.1-0.3 micron/min.  Additionally, both the direction and speed of 
actin flow is most closely coupled with α-actinin flow, while vinculin and talin had slightly less coupling 
with actin
107
.  Integrin and paxillin flow has the lowest observed coupling with actin flow speed and 
direction.  This suggests that the forces of actin flow are dissipated as they are transmitted through a 
series of slipping linkages mediated by specific proteins organized along the vertical axis of the FA. 
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In addition to the conserved three-dimensional organization of proteins in FAs, there are also 
spatial differences in retrograde flow and traction forces.  Thus, within a single FA, there are three-
dimensional nano-domains with varying protein composition and mechanical signatures (Fig. 1.2).  
Further work is needed to understand how this spatial organization influences protein activity at FAs.  
Perhaps the spatial compartmentalization of different groups of proteins helps to limit the types of 
interactions that can occur at FAs.  As proteins move up, down or rearward with actin retrograde flow, 
they could come into contact with different groups of binding partners and varying magnitudes of 
mechanical tension.   
1.9 Beyond FAs: molecular clutches at diverse adhesive interactions 
While FAs have been experimentally shown to act as a bona fide molecular clutch during cell 
migration, other sites of adhesion could also serve as molecular clutches in diverse cellular processes 
(Fig. 1.3).  Any immobilized transmembrane proteins that can indirectly bind the actin cytoskeleton could 
facilitate regulated force transmission in a similar manner to integrins at FAs.  Integrins themselves are 
involved in a variety of structures outside of FAs.  LFA-1 and ICAM mediate leukocyte-endothelial 
adhesion during leukocyte transmigration.  The leukocyte actin cytoskeleton can connect to LFA-1 via 
talin
43
 while the endothelial actin cytoskeleton can connect to ICAM via -actinin
120
, suggesting that both 
cells could actively transmit force across the adhesion via indirect protein interactions.  Furthermore, 
repair of endothelial cells following leukocyte transmigration involves integrin-dependent ventral 
lamellipodia that may form a molecular clutch involved in maintaining endothelial barrier function
121
.  
Rapid actin polymerization is essential for proper T-cell synapse formation, and the centripetal flow of 
actin organizes both T-cell receptors and LFA-1 at the immune synapse
122
.  Bacterial and viral pathogens 
frequently exploit cell adhesion molecules, including integrins and cadherins
123
, to gain entry into host 
cells, and virulence factors can activate key clutch regulators, such as vinculin
124
.  The ability of cadherins 
to indirectly connect to the actin cytoskeleton via -catenin and -catenin allows tension to be applied 
across cell-cell adhesions
125
.  Cell-cell adhesions are similar in many ways to FAs, and force transduction 
across cadherins is regulated by interactions between -catenin, vinculin and actin
125
.  Furthermore, N- 
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Figure 1.3.  Molecular clutches may mediate diverse cell adhesive interactions. 
(a) During leukocyte transmigration, initial cell-cell adhesion is mediated by LFA1-ICAM interactions.  
Transcellular migration occurs when the leukocyte migrates through a single endothelial cell.  The 
migrating leukocyte extends invasive protrusions into the endothelial cell, while the endothelial cell forms 
a transmigratory cup around the leukocyte.  Following successful transmigration, the transmigratory pore 
(TP) is closed by integrin-dependent ventral lamellipodia (VL) to restore endothelial barrier integrity.        
(b) Pathogens often seek entry into host cells by co-opting the integrin or cadherin adhesion machinery.  
Bacteria can bind to these adhesion receptors, stimulate actin polymerization, and activate clutch 
molecules to promote the formation of a phagocytic cup.  (c) The T-cell immunological synapse requires 
centripetal actin flow to organize adhesion receptors into distinct domains.  Rapid retrograde flow 
organizes and potentially activates LFA1 integrins in the actin rich regions. In contrast, the T-cell 
receptors (TCR) cluster in the actin-free center.  (d) Cadherins mediate cell-cell adhesion and connect 
indirectly to the actin cytoskeleton through -catenin, -catenin and vinculin.  Cadherins have been 
observed to undergo actin-dependent basal to apical flow that could generate force for epithelial 
morphogenesis.  In all panels, active polymerization of the actin cytoskeleton is depicted as a blue mesh. 
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cadherin engages actin retrograde flow to promote neuronal growth cone migration
126
, and VE-cadherin 
undergoes actin-dependent basal to apical flow
127
. Thus, force transduction at cell-cell junctions via a 
cadherin-based molecular clutch is likely critical for remodeling epithelia during morphogenesis
1,2
.  In 
conclusion, forces generated in the actin cytoskeleton could be harnessed by molecular clutches at a 
variety of adhesive interactions to regulate force transmission during diverse cellular functions, and the 
principles learned from studying force transmission at FAs could be applied to better understand these 
processes.      
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CHAPTER 2: ADHESIVE F-ACTIN WAVES ARE A NOVEL INTEGRIN-MEDIATED ADHESION 
COMPLEX COUPLED TO VENTRAL ACTIN POLYMERIZATION
1
 
2.1 Summary 
At the leading lamellipodium of migrating cells, protrusion of an Arp2/3-nucleated actin network is 
coupled to formation of integrin-based adhesions, suggesting that Arp2/3-mediated actin polymerization 
and integrin-dependent adhesion may be mechanistically linked.  Arp2/3 also mediates actin 
polymerization in structures distinct from the lamellipodium, in “ventral F-actin waves” that propagate as 
spots and wavefronts along the ventral plasma membrane.  Here we show that integrins engage the 
extracellular matrix downstream of ventral F-actin waves in a variety of mammalian cell types.  These 
“adhesive F-actin waves” require a cycle of integrin engagement and disengagement to the extracellular 
matrix for their formation and propagation, and exhibit morphometry and a hierarchical assembly and 
disassembly mechanism distinct from other integrin-containing structures.  After Arp2/3-mediated actin 
polymerization, zyxin and VASP are co-recruited to adhesive F-actin waves, followed by paxillin and 
vinculin, and finally talin and integrin.  Adhesive F-actin waves thus represent a previously 
uncharacterized integrin-based adhesion complex associated with Arp2/3-mediated actin polymerization.   
2.2 Introduction 
Cell migration is a coordinated event involving protrusion, adhesion to the extracellular matrix 
(ECM), myosin II-driven contraction of the cell body, and adhesion disassembly at the cell rear.  In the 
lamellipodium, protrusion of an Arp2/3-nucleated actin network is coupled to formation of integrin-based 
adhesions 
51
.  Arp2/3-mediated actin polymerization and integrin-dependent adhesion may be 
mechanistically linked, as the rate of adhesion assembly is directly correlated with the rate of lamellipodial 
protrusion 
51
, and the focal adhesion proteins vinculin and focal adhesion kinase (FAK) have been shown 
to interact with Arp2/3 
84,85
.  While the Arp2/3-nucleated dendritic actin network is a defining characteristic 
                                                          
1
 This chapter is adapted from work previously published as an article in PLoS ONE.  The original citation 
appears as follows: Case, L. B. & Waterman, C. M. Adhesive F-actin waves: a novel integrin-mediated 
adhesion complex coupled to ventral actin polymerization. PLoS One 6, e26631 (2011).  
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of the lamellipodium, Arp2/3-dependent actin polymerization is not limited to this structure.  Arp2/3-
dependent actin polymerization is important for the formation of the immunological synapse, endocytosis 
and vesicle fusion, membrane ruffling, and ventral F-actin waves 
128
.   
Ventral F-actin waves have been characterized in neutrophils, fibroblasts, and Dictyostelia
129–131
.  
In spite of their conservation across eukaryotic cells, the function of ventral F-actin waves is not well 
understood.  In neutrophils, F-actin waves are induced by chemoattractant and are proposed to mediate 
cell migration 
129
, while in Dictyostelium, they are thought to be involved in phagocytosis 
132
.  Ventral F-
actin waves occur when actin spontaneously nucleates and polymerizes on the ventral, substrate-
attached surface of cells, independently of the cell edge 
131,133
.  This polymerizing actin can form discrete 
spots, moving spots, or propagate in semicircular wave patterns 
134
.   
Several studies have begun to characterize the mechanism of ventral F-actin wave formation and 
propagation. In Dictyostelia, myosin II does not localize to ventral F-actin waves and the formation and 
motion of ventral F-actin waves occurs in myosin II null cells 
135
. However, their sensitivity to actin 
polymerization inhibitors and fluorescence recovery after photobleaching (FRAP) experiments indicate 
that ventral F-actin waves propagate by actin polymerization and treadmilling 
129,135,136
.  Localization 
studies have shown that ventral F-actin waves contain Arp2/3 and its activator, the WAVE complex, 
suggesting their involvement in stimulating actin treadmilling 
129,131
.  Actin assembly by Arp2/3 in ventral 
F-actin waves may be mediated by a PI3K/Rac1 signaling cascade, since they are sensitive to the PI3K 
inhibitor LY294002, 
132,137
 and active Rac1 forms propagating wave patterns similar to ventral F-actin 
waves 
129
.  Together, these data suggest that PI3K and Rac1 promote WAVE- and Arp2/3-dependent 
actin treadmilling to form ventral F-actin waves and drive their propagation.   
In spite of the knowledge on the mechanism of actin polymerization in ventral F-actin waves, 
whether they are associated with integrin-based attachment to the ECM is unknown. In this study we 
show that integrins engage the ECM downstream of ventral F-actin waves.  These “adhesive F-actin 
waves” require a cycle of integrin engagement and disengagement to the ECM for their formation and 
propagation.  We show that the morphometry and hierarchical assembly and disassembly pathway of 
adhesive F-actin waves is distinct from previously characterized integrin-based adhesion structures 
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including podosomes and focal adhesions (FAs).  Adhesive F-actin waves thus represent a previously 
uncharacterized integrin-based adhesion complex associated with Arp2/3-mediated actin polymerization.   
2.3 Results 
Ventral F-actin waves are followed by integrin waves in mammalian cells  
Since Arp2/3-mediated actin polymerization is coupled to integrin adhesion in lamellipodia, we 
sought to determine if ventral F-actin waves were also coupled to integrin adhesion.  To image ventral F-
actin waves, we transfected cells with the F-actin-binding probe F-tractin-GFP (Inositol 1,4,5-
Trisphosphate 3-Kinase A N66 actin binding domain fused to tdTomato 
138
), plated on 5µg/mL fibronectin, 
and imaged by Total Internal Reflection Fluorescence Microscopy (TIRFM).  We observed spontaneous 
ventral F-actin waves in a variety of cell types including U2OS (human osteosarcoma cell line), B16-F10 
(mouse melanoma cell line), and primary mouse embryonic fibroblasts (MEFs) (Figure 2.1a-f).  We will 
refer to both moving spots of F-actin and propagating semicircular waves of F-actin as “ventral F-actin 
waves”.  We measured ventral F-actin wave propagation velocities ranging from 1 -5 µm/min in the 
different cell types, comparable to the propagation speeds reported for Dictyostelium and mammalian cell 
ventral F-actin waves 
130,133,135,139
.   
To test the hypothesis that ventral F-actin waves are coupled to integrin adhesion, we co-
expressed F-tractin-GFP along with a fluorescent reporter for a fibronectin receptor, αV integrin-tagRFP 
and untagged β3 integrin.  Analysis by TIRFM showed that ventral F-actin waves were associated with αV 
integrin waves in all cell types (Figure 2.1a-f).  Dual color F-tractin and αV integrin kymographs revealed 
that while both waves propagated with a similar velocity and shape, ventral F-actin waves spatially and 
temporally preceded integrin waves in all cell types (Figure 2.1a-f).  To quantify the dynamics of ventral F-
actin and integrin waves, we plotted the normalized (to maximal in the series) average intensity over time 
in a region through which a wave propagated (Figure 2.1b, d, f).  To determine differences in assembly 
dynamics, we measured the lag time between when F-tractin and integrin reached half-maximal intensity, 
and to determine differences in disassembly dynamics we measured the lag time between when F-tractin 
and integrin decreased from peak to half-maximal intensity (Figure 2.1g).  This analysis indicated that 
U2OS ventral F-actin waves rise to half-maximal intensity an average of 83±45sec before αV integrin  
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Figure 2.1. Ventral F-actin waves are followed by integrin waves in mammalian cells 
 (a,c,e) LEFT: Total internal reflection microscopy (TIRFM) image of a U2OS cell (a) B16-F10 cell (c) or a 
primary mouse fibroblast (d) co-expressing F-tractin-GFP to label actin filaments (green) and αV integrin-
tagRFP (red).  The white asterisk is to aid in orientation of the region.  Scale bar = 10µm.  CENTER: 
Images from a time-lapse series of the region highlighted by a yellow box, time in min shown.  The white 
asterisk is to aid in orientation of the region.  Scale bar = 5µm.  RIGHT: Kymograph (Kym) along the 
trajectory of ventral F-actin wave propagation (highlighted with a yellow arrow a t=10min(a), t=6min(c) and 
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t=8min(e)) demonstrates that F-tractin-GFP temporally precedes αV integrin-tagRFP in ventral F-actin 
waves.  (b,d,f) Normalized average intensity of F-tractin-GFP (green) and αV integrin-tagRFP (red) over 
time.  The average intensity in the green and red channels was measured in the region highlighted by a 
magenta circle in (a,c,e, left) and the values were normalized to the maximal intensity in the time series.  
To quantify assembly dynamics, we measured the lag time between when ventral F-actin and integrin 
waves reached half-maximal intensity.  To quantify disassembly dynamics, we measured the lag time 
between when ventral F-actin and integrin waves fell from peak to half-maximal intensity.  Lag times are 
labeled in (b,d,f).  (g) Average lag times determined as described in (b,d,f) for the cell types noted, 
represented as mean ± SD, n= number of ventral F-actin waves analyzed.  
 
waves (n=18) and that ventral F-actin waves fall from peak to half-maximal intensity an average of 
135±46sec before αV integrin waves (n=16).  Ventral F-actin and integrin waves in MEFs exhibited similar 
dynamics to U2OS cells, while B16 cells had slightly faster recruitment and disassembly of integrin waves 
(Figure 2.1g).  However, in all cells observed, αV integrin was consistently recruited to ventral F-actin 
waves more than 20 seconds after ventral F-actin wave formation.  We conclude that ventral F-actin 
waves are followed by integrin waves in mammalian cells.    
Ventral F-actin waves were most prevalent in U2OS cells, with ~60% of U2OS cells observed to 
have spontaneously forming ventral F-actin waves.  In addition, co-transfection of F-tractin-tdTomato and 
Arp3-GFP confirmed that Arp2/3 co-localized with F-actin in U2OS ventral F-actin waves (Figure2.2a), 
similar to ventral waves reported in other cell types 
135
.  U2OS ventral F-actin and integrin waves were 
also visible with both widefield epifluorescence (Figure 2.2b) and spinning disk confocal imaging (data not 
shown), suggesting that ventral waves represent a localized increase in the concentration of the proteins 
and are not a proximity artifact of TIRFM imaging.  We confirmed that the measured lag times between F-
actin and integrin waves were not due to differences in the fluorescent protein tag by analyzing ventral F-
actin and V integrin waves in cells expressing F-tractin-tdTomato and V integrin-EGFP (Figure 2.2c).  
Thus, U2OS cells serve as a good model for further characterization of integrin recruitment to 
spontaneously formed ventral F-actin waves.   
Previous studies have shown that ventral F-actin waves require actin polymerization and PI3K 
activity, but not myosin II, and that active Rac1 localizes to ventral F-actin waves 
129,131,135,137,139
.  To test 
the hypothesis that integrin waves occur downstream of ventral F-actin waves, we examined the  
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Figure 2.2. Arp2/3-containing ventral F-actin waves are followed by integrin waves in U2OS cells  
 
(a) LEFT: Total internal reflection fluorescence microscopy (TIRFM) image of a U2OS cell expressing F-
tractin-tdtomato to label actin filaments (red) and Arp3-GFP (green).  Scale bar = 10µm.  The white 
asterisk is to aid in orientation of the region.  CENTER: Images from a time-lapse series of the region 
highlighted by a yellow box, time in min shown.  Scale bar = 10µm.  The white asterisk is to aid in 
orientation of the region.  RIGHT: Kymograph along the trajectory of ventral F-actin wave propagation 
(highlighted with a yellow arrow at t=13min) demonstrates that F-actin and Arp3 colocalize in space and 
time.  Time in min is on the x-axis and distance in µm is on the y-axis.  (b) RIGHT: Widefield 
epifluorescent images of a U2OS cell expressing F-tractin tdTomato to label actin filaments (red) and αV 
integrin-EGFP (green).  Scale bar = 10µm.  LEFT: Images from a time-lapse series of the region 
22 
 
highlighted by a yellow box, time in min shown.  Scale bar = 10µm.  (c) Comparison of lag times with 
different fluorescent tags.  Cells were co-transfected with either F-tractin-tdTomato and αV integrin-EGFP 
or F-tractin-GFP and αV integrin-tagRFP.  Graphs represent lag times between when ventral F-actin and 
integrin waves reach half-maximal intensity (“Rise to half-max”) as well as when they decrease from peak 
to half-maximal intensity (“Fall to half-max”).  Changing the fluorescent tags did not significantly change 
the lag time measurements.  Values are represented as mean ± SD, n= number of ventral waves 
analyzed.  P-values determined by Student’s t-test.  (d) Effects of pharmacological perturbation on 
integrin waves (Bleb= blebbistatin; LatA=latrunculin A; CytoD=cytochalasin D; Rac Inh=NSC23766; PI3K 
Inh=LY 294002, concentrations below).  Cells expressing either αV integrin-tagRFP or αV integrin-EGFP 
were imaged by TIRFM during perfusion of drugs.  We measured the number of waves per min 
(“frequency”) before and after the drugs were added.  We determined the effects of the drugs on integrin 
waves by dividing the post-drug frequency by the pre-drug frequency for each cell imaged.  A value 
greater than one reflects an increase in wave frequency after drug addition, while a value less than one 
reflects a decrease in wave frequency after drug addition.  n=number of cells analyzed.  Data are 
represented as mean ± SD; P-values determined with Student’s t-test.   
 
requirement of these activities for U2OS integrin wave formation.  We imaged αV integrin-tagRFP or αV 
integrin-EGFP during perfusion of Latrunculin A (to sequester actin monomers, 2µM), Cytochalasin D (to 
cap barbed actin filament ends, 2µM), LY294002 (to inhibit PI3K, 40µM), blebbistatin (to inhibit myosin II 
activity, 50uM), and NSC23766 (to inhibit Rac1, 100µM).  We measured the number of waves per min 
(“frequency”) and then determined the effects of drugs on integrin waves by normalizing the post-drug 
frequency to the pre-drug frequency for each cell imaged.  Latrunculin, Cytochalasin, NSC23766 and 
LY294002 all inhibited integrin wave frequency (Figure 2.2d).  Blebbistatin treatment did not inhibit 
integrin wave frequency, but rather led to an increase in the number of integrin waves observed.  This 
suggests that a decrease in myosin II contractility induces integrin wave formation.  Together, these 
results show that Arp2/3- containing ventral F-actin waves are followed by integrin waves in U2OS cells, 
and that, similar to ventral F-actin waves, U2OS integrin waves require actin polymerization, PI3K activity 
and Rac1 activity, but not myosin II contractility, suggesting that ventral F-actin waves and integrin waves 
are coupled processes.   
U2OS integrin waves are distinct from previously characterized integrin-containing structures 
We sought to determine if integrin waves were related to previously characterized integrin-
containing structures including podosomes, invadopodia and FAs 
140,141
.  Podosomes are peripheral 
adhesive structures with a core of F-actin surrounded by a small (~0.5-2µm) phase-dense ring of FA 
proteins 
140–142
.  Phase contrast and spinning-disk confocal imaging of αV integrin-EGFP revealed that 
integrin waves were not phase-dense (Figure 2.3a), did not exhibit ring-like podosome structure, always 
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exhibited propagating movement, and no podosome-like structures were ever observed in U2OS cells 
(Figure 2.1a).  Invadopodia are punctate, adhesive structures specialized for ECM degradation that are 
small (~0.50m), stable (>30 min lifetime), form in the cell center, and contain Arp2/3 and integrins 
141
. 
Although Arp2/3-containing puncta were sometimes observed in the center of U2OS cells, these 
structures did not directly co-localize with integrins, and were short-lived and dynamic (data not shown).  
To verify that integrin waves did not degrade matrix, we plated U2OS cells on fluorescent gelatin for 8 
hours, fixed cells, and immunostained for paxillin.  Invadapodia and podosomes both degrade fluorescent 
gelatin, resulting in a decrease in fluorescence intensity appearing as dark holes in the substrate.  We did 
not observe gelatin degradation beneath U2OS cells, even when the cells appeared to have paxillin-
containing ventral wave structures (Figure 2.3b).  Thus, in U2OS cells, integrin waves are not related to 
matrix-degrading podosomes or invadopodia.   
To determine if integrin waves were similar to or precursors of FAs, we performed TIRFM imaging 
of αV integrin-EGFP and compared the morphometry and dynamics of integrin waves and FAs.  
Morphometric analysis of the distance of integrin-containing FAs and integrin waves from the cell edge 
revealed that, on average, integrin waves were significantly further from the cell edge than FAs (Figure 
2.3c).  Integrin waves were also larger, with an average area of 16.6 ± 4.5 m
2
 as compared with FAs at  
2.9 ± 2.3 µm
2
 (Figure 2.3d).  Analysis of fluorescence intensity per unit area showed that αV integrin-
EGFP in integrin waves was significantly less dense than in FAs (Figure 2.3e), suggesting that integrins 
in integrin waves are less clustered than in FAs.  Analysis of time-lapse images revealed that integrin 
waves were transient structures with an average lifetime of 6.9 ± 3.2 min (n=26) (Figure 2.3f) and were 
never observed to transition into more stable, long-lived structures.  In contrast, FAs had an average 
lifetime of 41.9 ± 8.5 min under our culture conditions. In addition, integrin waves formed and propagated 
at random sites throughout the ventral cell surface, while FAs formed exclusively in lamellipodia and 
matured in the lamella near the cell edge.  By analyzing waves and FAs with fluorescent speckle 
microscopy 
143
, we were able to track integrin speckles within FAs or wave structures (Figure 2.3g-h).  
Kymograph analysis showed that integrin speckles within waves remained stationary relative to the   
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Figure 2.3.  Integrin waves are distinct from podosomes and focal adhesions in U2OS cells 
 (a) LEFT: Spinning disk confocal and phase-contrast images of a U2OS cell expressing αV integrin-
EGFP.  Scale bar = 10µm. RIGHT: Images from a time-lapse series of the region highlighted by a yellow 
box, time in min shown.  The phase contrast image does not exhibit podosome structures as the integrin 
wave propagates across the ventral surface of the cell.  Scale bar = 5 µm.  (b) Spinning disk image of 
fixed U2OS cells plated on Oregon Green-gelatin (left) and stained for paxillin (right).  Yellow arrow 
highlights possible paxillin-containing waves.  (c) Distance from the cell edge of integrin waves (wave) 
and focal adhesions (FA) measured in U2OS cells expressing αV integrin-EGFP.  Values are represented 
as mean ± SD; P-values determined with Student’s t-test.  (d) Area of waves and FAs measured in U2OS 
cells expressing αV integrin-EGFP.  Values are represented as mean ± SD; P-values determined with 
Student’s t-test.  (e) Fluorescence density of waves and FAs measured in U2OS cells expressing αV 
integrin-EGFP.  Values are represented as mean ± SD; P-values determined with Student’s t-test. 
(f) Lifetimes of waves and FAs measured in U2OS cells expressing αV integrin-EGFP.  FA lifetimes longer 
than 45min were recorded as 45min.  Values are represented as mean ± SD; P-values determined with 
Student’s t-test.  (g) LEFT: TIRFM image of a cell expressing αV integrin-EGFP.  Scale bar = 10µm. 
RIGHT: Fluorescent speckle microscopy kymographs of the regions (highlighted with arrows at left) of i) a 
sliding focal adhesion (FA) and ii) a propagating integrin wave (wave).  Magenta lines highlight the path of 
integrin spekcles within kymographs.  Velocity was measured from the slope of the line.  (h) Average 
velocity of integrin speckles within FA or wave structures.  Velocity of integrin speckles in FA or waves 
were measured from the slope of kymographs, as in (F).  Integrin speckles in waves remain stationary 
relative to the substrate.  Values are represented as mean ± SD. 
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substrate (Figure 2.3g), similar to actin in ventral F-actin waves, which propagate by actin polymerization 
and treadmilling 
131
.  This differed from FAs, in which integrin speckles moved coherently relative to the 
substrate as FAs released from the ECM and slid (Figure 2.3g and 
107
).  Furthermore, integrin speckles 
moved significantly faster in FAs as compared to in waves (Figure 2.3h).  Together, these results support 
the notion that U2OS integrin waves are distinct from podosomes, invadopodia and FAs. 
Ventral F-actin and integrin waves are ECM-dependent and require a cycle of integrin engagement to and 
disengagement from the ECM 
 
Next, we sought to determine if integrins in ventral waves were interacting with the ECM.   To 
determine if integrin appearance in ventral waves corresponded to the membrane contacting the ECM,  
we performed Interference Reflection Microscopy (IRM) and TIRFM imaging of cells expressing αV 
integrin-mCherry.  Dark areas in IRM images indicate regions of the plasma membrane in very close  
 (~10-30 nm) proximity to the coverslip 
144
.  This showed that integrin waves co-localized with regions of 
local IRM darkening (Figure 2.4a-b). To determine if ventral F-actin waves were coupled to adhesion in 
cells without expression of exogenous integrin, we performed IRM and TIRFM of cells expressing F-
tractin-GFP (Figure 2.4c-d).  This revealed that ventral F-actin waves were followed by IRM darkening, 
similar to the dynamics of αv integrin relative to those of F-actin.  Indeed, analysis of when αv integrin or F-
actin and inverse IRM reached half-maximal intensities in the region of a wave showed that dark areas in 
IRM appeared simultaneous with integrin appearance (-13.7 ±16.4sec after integrin, n=19) and followed 
F-actin appearance (48 ± 30sec after F-actin, n=12) (Figure 2.4e).  These results suggest that when 
integrins appear after ventral F-actin waves, they bring the membrane into close proximity to the 
substrate, and that integrin waves are not an artifact of αVβ3 integrin over-expression.   
We next sought to determine if ventral F-actin and integrin wave formation and/or propagation 
require integrin-ECM engagement.  To test the requirement of ECM, we plated cells transfected with F-
tractin-GFP and αV integrin-tagRFP on either 5µg/mL fibronectin or 0.01% poly-L-lysine-coated coverslips 
(Figure 2.5a).  Analysis of ventral F-actin and integrin wave frequency showed that both ventral F-actin 
and integrin waves were inhibited in cells plated on poly-L-lysine (n=19) compared with cells on 
fibronectin (n=15). Although we imaged cells soon after plating, immunostaining revealed low levels of 
secreted fibronectin on poly-L-lysine-coated coverslips, suggesting that cells exhibiting ventral F-actin and 
integrin waves on poly-L-lysine could still be responding to ECM (data not shown).  To further test the  
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Figure 2.4.  Integrin waves and ventral F-actin waves are visible by Interference Reflection 
Microscopy  
 
(a) LEFT: Interference reflection microscopy (IRM) and total internal reflection (TIRF) images of a U2OS 
cell expressing αV integrin-mCherry.  Inset (yellow box) shows focal adhesion morphology in IRM and 
TIRF.  Scale bar = 10µm.  RIGHT: Images from a time-lapse series from the regions highlighted by a 
magenta box, time in min shown. Scale bar = 5µm.  (b) Normalized average intensity of αV integrin-
mCherry (red) and inverted IRM intensity (blue) over time in the regions highlighted by a magenta in (a, 
left).  (c) LEFT: Interference reflection microscopy (IRM) and total internal reflection (TIRF) images of a 
U2OS cell expressing F-tractin-GFP to label actin filaments.  Scale bar = 10µm.  
RIGHT: Images from a time-lapse series from the regions highlighted by a magenta box, time in min 
shown. Scale bar = 5µm.  (d) Normalized average intensity of F-tractin-GFP (green) and inverted IRM 
intesnsity (blue) over time from the region highlighted in (c, left).  (e) IRM lag time to rise to half-maximal 
inverted intensity, relative to rise to half maximal intensity of F-tractin and Integrin.  The lag time between 
when αv integrin or F-tractin reached half-maximal intensity and when IRM reached half-maximal intensity 
was measured in multiple cells.  Actin intensity increase precedes IRM inverted intensity increase, while 
integrin intensity and IRM inverted intensity increase simultaneously.  Values are represented as mean ± 
SD. 
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requirement of ECM for ventral F-actin and integrin waves, we plated cells expressing F-tractin-GFP and 
αV integrin-tagRFP on increasing concentrations of fibronectin.  We found that both ventral F-actin and 
integrin wave frequency increased in a dose-dependent manner (Figure 2.5b). These results suggest that 
formation of ventral F-actin and integrin waves is ECM-dependent.   
We next plated cells on fibronectin in the presence or absence of the function-blocking LM609 
antibody to αVβ3 integrin (Figure 2.5c 
145
).  αV integrin-tagRFP did not localize to paxillin-EGFP labeled 
adhesions in cells plated on fibronectin in the presence of 20µg/mL LM609, confirming that 20µg/mL of  
LM609 is sufficient to block αVβ3 interaction with fibronectin (data not shown).  Analysis of ventral F-actin 
wave frequency showed that integrin waves, but not ventral F-actin waves, were inhibited in cells plated 
in the presence of 20µg/mL LM609 (n=16) compared with control cells (n=15).  To determine if the ventral 
F-actin waves observed in the presence of LM609 were dependent on β1 integrins, we plated cells in the 
presence of LM609 and the function-blocking P4C10 antibody to β1 integrin
146
. This resulted in fewer 
cells attached to the coverslip, likely due to adhesion defects (data not shown). However, analysis of 
wave frequency in cells that adhered and spread showed that both ventral F-actin and αV integrin waves 
were inhibited in the presence of LM609 and P4C10 (n= 13) compared with control cells (n= 15) (Figure 
2.5c). Thus, ventral F-actin and integrin waves require integrin activation. 
Since integrin waves require integrin engagement to the ECM and appear to propagate by 
treadmilling engagement to the ECM (Figure 2.3g), we sought to determine if they also required integrin 
disengagement from the ECM.  Mn
2+
 binds to the extracellular metal ion binding sites of integrin inducing 
conformational changes correlated with higher affinity binding to ligand and is commonly used to induce 
integrin activation 
147
.  We analyzed ventral F-actin and integrin wave frequency in cells expressing F-
tractin-GFP and αV integrin-tagRFP and treated with 2mM MnCl2 to induce integrin activation (Figure 
2.5d).  This revealed that MnCl2 significantly inhibited both ventral F-actin and integrin waves.  
Furthermore, imaging cells during perfusion revealed that MnCl2 produced an immediate effect on ventral 
F-actin and integrin waves by ceasing their motion and blocking their disassembly, essentially freezing 
them in place (Figure 2.5d).  Collectively, these results suggest that ventral F-actin and integrin wave 
formation and propagation require a cycle of integrin engagement to the ECM and disengagement from 
the ECM.  Together with our observation that integrin waves spatially and temporally follow ventral F-actin  
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Figure 2.5.  Ventral F-actin and integrin waves require integrin engagement to extracellular matrix  
  
(a) Ventral F-actin and integrin waves require ECM.  U2OS cells expressing F-tractin-GFP to label actin 
filaments and αV integrin-tagRFP were plated on either 5µg/mL fibronectin (FN) or 0.01% poly-L-lysine 
(PLL).  In A, B, and C, cells were imaged for 10 min and the average number of waves per min per µm
2
 
was measured.  P-values determined with Student’s t-test. n=number of cells analyzed.  (b) Ventral F-
actin and integrin waves are sensitive to FN concentration.  U2OS cells expressing F-tractin-GFP and αV 
integrin-tagRFP were plated on increasing concentrations of FN (1µg/mL, 5µg/mL and 10µg/mL).  (c) 
Integrin waves require integrin engagement to ECM.  U2OS cells expressing F-tractin-GFP and αV 
integrin-tagRFP were plated on 5µg/mL FN in the presence of 20µg/ml LM609 antibody to block αVβ3 
binding to FN (“αVβ3”) or 20µg/ml LM609 antibody + P4C10 (1:20 dilution) to block αVβ3 and β1 binding to 
FN (“αVβ3 + β1”).  (d) Effect of MnCl2 on ventral F-actin and integrin waves.  Cells expressing F-tractin-
GFP and αV integrin-tagRFP were imaged 15min prior to and 30min after perfusion of 2mM MnCl2.  We 
measured the number of waves per min (“frequency”) before and after MnCl2 was added.  We determined 
the effects of MnCl2 on waves by dividing the post-drug frequency by the pre-drug frequency for each cell 
imaged.  A value greater than one reflects an increase in wave frequency after drug addition, while a 
value less than one reflects a decrease in wave frequency after drug addition.  n=number of cells 
analyzed.  Data are represented as mean ± SD; P-values determined with Student’s t-test.  (e) Total 
internal reflection fluorescence microscopy (TIRFM) images of a U2OS cell expressing F-tractin-GFP and 
αV integrin-tagRFP immediately prior to (LEFT) and after (CENTER) perfusion of 2 mM MnCl2 addition.  
RIGHT:  Kymograph along the trajectory of ventral F-actin wave propagation (highlighted with yellow 
arrows).  MnCl2 stops the propagation of both F-actin and integrin waves.  Scale bar = 10µm.  (f) Effect of 
Dynasore hydrate (Dyn) on integrin waves.  Cells expressing either αV integrin-EGFP were imaged by 
TIRFM during perfusion of Dyn.  We measured the number of waves per min (“frequency”) before and 
after Dyn was added.  We determined the effects of Dyn. on integrin waves by dividing the post-drug 
frequency by the pre-drug frequency for each cell imaged.  n=number of cells analyzed.  Data are 
represented as mean ± SD; P-values determined with Student’s t-test.   
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waves and require actin polymerization, these results further suggest a positive feedback loop between 
integrin adhesion and Arp2/3-mediated actin polymerization in ventral F-actin waves.   
To determine if U2OS integrin waves required endocytic recycling of integrins
148
, we imaged αV 
integrin-tagRFP during perfusion of Dynasore hydrate (to inhibit dynamin GTPase activity, 80 M). 
Dynasore hydrate did not affect integrin wave frequency, suggesting that integrin waves do not require 
dynamin-mediated endocytosis of integrins for their turnover (Figure 2.5f).  These results suggest that 
integrin waves do not require recycling of integrins from the plasma membrane, but rather require a cycle  
of activation and inactivation of integrins already at the cell surface.  We conclude that ventral F-actin 
waves are adhesive structures that consistently recruit and activate integrins to engage with the ECM.   
We will henceforth refer to these actin- and integrin- containing ventral wave structures as “adhesive F-
actin waves”.   
Adhesive F-actin waves contain focal adhesion proteins that assemble and disassemble in a distinct 
stepwise order 
 
Since actin does not directly bind integrin, we sought to determine what proteins may be involved 
in coupling actin polymerization to integrin adhesion in adhesive F-actin waves.  We co-expresssed 
fluorescently tagged FA adapter and actin-binding proteins together with αV -integrin-tagRFP and imaged 
by TIRFM to identify proteins that localized to adhesive F-actin waves.  This revealed that zyxin-EGFP, 
VASP-venus, paxillin-EGFP, vinculin-EGFP and talin-EGFP all localized to αV integrin-tagRFP containing 
adhesive F-actin waves (Figure 2.6a, left).  However, kymograph analysis of time-lapse images revealed 
that many of these proteins did not temporally coincide with the appearance of αV integrin, but, similar to 
F-actin, preceded αV integrin appearance in ventral F-actin waves (Figure 2.6a, center).  To confirm that 
FA protein expression did not promote association with ventral F-actin waves, we immunolocalized 
endogenous paxillin and F-actin in fixed U2OS cells and found that endogenous paxillin was associated 
with ventral F-actin wave-like structures (data not shown).  However, similar to fluorescently tagged 
proteins, F-actin and endogenous paxillin did not perfectly overlap; rather, they were separated into a 
region of F-actin, followed by a region of paxillin and F-actin colocalization, followed by a region of 
paxillin.   
To determine the order of protein assembly into adhesive F-actin waves, we analyzed the 
intensity of the various fluorescent FA proteins and αV integrin over time in a region through which a wave  
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Figure 2.6.  Focal adhesion (FA) proteins assemble into integrin waves in a precise order  
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(a) αV integrin-tagRFP (Int, red) was co-expressed with the following proteins: αV integrin-EGFP (Int, 
green), talin-EGFP (Tln, green), vinculin-EGFP (Vcl, green), paxillin-EGFP (Pax, green), VASP-Venus 
(VASP, green), zyxin-EGFP (Zyx, green), Arp3-GFP (Arp, green) and F-tractin-GFP (Act, green).   
LEFT: Total internal reflection fluorescence microscopy (TIRFM) images showing an inset (yellow box) of 
a ventral wave.  Still image was taken from a time series at the labeled time.  Scale bar = 10µm.  Inset 
scale bar = 5µm.  Yellow arrow indicates region of kymograph measurement.  CENTER:  Kymograph 
along the trajectory of integrin wave propagation.  The yellow arrow corresponds to the arrow in (A, left) to 
demonstrate the direction of wave propagation as well as the time the still image corresponds to in the 
kymograph. Cells imaged at 20sec intervals.  Kymograph region = 10µm.  RIGHT: Representative 
quantification of normalized average fluorescence intensity (“Intensity”) over time for ventral waves in 
cells imaged at 5sec intervals.  (b) Average lag time between when fluorescence intensity of FA proteins 
and αV integrin rise to half-maximal.  In B and C, the graphs represent the mean and standard deviation of 
n>10 integrin wave measurements per condition.  Brackets denote lag-times that do not significantly differ 
from each other as determined by Student’s t-test.  (c) Average lag time between when fluorescence 
intensity of FA proteins and αV integrin fall from peak to half-maximal.   
 
 
propagated (Figure 2.6a, right), and measured the lag time between when the FA protein and αV integrin 
intensities rose to half-maximal (Figure 2.6b).  We used co-expression of αV -integrin-EGFP with αV -
integrin-tagRFP as a control.  Statistical analysis revealed that proteins were recruited to adhesive F-actin 
waves in five distinct temporal steps: 1. F-actin and Arp3 appear (half maximal intensity reached 99 ± 47 
and 75 ± 27sec before αV -integrin, respectively); 2.  Zyxin and VASP appear (half maximal intensity 
reached 42 ± 12 and 43 ± 14sec before V integrin, respectively); 3. Paxillin and vinculin appear (half 
maximal intensity reached 31 ± 16 and 25 ± 12sec before V integrin, respectively); 4. Talin appears (half 
maximal intensity reached 12 ± 10sec before αV integrin); 5.  Integrin appears (αV  integrin-EGFP reached 
half maximal intensity 1 ± 10sec before αV integrin-tagRFP) (Figure 2.6b).  Similarly, we determined 
adhesive F-actin wave disassembly order by measuring the lag time between when the FA protein and αV  
integrin intensities fell from peak to half-maximal intensity (Figure 2.6c).  This showed that wave 
disassembly was also hierarchical and largely mirrored the assembly process: 1. F-actin and Arp3 
dissociate (half maximal intensity reached 112 ± 27 and 110 ± 35sec before αV integrin, respectively); 2. 
Zyxin and VASP dissociate (half maximal intensity reached 73 ± 21 and 80 ± 25sec before V integrin, 
respectively); 3. Paxillin, vinculin and talin dissociate (half maximal intensity reached 41 ± 22, 42 ± 11 and 
32 ± 16sec before αV integrin, respectively); 4. Integrin dissociates (half maximal intensity of αV integrin-
EGFP reached 2 ± 11sec before αV integrin-tagRFP) (Figure 2.6c).  Measurements did not differ when 
images were acquired in the reverse order (i.e. green before red vs. red before green, data not shown).   
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Together, these results show that adhesive F-actin waves contain many FA proteins that assemble and 
disassemble in a distinct stepwise order. 
2.4 Discussion 
We show here that ventral F-actin waves are associated with integrin-based ECM adhesion in 
“adhesive F-actin waves.” Adhesive F-actin waves represent a novel type of integrin-mediated adhesion 
complex that is distinct from previously described integrin-based structures including podosomes, 
invadopodia and FAs.  These findings also support the notion of an inherent coupling between Arp2/3-
mediated actin polymerization at the plasma membrane and integrin-based adhesion.  We show that 
integrin waves spatially and temporally follow ventral F-actin waves and require actin polymerization, 
suggesting that integrin adhesion is downstream of Arp2/3-mediated actin polymerization.  However, we 
find that ventral F-actin waves require a cycle of integrin engagement and disengagement for formation 
and propagation, since removing fibronectin, blocking αVβ3 and β1 integrin activation, or treating with 
MnCl2 inhibited ventral F-actin waves.  This suggests that while integrin appearance in waves is 
downstream of actin polymerization, there could be a positive feedback between integrin engagement 
and induction of actin polymerization.  For example, an integrin-PI3K-Rac signaling cascade has been 
shown promote Arp2/3 activation and actin polymerization 
149
 (Figure 2.7).  However, future work will 
need to address the contribution of downstream targets of integrin signaling to fully understand the 
relationship between integrin adhesion and actin polymerization in ventral F-actin waves. 
Although the function of adhesive F-actin waves is not known, several intriguing possibilities exist.  
First, adhesive F-actin waves could be a weaker adhesion structure than FAs that could be involved in 
ameboid migration modes.  Alternatively, since they are more dynamic than FAs and sensitive to ECM 
concentration, adhesive F-actin waves could be a mechanism to sense the surrounding matrix and 
promote actin polymerization where there is a higher concentration of ECM, thus possibly contributing to 
haptotaxis.  Adhesive F-actin waves were induced upon inhibition of myosin ATPase activity with 
blebbistatin, suggesting that they could be sensitive to global or local decreases in cortical tension.  Thus 
while canonical focal adhesions form and reorganized the cytoskeleton to adapt to an increase in 
actomyosin tension, perhaps adhesive F-actin waves form and reorganize the cytoskeleton to adapt to a 
decrease in actomyosin tension.   
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Ventral F-actin waves could be regulated differently in different cell types, possibly due to 
differences in Arp2/3 activators.  Regardless of any differences in events upstream of actin 
polymerization, we have shown that integrin recruitment to ventral F-actin waves is common for all the 
mammalian cells analyzed.  These findings support the idea that Arp2/3-mediated actin polymerization at 
the plasma membrane is inherently coupled to integrin-mediated adhesion, possibly through the 
molecular interactions of FAK and vinculin or through force-induced changes in integrin conformation by 
actin polymerization 
76,84,85
.  Thus, an important role of Arp2/3 actin polymerization is to organize integrin 
adhesion 
82,83
.        
Our results suggest a speculative hierarchical model of adhesive F-actin wave assembly and 
disassembly based on the average wave lifespan of 7 min (Figure 2.7).  First, Arp2/3 mediates actin 
polymerization.  ~50sec later, the adapter and actin regulatory proteins zyxin and VASP are co-recruited, 
likely to regulate F-actin barbed end assembly. This is followed rapidly by co-recruitment of the VASP- 
and actin-binding protein vinculin and its binding partner, the adapter protein paxillin, at ~60s.  At 80s, the 
actin and integrin binding protein talin is recruited, possibly by interaction with vinculin.  Talin association 
with ventral F-actin waves then presumably facilitates the inside-out activation of integrin and induces 
ECM adhesion.  ~310sec after initial polymerization in adhesive F-actin waves, F-actin depolymerizes 
and Arp2/3 dissociates.  By 340s, VASP and zyxin co-disassemble, followed by paxillin, vinculin, and talin 
co-disassembly at 380s.  Finally, at 420sec integrin dissociates from adhesive F-actin waves by 
inactivation, and the membrane is no longer tethered to the ECM.  The co-assembly and -disassembly of 
groups of proteins that are known to bind to one another (zyxin and vasp; paxillin and vinculin) suggests 
they may interact with adhesive F-actin waves as pre-formed complexes, just as paxillin-vinculin and 
zyxin-VASP have been observed to enter focal adhesions as pre-formed cytoplasmic complexes 
72
.   
The order of adhesive F-actin wave assembly, in which the recruitment of FA adapter and actin-
binding proteins precedes integrin recruitment and activation, appears to differ dramatically from the 
assembly of FAs.  It is well-accepted that integrin activation by talin is the first step in FA assembly, 
followed by recruitment of cytosolic FA proteins 
150
.  However, FA assembly and turnover is a complex,  
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Figure 2.7. Speculative model of adhesive F-actin wave assembly and disassembly 
Speculative model of adhesive F-actin wave assembly and disassembly, based on the average wave 
lifetime of 7min.  First, Arp2/3 mediates actin polymerization.  ~50sec later, the adapter and actin 
regulatory proteins zyxin and VASP are co-recruited, likely to regulate F-actin barbed end assembly. This 
is followed rapidly by co-recruitment of the VASP- and actin-binding protein vinculin and its binding 
partner the adapter protein paxillin at ~60s.  At 80s, the actin and integrin binding protein talin is recruited, 
possibly by interaction with vinculin.  Talin association with ventral F-actin waves then presumably 
facilitates the inside-out activation of integrin and induces ECM adhesion.  ~310sec after initial 
polymerization in adhesive F-actin waves, F-actin depolymerizes and Arp2/3 dissociates.  By 340s, VASP 
and zyxin co-disassemble, followed by paxillin, vinculin, and talin co-disassembly at 380s.  Finally, at 
420sec integrin dissociates from adhesive F-actin waves by inactivation, and the membrane is no longer 
tethered to the substrate.  A possible positive feedback loop between integrin adhesion and actin 
polymerization with unknown timing is denoted by dashed arrows, as described in the discussion. 
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hierarchical process involving a series of decision points.  Initially, diffraction limited “nascent adhesions” 
containing β1 integrin and paxillin form coupled to lamellipodial actin assembly and independently of 
myosin II activity, reminiscent of the coupling of actin assembly to integrin adhesion in adhesive F-actin 
waves.  Nascent adhesions subsequently either disassemble rapidly ~75sec after formation, or undergo 
myosin II-dependent “adhesion maturation” 
51
.  Adhesion maturation is characterized by further 
recruitment of integrins and additional cytosolic proteins such as vinculin and zyxin to lengthen nascent 
adhesions into focal complexes and facilitate additional growth into mature FA.  Mature FA then either 
disassemble or continue to grow into fibrillar adhesions that remodel ECM 
150
.   Mature focal adhesions 
are organized into distinct vertical layers with paxillin localized with integrin near the plasma membrane, 
while VASP and zyxin are colocalized with actin >50nm above the membrane
57
.  The talin head 
colocalizes with integrin near the membrane, while the tail is extended ~30nm higher, such that the 
majority of vinculin binding sites in the rod domain localize ~10-30nm above the membrane 
57
.  Thus, the 
assembly order of proteins into focal adhesions may reflect that they are assembled from the plasma 
membrane up, while the reverse assembly order of adhesive F-actin waves may reflect that they are 
assembled from the actin cytoskeleton down.  
Both nascent adhesion and adhesive F-actin wave formation require actin polymerization and are 
independent of myosin II; however, in spite of these similarities, the long lag time (~1 min) between 
assembly of FA proteins and activation of integrins in adhesive F-actin waves and the fact that these 
structures never mature into FAs suggest that adhesive F-actin waves are different from nascent 
adhesions.  Since the rapid assembly rate of nascent adhesions (~1sec vs ~80sec for adhesive F-actin 
wave assembly) has precluded determination of a temporal hierarchy of protein recruitment, it is not yet 
possible to directly compare nascent adhesion assembly with the adhesive F-actin wave assembly 
hierarchy demonstrated in this study.  Therefore, we cannot rule out the possibility that adhesive F-actin 
wave assembly may reflect a more general mechanism of adhesion assembly, only on a different time-
scale.  Future work should aim to determine which FA proteins are required for adhesive F-actin wave 
propagation and if these proteins have similar roles in FA and adhesive F-actin waves.  This study 
presents an initial characterization of the morphology, dynamics, ECM-dependence, and assembly 
mechanism of adhesive F-actin waves and provides compelling evidence that adhesive F-actin waves 
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represent a novel integrin-mediated adhesion complex distinct from previously characterized integrin-
containing adhesion structures.  
2.5 Experimental Procedures 
Cell culture, Transfection, and Reagents 
U2OS cells were obtained from American Type Culture Collection (ATCC, Manassas, VA, USA) 
and maintained at 37°C in McCoy’s 5A medium supplemented with 10% FBS (Gibco Labs) at 5% CO2. 
B16-F10 cells were obtained from ATCC and maintained at 37°C in DMEM (Gibco Labs, Carlsbad, CA, 
USA) supplemented with 10% FBS at 5% CO2.  Primary Mouse Embryonic Fibroblasts (MEFs) were 
isolated as follows.  Animals were maintained according to the protocol approved by the NHLBI Animal 
Care & Use Committee on 12/08/2010.  Mice were kept on a C57J/BL6 background.  E13.5 embryos 
were dissected from pregnant females, obtained from timed matings, and decapitated before internal 
organs were removed.  Remaining tissue was cut into pieces and incubated 3 x 10 min in 0.25 mg/ml 
Trypsin/EDTA (Life technologies, Carlsbad, CA, USA).  Single cells were transferred into DMEM 
supplemented with 20% FBS after each incubation. Pooled suspensions were passed through 100µm 
nylon mesh, and cells were pelletted (5 min, 1200 rpm) and plated.  Non-adherent cells were removed 
after 2h and cultures were maintained in DMEM supplemented with 20% FBS at 5% CO2.  MEFs were 
used for experiments at passage 2-3.  Transfections were performed using a Nucleofector (U2OS: 
solution V, program X-001; B16: solution V, program P-020; MEF: solution MEF1, program T-020. Lonza, 
Basel, Switzerland).  For experiments, cells were plated for 16-20 hrs prior to imaging on 22 x 22mm #1.5 
coverslips pre-coated with 5 µg/ml fibronectin (2 hr at 37°C, Millipore, Billerica, MA). For determining 
ECM-dependence, 22 x 22mm #1.5 coverslips pre-coated with 0.01% poly-L-Lysine (7 min at 20°C, 
washed 10 times, Sigma-Aldrich, St. Louis, MO, USA). Imaging was performed in growth media without 
phenol red and supplemented with 30 units/mL Oxyrase. The following pharmacological inhibitors were 
used: 2µM Latrunculin A (Invitrogen, Carlsbad, CA, USA), 2µM Cytochalasin D (Enzo Life Sciences, 
Plymouth Meeting, PA, USA), 40µM LY294002 (Calbiochem, Darmstadt, Germany), 100µM NSC23766 
(EMD Chemicals), 20µM blebbistatin (Torronto Research Chemicals, North York, Ontario, Canada), 80 
µM Dynasore Hydrate (Sigma-Aldrich, St. Louis, MO, USA), 2mM MnCl2 (Sigma-Aldrich, St. Louis, MO, 
USA).   
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The following antibodies were used: LM609 (Millipore, Billerica, MA), P4C10 (Millipore, Billerica, 
MA), rabbit anti-fibronectin (for immunofluorescence at 1:400, Sigma-Aldrich, St. Louis, MO, USA), mouse 
anti-paxillin (for immunofluorescence at 1:250, BD Transduction Labs, Franklin Lakes, NJ, USA). Alexa 
488 phalloidin was obtained from (Invitrogen, Carlsbad, CA, USA). Immunofluorescence staining was 
performed as described in 
151
. The following cDNA expression constructs were used: EGFP conjugates of 
talin, paxillin and zyxin were described previously 
107
;  vinculin-EGFP, αV integrin-tagRFP, αV integrin-
mCherry, αV integrin-EGFP, and VASP-Venus were provided by Mike Davidson (Florida State University, 
Tallahassee, FL), β3 integrin was provided by Mark Ginsberg (UCSD); Arp3-GFP was provided by John 
Hammer (NHLBI, Bethesda, MD); F-tractin-GFP and F-tractin-tdTomato were provided by Mike Schell 
(Uniformed Services University of Health Sciences, Bethesda, MD).    
Microscopy 
Dual-color time-lapse TIRF microscopy of EGFP and tagRFP or td-Tomato tagged proteins in 
living cells was performed at 37ºC using an Apo TIRF 100x 1.49 NA oil immersion objective lens (Nikon 
Instruments, Melville, NY, USA) on an inverted TE2000E2 microscope system (Nikon Instruments, 
Melville, NY, USA, 
152
 with an evanescent field depth of ~150 nm.  Pairs of EGFP (using 488nm laser 
illumination) and tagRFP or tdTomato (using 561nm laser illumination) images were captured in rapid 
succession at 20-sec or 5-sec intervals using an EMCCD (Cascade II:1024; Photometrics, Tuscon, AZ, 
USA) operated in the 5 MHz readout mode using EM gain.  Confocal images of V integrin-EGFP and 
phase contrast images were captured using a Plan Apo 100x 1.40NA Ph oil immersion objective lens on 
an inverted TE2000E2 microscope system (Nikon Instruments, Melville, NY, USA,
152
 equipped with a 
spinning disk confocal scan head (CSU-X; Yokogawa, Tokyo, Japan). Pairs of EGFP and phase contrast 
images were captured in rapid succession at 20-sec intervals using a CCD camera (CoolSNAP HQ2; 
Photometrics, Tuscon, AZ) operated in the 14-bit mode.  Interference reflection microscopy was 
performed using an Apo TIRF 100x 1.49 NA oil immersion objective lens (Nikon Instruments, Melville, NY, 
USA).  Illumination was provided by a mercury arc lamp and a 640/30 bandpass excitation filter (Chroma 
Technology Corp, Bellows Falls, VT, USA) with a multi-bandpass TIRF dichromatic mirror (Chroma 
Technology Corp, Bellows Falls, VT, USA) and a DIC analyzer (Chroma Technology Corp, Bellows Falls, 
VT, USA) in the emission filter wheel to reduce image intensity.  Pairs of IRM and either mCherry or GFP 
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images were captured in rapid succession at 20-sec intervals using an EMCCD camera (Cascade II:1024; 
Photometrics, Tuscon, AZ) operated in the 5 MHz readout mode using EM gain.  Fixed cells were imaged 
using an Apo TIRF100x 1.49 NA plan objective lens (Nikon Instruments, Melville, NY, USA) and an 
inverted TE2000E2 microscope system (Nikon Instruments, Melville, NY, USA, 
152
.  Cells were imaged 
with widefield epi-illumination and with TIRF as described above. Drug perfusion during high resolution 
imaging was performed using an RC-30 perfusion chamber (Warner Instruments, Hamden, CT, USA) as 
described in 
151
. 
Analysis 
All image analyses were performed using Metamorph software (MDS Analytical Technologies, 
Downingtown, PA, USA).  Ventral F-actin waves were defined as moving F-actin features that underwent 
>30% increase in F-tractin average fluorescent intensity, had a lifetime between 1min and 15min, and an 
area >1.5 µm
2
.  Kymographs were created from lines drawn along the path of wave propagation, and the 
velocity of ventral wave propagation was calculated from the slope of these kymographs.  Quantitative 
analysis of the dynamics of EGFP-tagged proteins and αV integrin-tagRFP in ventral waves was 
performed as follows.  Images were background corrected and the average intensity of the entire cell over 
the time-lapse was fit to a double-exponential for photobleaching correction.  Circular regions of at least 
1.6 µm
2
 were drawn around waves in the EGFP channel, and the average fluorescent intensity in both 
channels was recorded for each point in the time-series.  The average of intensities of the 8 frames 
immediately prior to fluorescence increase was subtracted from all measurements in the series and the 
values were then normalized to the maximal intensity in the series, so that the normalized intensity 
ranged from 0-1.  To compare assembly and disassembly dynamics of different molecules, lag times were 
measured from these normalized values.  To determine differences in assembly dynamics we measured 
the lag time between when F-tractin and integrin reached half-maximal intensity, and to determine 
differences in disassembly dynamics we measured the lag time between when F-tractin and integrin 
decreased from peak to half-maximal intensity.  IRM images were inverted, so that for a 12-bit image, an 
intensity of 0 became 4095 and an intensity of 4095 became 0.  TIRF-IRM quantitative analysis of wave 
dynamics was performed as for fluorescent protein pairs, except using the values for inverted IRM 
intensity.   
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CHAPTER 3: ADHESIVE F-ACTIN WAVES ARE INHIBITED BY THROMBIN-INDUCED MYOSIN 
CONTRACTILITY IN ENDOTHELIAL CELLS 
3.1 Summary 
  Adhesive F-actin waves are sites of Arp2/3-mediated actin polymerization coupled to integrin 
adhesion to the extracellular matrix.  Adhesive F-actin waves have been observed to spontaneously form 
near the ventral cell surface of many cells and were recently implicated to help heal wounds in endothelial 
cells following leukocyte transmigration across the endothelium.  Endothelial barrier integrity is regulated 
by “vascular permeability factors,” such as VEGF, TNFand thrombin, which can signal through 
RhoGTPases to remodel the endothelial actin cytoskeleton.   Thus, we sought to test the hypothesis that 
adhesive F-actin waves are regulated downstream of vascular permeability factors.  We found that resting 
HUVECs form adhesive F-actin waves containing v integrin and paxillin.  Adhesive F-actin waves are 
not contact-inhibited and do not degrade the extracellular matrix. Adhesive F-actin waves were inhibited 
by acute treatment with thrombin and TNFand thrombin-mediated inhibition of adhesive F-actin waves 
requires ROCK activity.  Thus, adhesive F-actin waves are inhibited by physiologically-induced myosinII 
contractility in endothelial cells.   
3.2 Introduction 
The vascular endothelium forms a barrier between circulating blood and the interstitium, and 
endothelial dysfunction contributes to atherosclerosis, edema, ischemia, and tumor angiogenesis
153–155
.  
Endothelial cells attach to each other by intercellular adherens junctions, tight junctions, and gap 
junctions, and the ventral surface of endothelial cells is connected to the basement membrane via 
integrins
156
.  This monolayer of endothelial cells must maintain barrier integrity despite the mechanical 
stresses of fluid shear, tissue stretching, and hydrostatic pressure.  Additionally, leukocytes are able to 
migrate thru the endothelial barrier, either via paracellular gaps or transcellular pores
157
.  Thus, 
endothelial cells must rapidly remodel their cytoskeleton and adhesions to maintain a barrier while 
allowing for regulated leukocyte transmigration.   
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Endothelial monolayer permeability is regulated by a variety of growth factors and cytokines 
released during inflammation to promote leukocyte-endothelial cell adhesion, modulate junctional integrity 
of the endothelium, and induce changes in the endothelial actin cytoskeleton
156,157
.  For example, 
vascular endothelial growth factor (VEGF) binds the VEGF receptor tyrosine kinase and activates Src, 
PKC and PI3K signaling pathways, tumor necrosis factor alpha (TNF) is a proinflammatory cytokine that 
activates NF-kB and MAPK, and thrombin is a protease that regulates protease activated receptors to 
activate RhoA
158–160
.  However, VEGF, TNF and thrombin can all stimulate remodeling of the actin 
cytoskeleton by signaling through RhoGTPases to promote stress fiber formation, myosin contractility or 
actin polymerization
161,162
.  Thus, the endothelial actin cytoskeleton is dynamically regulated during 
inflammation and leukocyte transmigration.      
Recently, adhesive F-actin waves and ventral lamellipodia were implicated in healing the 
endothelial microwounds remaining on the ventral cell surface after leukocyte transmigration or 
mechanical wounding
121
.  Adhesive F-actin waves are sites of Arp2/3-mediated actin polymerization 
coupled to integrin adhesion, but not membrane protrusion.  Adhesive F-actin waves have been observed 
in diverse cell types and can be induced by inhibiting myosinII activity
163
.  Actin polymerization in 
endothelial adhesive F-actin waves was proposed to be induced by the local decrease in cortical tension 
after leukocyte transmigration
121
.  Since the endothelial actin cytoskeleton is regulated by vascular 
permeability factors, we sought to understand whether adhesive F-actin waves were regulated 
downstream of VEGF, TNF or thrombin.  We found that unstimulated human umbilical vein endothelial 
cells (HUVECs) form constitutive adhesive F-actin waves containing actin, integrin and paxillin.  Adhesive 
F-actin waves form in both sparsely plated cells and in confluent monolayers, suggesting that adhesive F-
actin waves form independently of cell-cell junctions.  We found that adhesive F-actin waves are inhibited 
by TNF and thrombin, and thrombin inhibits adhesive F-actin waves by stimulating myosinII activity 
through Rho kinase (ROCK).   We propose that adhesive F-actin waves are regulated by mechanical 
tension in endothelial cells.  Vascular permeability factors such as thrombin induce myosin contractility 
leading to an inhibition of adhesion F-actin waves.  However, as previously observed
121
, following 
leukocyte transmigration, there is a local decrease in tension, triggering the formation of adhesive F-actin 
waves to help repair the ventral actin cytoskeleton.   
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3.3 Results 
Adhesive F-actin waves spontaneously form in resting endothelial cells 
Adhesive F-actin waves are an integrin-mediated adhesion complex coupled to ventral actin 
polymerization and were recently observed in vascular endothelial cells
121,163
.  To characterize adhesive 
F-actin waves in endothelial cells, we transfected human umbilical vein endothelial cells (HUVECs) with 
the F-actin-binding probe F-tractin-GFP (Inositol 1,4,5-Trisphosphate 3-Kinase A N66 actin binding 
domain fused to tdTomato 
138
) , V integrin-tagRFP and untransfected B3 integrin.  We plated HUVECs 
on 10µg/mL fibronectin and imaged by Total Internal Reflection Fluorescence Microscopy (TIRFM).  We 
observed spontaneous adhesive F-actin waves forming and propagating along the ventral cell surface of 
endothelial cells (Figure 3.1a).  Adhesive F-actin waves formed randomly in the cell center as well as the 
cell periphery (data not shown).  Similar to previously characterized adhesive F-actin waves in U2OS cells 
and MEFs, actin polymerization consistently preceded integrins appearance in adhesive F-actin waves.  
Dual color F-tractin and αV integrin kymographs revealed that while both waves propagated with a similar 
velocity and shape, ventral F-actin waves spatially and temporally preceded integrin waves in all cell 
types (Figure 3.1a, right).  To quantify the dynamics of ventral F-actin and integrin waves, we plotted the 
normalized (to maximal in the series) average intensity over time in a region through which a wave 
propagated (Figure 3.1b).  To determine differences in assembly dynamics, we measured the lag time 
between when F-tractin and integrin reached half-maximal intensity.  This analysis indicated that HUVEC 
ventral F-actin waves rise to half-maximal intensity an average of 24±19sec before αV integrin waves 
(n=70, Figure 3.1c).  Adhesive F-actin waves propagated with a velocity of 3.2±0.95 um/min (Figure 
3.1d), comparable to adhesive F-actin wave dynamics in other cell types
163
.   
Adhesive F-actin waves in U2OS cells recruit FA proteins, including paxillin, downstream of F-
actin polymerization
163
.  To confirm that endothelial adhesive F-actin waves contained FA proteins, we 
coexpressed actin-mApple with paxillin-GFP.  We found that paxillin localized to actin-mApple containing 
ventral waves, but paxillin did not perfectly colocalize with actin (Figure 3.1d).  Rather, actin localized to 
the front of the propagating wave while paxillin localized toward the back of the wave.  Thus, actin 
polymerization precedes the recruitment of both paxillin and integrin to adhesive F-actin waves.  
Furthermore, localization of actin-mApple to adhesive F-actin waves confirms that they are not an artifact  
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Figure 3.1.  HUVECs form adhesive F-actin waves containing integrin and paxillin 
 (a) LEFT: Total internal reflection fluorescence microscopy (TIRFM) image of a HUVEC expressing F-
tractin-GFP to label actin filaments (green) and v-integrin-tagRFP-GFP (red).  The white asterisk is to 
aid in orientation of the region.  CENTER: Images from a time-lapse series of the region highlighted by a 
yellow box, time in min shown.  The white asterisk is to aid in orientation of the region. 
RIGHT: Kymograph along the trajectory of ventral F-actin wave propagation (highlighted with a yellow 
arrow at t=5min) demonstrates that integrin appears after F-actin polymerization.  Time in min is on the x-
axis.  (b) Normalized average intensity of F-tractin-GFP (green) and αV integrin-tagRFP (red) over time.  
The average intensity in the green and red channels was measured in the region highlighted by a yellow 
box in (a) and the values were normalized to the maximal intensity in the time series.  To quantify 
assembly dynamics, we measured the lag time between when ventral F-actin and integrin waves reached 
half-maximal intensity.  (c) Average lag times determined as described in (b), represented as mean ± SD, 
n= number of adhesive F-actin waves analyzed.  (d) Ventral F-actin wave velocities measured in 
HUVECs expression F-tractin-GFP.  To measure ventral F-actin wave velocities, kymographs were made 
along the trajectory of F-actin wave propagation and the slope of the kymograph was measured.  
N=number of ventral F-actin waves analyzed.  (e) Total internal reflection fluorescence microscopy 
(TIRFM) image of a HUVEC expressing F-actin-mApple (red) and paxillin-GFP (green).  Still image is 
from a timelapse, and the white arrow points in the direction of wave movement.  Scalebar = 10 microns.       
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of F-tractin expression.  We conclude that, similar to U2OS cells, paxillin and integrin are recruited down 
stream of actin polymerization in endothelial adhesive F-actin waves. 
Adhesive F-actin waves are not contact-inhibited 
Integrin-based cell-ECM adhesions and cadherin-based cell-cell adhesions share many adaptor 
and signaling proteins, and there are many examples of cross-talk and coordination between these 
different adhesion structures
164
.  Additionally, inhibition of protrusion often occurs when two cells come 
into contact
165
.  To determine if adhesive F-actin waves were contact-inhibited in confluent endothelial 
cells, we transfected HUVECs with actin-mApple and paxillin-GFP, plated cells on 10ug/mL fibronectin at 
low or high density, and allowed them to grow for 24-48hrs.  Cells plated at low density (“sparse”) did not 
come into contact with neighboring cells, while cells plated at high density formed a monolayer 
(“confluent”).  We observed actin and paxillin containing adhesive F-actin waves in both sparse and 
confluent cells (Figure 3.2a-b).  To compare spare and confluent cells, we imaged randomly selected 
cells for 20min and counted the number of actin and paxillin containing adhesive F-actin waves per 
minute.  We observed the same number of adhesive F-actin waves in sparse and confluent cells (Figure 
3.2c).  Thus, adhesive F-actin waves form independently of cell-cell contacts and are not contact 
inhibited. 
Thrombin inhibits adhesive F-actin waves by the ROCK-dependent upregulation of myosinII contractility 
 Although VEGF, TNF and thrombin stimulate distinct signaling pathways to increase vascular 
permeability, they have all been observed to modulate RhoGTPase signaling to remodel the actin 
cytoskeleton
161
.  To determine if adhesive F-actin waves are induced or inhibited by these “vascular 
permeability factors”, we imaged actin-mApple and paxillin-GFP during perfusion of VEGF, TNF, or 
thrombin.  We imaged cells for thirty minutes, added the vascular permeability factor, and imaged the 
same cell for an additional thirty minutes.  We quantified the number of adhesive F-waves before and 
after stimulation and normalized to the pre-stimulated measurement.  Thus a normalized wave/min less 
than one represents a decrease in adhesive F-actin waves following stimulation.  We that TNF and 
thrombin significantly inhibited adhesive F-actin waves (Figure 3.3a-b).  Both TNF and thrombin induce 
myosinII contraction in endothelial cells through a RhoA/ROCK pathway
161,166,167
.  Since thrombin was the  
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Figure 3.2.  Adhesive F-actin waves are not contact inhibited 
(a) LEFT: Total internal reflection fluorescence microscopy (TIRFM) image of a densely plated HUVEC 
expressing F-actin-mApple (red) and paxillin-GFP (green).  The cell is in a confluent monolayer of 
transfected and untransfected cells.  White asterisks mark individual cells, visible by DIC (not shown).    
CENTER: Images from a time-lapse series of the region highlighted by a yellow box, time in min shown.  
RIGHT: Kymograph along the trajectory of ventral F-actin wave propagation (highlighted with a magenta 
arrow in (a)).  Time in min is on the x-axis.  (b) LEFT: Total internal reflection fluorescence microscopy 
(TIRFM) image of a sparsely plated HUVEC expressing F-actin-mApple (red) and paxillin-GFP (green).     
CENTER: Images from a time-lapse series of the region highlighted by a yellow box, time in min shown.  
RIGHT: Kymograph along the trajectory of ventral F-actin wave propagation (highlighted with a magenta 
arrow in (a)).  Time in min is on the x-axis.  (c) Quantification of the average number of actin and paxillin 
containing adhesive F-actin waves per cell in confluent and sparse HUVECs.  Graphs are represented as 
mean ± SD, n= number of cells analyzed. 
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Figure 3.3.  Thrombin inhibits adhesive F-actin waves through a RhoA-Rock pathway 
 
(a) Representative images of HVUECs expressing F-tractin-tTomato and Paxillin-GFP treated for 30min 
with DMSO (control), VEGF, TNFα, thrombin, or thrombin+Y-27632 (to inhibit ROCK).  Yellow white 
arrows point out adhesive F-actin waves.  Scale bar = 10 microns.  (b) Effects of DMSO (control), VEGF, 
TNF(TNF), thrombin (Throm), and Y-27632 (Y) on adhesive F-actin waves.  Cells expressing either 
actin-mApple and paxillin-GFP were imaged by TIRFM during perfusion of drugs.  We measured the 
number of waves per min (“frequency”) before and after the drugs were added.  We determined the 
effects of the drugs on waves by dividing the post-drug frequency by the pre-drug frequency for each cell 
imaged.  “Normalized waves/min” values greater than one reflects an increase in wave frequency after 
drug addition, while a value less than one reflects a decrease in wave frequency after drug addition.  
n=number of cells analyzed.  Data are represented as mean ± SD; P-values determined with Student’s t-
test.   
  
46 
 
strongest inhibitor of adhesive F-actin waves, we sought to test the hypothesis that thrombin inhibited 
adhesive F-actin waves by activating ROCK to increase myosin activity.  We pretreated HUVECs for 2hrs 
with Y-27632 to inhibit ROCK activity.  We then imaged Y-27632 treated cells for thirty minutes and 
stimulated with thrombin for an additional 30min.  In contrast to WT HUVECs, HUVECs pretreated with Y-
27632 exhibited frequent adhesive F-actin waves even after the addition of thrombin (Figure 3.3a-b).  We 
conclude that thrombin inhibits adhesive F-actin waves by the ROCK-dependent upregulation of myosinII 
contractility.     
Adhesive F-actin waves do not degrade the extracellular matrix 
Podosomes are punctate actin-rich adhesion structures that secrete proteases to degrade the 
ECM
168
.  Endothelial cells have previously been shown to form podosomes in response to PKC and 
CDC42 activation
169
.  Furthermore, podosomes are induced by treatment of HUVECs with VEGF or 
TNF.  To confirm that adhesive F-actin waves are distinct from podosomes in HUVECs, we compared 
endogenous adhesive F-actin waves with PMA-induced podosomes.  To induce canonical podosome 
formation, we plated HUVECs on OregonGreen-conjugated gelatin and treated with PMA for 30min to 
activate PKC prior to fixation and immunostaining (Figure 3.4a).  As previously reported
169
, we observed 
punctate podosomes containing actin, Arp3, cortactin, and low levels of paxillin, and the podosomes often 
assembled into rosette and belt structures (Figure 3.4a).  Podosomes colocalized with spots of matrix 
degredation, visible as black holes where the fluorescent gelatin was lost.  In contrast to PMA-treated 
HUVECs, wildtype HUVECs plated on fluorescent gelatin did not exhibit significant matrix degradation 
(Figure 3.4b).  Additionally, immunostaining revealed that adhesive F-actin waves containing F-actin, 
Arp3 and paxillin did not colocalize with matrix degradation (Figure 3.4b).  Adhesive F-actin waves also 
contained less cortactin than PMA-induced podosomes.  Finally, since adhesive F-actin waves are most 
clearly defined by their dynamic propagation, we transfected HUVECs with paxillin-GFP and plated them 
on Cy3-conjugated gelatin for live cell imaging.  We imaged cells with spinning-disk microscopy and 
found that paxilin waves propagated on fluorescent gelatin similar to fibronectin (Figure 3.4c).  
Kymograph analysis revealed that there was no decrease in gelatin intensity during or after paxillin wave 
propagation (Figure 3.4c, right).  We conclude that adhesive F-actin waves do not degrade the ECM and 
are distinct from PMA-induced podosomes.    
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Figure 3.4.  Adhesive F-actin waves do not degrade the ECM 
 
(a) HUVECs plated on OregonGreen-gelatin, stimulated with 200nM phorbol myristate acetate (PMA) for 
30min, fixed and immunostained for paxillin, Arp3, and cortactin.  Actin is labeled with fluorescent 
phalloidin.  (b) Control HUVECs plated on OregonGreen-gelatin, fixed and immunostained for paxillin, 
Arp3, and cortactin.  Actin is labeled with fluorescent phalloidin.  (c) LEFT: Spinning disk image of a 
HUVEC expressing paxillin-GFP (green) and plated on Cy3-gelatin (red).  CENTER: Images from a time-
lapse series of the region highlighted by a yellow box, time in min shown.  RIGHT: Kymograph along the 
trajectory of ventral F-actin wave propagation (highlighted with a yellow arrow at t=14).  Time in min is on 
the x-axis. 
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3.4 Discussion 
We show here that endothelial adhesive F-actin waves are inhibited during the physiological 
activation of myosinII contractility by thrombin.  Adhesive F-actin waves were present in confluent and 
sparsely plated HUVECs, suggesting that adhesive F-actin waves are not contact inhibited.  While 
adhesive F-actin waves contained paxillin and integrin, they did not degrade ECM.  We found that 
adhesive F-actin waves were inhibited downstream of the vascular permeability factors TNF and 
thrombin.  Thrombin was the strongest inhibitor of adhesive F-actin waves, and thrombin inhibits adhesive 
F-actin waves through ROCK.   
This study provides further evidence that adhesive F-actin waves are regulated by actomyosin 
contractility.  We previously observed that myosin inhibition stimulates adhesive F-actin waves in U2OS 
cells
163
, and others have speculated that decreased tension signals the formation of endothelial adhesive 
F-actin waves
121
.  We found that inhibition of adhesive F-actin waves downstream of thrombin required 
ROCK activity, suggesting that adhesive F-actin waves are inhibited by increased myosin contractility in 
thrombin-treated cells.  Thus, in U2OS cells the pharmalogical inhibition of myosin contractility induces 
adhesive F-actin waves, while in HUVECs the physiological stimulation of myosin contractility by thrombin 
inhibits adhesive F-actin waves.  This suggests that adhesive F-actin waves are a regulated by myosin II-
mediated cortical tension in diverse cell types.   
We also found that, unlike podosomes, endothelial adhesive F-actin waves do not degrade the 
ECM.  Interestingly, podosomes were previously shown to be induced by treatment of HUVECs with 
VEGF or TNF via a RhoA-dependent pathway
170
.  In contrast, adhesive F-actin waves are inhibited by 
treatment with TNF or thrombin, likely via a RhoA-dependent pathway.  Thus, conditions that promote 
podosomes inhibit adhesive F-actin waves, suggesting that podosomes and adhesive F-actin waves 
could be differentially regulated during inflammation.       
 We speculate that adhesive F-actin waves are involved in actively maintaining an intact, well-
adhered cortical actin cytoskeleton.  In resting endothelial cells, local fluctuations in cortical tension trigger 
adhesive F-actin waves to polymerize actin and maintain connection to the ECM.  However, during the 
immune response, leukocytes must breach the endothelial monolayer.  Vascular permeability factors 
such as TNF and thrombin activate RhoA, resulting in a ROCK-dependent increase in myosinII 
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contractility
161
.  This increased contractility not only pulls apart cell-cell junctions, but also globally inhibits 
adhesive F-actin waves.  As leukocytes transmigrate through transcellular or paracellular routes, the 
endothelial cytoskeleton is further disrupted and likely experiences fluctuations in local tension.  Following 
leukocyte transmigration, there is a local decrease in tension, triggering the formation of adhesive F-actin 
waves to help repair the ventral actin cytoskeleton and reestablish barrier integrity
121
.     
3.5 Experimental Procedures 
Cell culture, Transfection, and Reagents 
Primary HUVECs were obtained from Lonza and maintained in endothelial cell basal medium 
(EBM) supplemented with EGM-MV Single Quots (Lonza) at 37°C in 5% CO2. For live imaging, medium 
was supplemented with 25 mM Hepes, pH 7.2, and 30 U/ml Oxyrase. Transfection of DNA constructs was 
performed using a nucleofector (Amaxa Biosystems) with solution kit V (Lonza), setting A-034.  For 
imaging, cells were plated on 10g/mL fibronectin (Millipore) for 4-8 hours prior to imaging.  Gelatin 
coated coverslips were prepared as described
171
 using OregonGreen-gelatin (Molecular Probes) or Cy3-
Gelatin (Millipore).  The following pharmacological inhibitors were used: 10 µM Y-27632 ROCK inhibitor 
(EMD), 200nM phorbol myristate acetate (PMA, Sigma-Aldrich).  The following vascular permeability 
factors were used: 50nM vascular endothelial growth factor (VEGF, Invitrogen), 0.2U/mL Thrombin 
(Sigma-Aldrich), 20ng/mL tumor necrosis factor alpha (TNFa,Invitrogen).  The following cDNA expression 
constructs were used: EGFP conjugates of F-tractin, paxillin and aV integrin, mApple-actin, V-tagRFP, 
and F-tractin-tdTomato were described previously
88,163
.     
Microscopy 
Dual-color time-lapse TIRF microscopy of EGFP and tagRFP, mApple, or td-Tomato tagged 
proteins in living cells was performed at 37ºC using an Apo TIRF 100x 1.49 NA oil immersion objective 
lens (Nikon Instruments, Melville, NY, USA) on an inverted TE2000E2 microscope system (Nikon 
Instruments, Melville, NY, USA, 
152
 with an evanescent field depth of ~150 nm.  Pairs of EGFP (using 
488nm laser illumination) and tagRFP or tdTomato (using 561nm laser illumination) images were 
captured in rapid succession at 20-sec or 30-sec intervals using an EMCCD (Cascade II:1024; 
Photometrics, Tuscon, AZ, USA) operated in the 5 MHz readout mode using EM gain.  Confocal images 
of paxillin and fluorescent gelatin substrates were captured using a Plan Apo 60x 1.40NA oil immersion 
50 
 
objective lens on an inverted TE2000E2 microscope system (Nikon Instruments, Melville, NY, USA,
152
 
equipped with a spinning disk confocal scan head (CSU-X; Yokogawa, Tokyo, Japan). Images were 
captured using a CCD camera (CoolSNAP HQ2; Photometrics, Tuscon, AZ) operated in the 14-bit mode.  
Drug and growth factor perfusion during high resolution imaging was performed using an RC-30 perfusion 
chamber (Warner Instruments, Hamden, CT, USA) as described in 
151
. 
Analysis 
All image analyses were performed using Metamorph software (MDS Analytical Technologies, 
Downingtown, PA, USA).  Ventral F-actin waves were defined as moving F-actin features that underwent 
>30% increase in F-tractin average fluorescent intensity, had a lifetime between 1min and 15min, and an 
area >1.5 µm
2
.  Kymographs were created from lines drawn along the path of wave propagation, and the 
velocity of ventral wave propagation was calculated from the slope of these kymographs.  Quantitative 
analysis of the dynamics of F-tractin-EGFP and αV integrin-tagRFP in ventral waves was performed as 
follows.  Images were background corrected and the average intensity of the entire cell over the time-
lapse was fit to a double-exponential for photobleaching correction.  Circular regions of at least 1.6 µm
2
 
were drawn around waves in the EGFP channel, and the average fluorescent intensity in both channels 
was recorded for each point in the time-series.  The average of intensities of the 8 frames immediately 
prior to fluorescence increase was subtracted from all measurements in the series and the values were 
then normalized to the maximal intensity in the series, so that the normalized intensity ranged from 0-1.  
To determine differences in assembly dynamics we measured the lag time between when F-tractin and 
integrin reached half-maximal intensity. 
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CHAPTER 4: USING INTERFEROMETRIC PHOTOACTIVATED LOCALIZATION MICROSCOPY 
(“iPALM”) TO STUDY FOCAL ADHESION NANOSCALE ARCHITECTURE 
4.1 Introduction 
 Focal adhesions (FAs) were first observed by electron microscopy (EM) techniques in 1971 as 
~1.5 micron long electron dense plaques where the plasma membrane approaches to within 30nm of the 
substrate 
13
.  These plaques frequently occur at the lamellipodia/lamella border, and the electron dense 
cytoplasm extends vertically ~60nm into the cell where they approach parallel, filamentous bundles.  In 
subsequent decades, the molecular complexity of these “focal adhesion plaques” was revealed 
46
.  FAs 
are formed around the transmembrane  integrin heterodimer, and the large (~20nm) extracellular 
domain of integrins serve as receptors for extracellular matrix proteins accounting for the gap observed 
between the substrate and the membrane
38,40
.  Actin stress fibers attach to FAs physically connecting the 
external environment with the internal actin cytoskeleton
35,36
.  Integrins do not exhibit actin binding or 
enzymatic activity, so structural and signaling events are mediated via the assembly of a large 
macromolecular complex
43
.  However, despite the growing knowledge of the composition, interactions, 
and dynamics of FAs, their ultrastructure remained poorly understood until the advent of superresolution 
light microscopy.   
EM has long been the primary tool for observing nanoscale structures and provided the initial 
insight into FA structure.  In immuno-EM studies of FAs, vinculin was observed to densely localize at FAs 
within ~60nm of the plasma membrane, while alpha-actin was often observed to localized slightly higher, 
hinting at the possible spatial organization of proteins within the dense FA plaque 
172,173
.  However, to 
image spatial organization relative to the substrate with EM, cells were frozen and sectioned 
perpendicular to the substrate, and the relative distributions of vinculin and alpha-actinin were difficult to 
determine reproducibly
173
.  Additionally, EM is limited to fixed and dehydrated specimen and has 
restricted molecule-specific labeling capabilities making it difficult to probe the relative organization of 
multiple proteins.  In contrast, fluorescence microscopy provides an abundance of molecular-labeling 
approaches allowing for simultaneous imaging of multiple colors in live or fixed cells
174
.  The light 
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microscope is also capable of optical sectioning, reducing the need for physical sectioning of the 
specimen
175,176
.  While resolution of the conventional light microscopy is limited laterally to ~200-250nm 
by the diffraction of light, recent advances have pushed the resolution of the light microscope into the nm 
range
177
.  This has allowed a better understanding of how proteins are organized within dense 
macromolecular structures.  Interferometric photoactivated localization microscopy (“iPALM”) is a single 
molecule localization based superresolution technique that allowed for the characterization of the 
nanoscale molecular architecture of FAs 
56,57
.  In this chapter, I will describe the iPALM method in detail 
and review how iPALM was applied to study the molecular architecture of FAs.    
4.2 Interferometric photoactivated localization microscopy  
Achieving lateral resolution with single molecule localization 
 A single fluorescent molecule acts as a point source of polarized light with a specific wavelength. 
However, as light passes through the aperture of the microscope’s objective lens, diffraction (the 
scattering and bending of light) results in the loss of high spatial frequency information
174
.  Thus, the 
resulting image of a point source is an “Airy disk” consisting of a central spot surrounded by a series of 
diffraction rings, and the size of the Airy disk depends on both the wavelength of light and the numerical 
aperture of the lens
174
.  The imaged three-dimensional diffraction pattern of light emitted from an infinitely 
small point source is referred to as the pointspread function (PSF) of the microscope
178
.  
The diffraction of light imposes physical limitations on the resolving power of the light microscope 
such that the minimum resolvable distance between two points is 0.61λ/NA (~200-250nm), and axial 
resolution (resolution in the z-plane) is limited to ~500nm
174
.  However, if a diffraction-limited image 
originates from a single point-source, such as a fluorophore, it is possible to estimate the lateral position 
of the point-source with nm precision
179
.  In single-molecule localization microscopy techniques, the 
observed Airy disk of each single molecule is fit with a model of the PSF, and the uncertainty of the 
localization is inversely proportional to the number of photons detected
179,180
.  It is possible to achieve 
10nm localization precision of a molecule emitting >1000 photons.  Practical application of single-
molecule localization requires sparse-fluorescent labeling, low background, and highly sensitive 
detection.  Illumination by total internal reflection (TIRF) allows for low fluorescence background and 
EMCCD cameras provide sufficient sensitivity for single molecule detection.  However, for many years 
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single-molecule localization techniques were limited to in vitro studies, since the majority of proteins in 
cells are densely distributed with many molecules in a diffraction-limited volume.   
To achieve high-density labeling in cells while also allowing for the imaging of single fluorophores, 
scientists have taken advantage of fluorophores that can be selectively “turned on”.  Photoactivatable and 
photoswitchable proteins undergo a chemical modification when hit with UV light resulting in a change in 
their fluorescent properties.  Photoactivatable molecules, such as photoactivatable-GFP, exist in a dark 
state, but become fluorescent upon UV illumination.  Photoconvertable molecules, such as Eos, undergo 
an irreversible change in their excitation and emission spectrum upon UV illumination.  Photoswitchable 
molecules, such as Dronpa, can undergo repeated cycles of activation and inactivation between dark and 
bright fluorescent states
181
.  An alternative approach is the use of synthetic fluorescent dyes, which have 
increased brightness and can therefore provide higher resolution than the genetically encoded fluorescent 
proteins. For example, with proper chemical buffers and laser illumination, standard Alexa Fluor dyes can 
be switched between a dark-state and a fluorescent state
182
.   
Regardless of fluorescent labeling technique, the principle method of single-molecule localization 
superresolution techniques begins with the vast majority of labels in an inactive state, not contributing to 
the fluorescence
183,184
.  By carefully controlling the rate of photoactivation, for example with low-powered 
UV activation of a photoconvertible probe, it’s possible to obtain a low-density of fluorescent events.  
However, resolving structural information from single-molecule localization techniques requires a high-
density of single-molecule coordinates.  This is achieved by repeatedly photoactivating a small number of 
molecules in the structure of interest.  By accumulating thousands of images that each contains a few, 
well-spaced fluorescent events, it is possible to reconstruct a composite high-resolution image of the 
cellular structure.     
Achieving axial resolution with interferometry 
 Although single-molecule localization allows improved lateral resolution, it does not improve the 
axial resolution of the microscope
180
.  Thus, to achieve superresolution in three-dimensions it’s necessary 
to employ alternative techniques to measure molecular Z-coordinates.  The highest axial resolution has 
been achieved using the multiphase-interferometry approach of iPALM
56,180
.  Interferometric-based 
imaging techniques apply the wave superposition principle to determine the length differences of two light 
54 
 
paths based on intensity fluctuations of the resultant wave
56
.  When two coherent light waves are 
interfered, the resultant wave amplitude depends upon the phase difference between the two waves
174
.  
Waves that are in phase will undergo constructive interference resulting in increased amplitude, while 
waves that are phase-shifted will undergo destructive interference resulting in decreased amplitude
174
.  
The iPALM approach uses a 4π dual-opposed objective geometry
185
, where the sample is placed 
in-between two high-NA objectives to produce excitation light at a common focal plane (Figure 4.1).  Each 
emitted photon can be considered to propagate through the two optical paths (i.e. the two objectives) and 
is then self-interfered in a custom-designed three-way beam splitter
56
.  The relative phase of the light in 
the two optical paths is directly proportional to the path length difference.  For example, a photon emitted 
exactly equidistance from both objectives will travel equal path lengths through each objective and remain 
in phase.  However, multiphase measurements are required to achieve nm scale resolution with 
interferometry.  To achieve multiphase measurements from a single fluorescent event, the beamsplitter is 
designed so that each of the three output beams is phase-shifted relative to the others
56
.  Molecules have 
the same x-y coordinate on each of the three images, and this position can be determined using 
conventional single-molecule localization.  However, since the three output beams have mutual phase 
differences of ~120°, molecules have a different intensity in each of the three images.  This allows the z-
coordinate to be extracted by comparing the observed intensity ratio in camera1 vs camera2 vs camera3 
to a calibration curve (Figure 4.1).  A detailed explanation of the iPALM optical setup can be found in 
Figure 4.1.    
Fiducial-based drift-correction, alignment and calibration 
High localization precision requires low sample-drift and reliable drift correction.  Additionally, the 
images from the three cameras must be accurately aligned, and careful calibration is required to extract z-
coordinate information.  Gold (Au) nanoparticles have fluorescent properties suitable for drift correction
184
, 
image registration
55
, and iPALM calibration
56
, and 25 nm x 100 nm Au nanorods can be used in the 480–
800 nm range with 5–10 nm localization accuracy.  Au nanoparticles are deposited onto precleaned glass 
coverslips with a density of 2,000–20,000 mm
2
 and then sputter-coated with a thin layer of SiO
2
. This 
ensures the nanoparticles are stably immobilized throughout the image acquisition to serve as reliable 
fiducial markers. For drift correction, the localized fiducial coordinates report frame-to-frame positional 
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variation, which, after polynomial fitting, can be subtracted from the coordinates of all detected molecules. 
With bright fiducials one can correct for Z- sample drift up to ~100nm.  
 For each iPALM image set, the optics must be properly aligned to achieve interference, and a 
calibration curve is required to extract z-position information from relative intensity
180
.  Real-time subpixel 
localization of a single fiducial is used to focus and align the two objectives.  The focal plane is found with 
the bottom objective, which is then held constant, while the top objective is adjusted to the same focal 
plane and lateral position.  To achieve interference, the sample holder is continuously oscillated along the 
z-axis over a range of 400 nm.  The beam splitter is then translated up or down until the intensity of the 
fiducial oscillates due to the interferometric effect.  Proper alignment for optimal axial resolution should 
result in an intensity oscillation with a peak-to-valley ratio greater than 10.  Finally, fine alignment of the 
beamsplitter is carried out by optimizing the calibration curve (Figure 4.1b).  A calibration curve is 
acquired by translating the sample in discrete z steps of 1 nm.  The intensity of the fiducial will oscillate 
with a similar period but with phase differences between the cameras (Figure 4.1b). The position and tilt 
of the bottom mirror can then be adjusted so the phase difference between each camera is ~120°.  Once 
alignment is achieved and a final calibration curve is taken, the acquisition of raw image sets can 
proceed.  Typically, 20,000-40,000 triplicate images are acquired for a single dataset.  
iPALM data processing 
After image acquisition is complete, the raw datasets must be processed to localize individual 
molecules and extract their x, y, and z coordinates
180
.  The first step of processing is to properly align 
images from the three cameras, and then the three aligned images are added together to form a sum 
image.  This is done for each frame of the dataset.  Individual fluorescent particles in the sum image are 
fit to a two-dimensional Gaussian by non-linear leastsquares fitting to obtain x and y coordinates.  Each 
individual camera is also fit to a two-dimensional Gaussian, to determine the amplitude of the fluorescent 
particle.  These amplitudes are used to extract the z-coordinate of each fluorescent molecule from a 
nonlinear least-square fit of the calibration data (Figure 4.1c).  Both lateral and verticle sample drift are 
calculated by tracking the x, y, and z position of a bright Au fiducial, and the calculated drift is subtracted  
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Figure 4.1.  The iPALM system (Adapted by permission from Macmillan Publishers Ltd: NATURE
57
, 
copyright 2010) 
(a) Description of the iPALM optical setup.  For iPALM of Eos fluorophores, which photoconvert from a 
green to a red spectrum, a 488nm laser can be used to find appropriately labeled, unconverted cells.  A 
50mW 405nm diode laser attenuated by neutral density filters is used to achieve low-density photo-
activation, and a 150mW 561nm diode pumped solid-state laser is used to excite activated fluorophores.  
The sample is mounted between two dual-opposed infinity-corrected 60x 1.49 NA objectives.  The 
objective and the sample holder must be equipped with piezoelectric actuators to facilitate focusing, 
alignment and calibration.  Narrow-bandwidth laser line filters are used to reject emission noise from the 
laser and autofluorescence generated in the optical path before the objectives.  The activation and 
excitation beams enter the back focal planes of the objectives through slots in custom turning mirrors.  
The emission fluorescence signal is collected by the two objectives, and mirrors are used to direct the 
emitted light from the objectives into the custom designed three-way beamsplitter.  The beamsplitter is 
designed to project three beams with 120° phase difference between one another.  The three output 
beams are then focused onto three EMCCD cameras with achromatic lenses.  Long-pass and band-pass 
optical filters are placed in front of the cameras to reject excitation light.  (b) Sample calibration curve 
shows the z-dependent fluctuation in fiducial intensity of three images.  (c)  The fit parameters of the 
sample calibration curve.  The calibration data is fit with a two-dimensional Gaussian to extract the 
amplitudes and the data is fit using Equation 1 to determine the dependence of the amplitudes on the z-
coordinate.    
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from the coordinates of all fluorescent particles.  Processed iPALM data contains the x, y, and z 
coordinates of all identified single fluorescent particles as well as the uncertainty of each localization.  
iPALM images can be rendered from the three-dimensional molecular coordinates.   
4.3 Application of iPALM to the study of focal adhesions 
FAs are dense macromolecular structures formed on the ventral cell surface adjacent to the 
coverslip, making them ideal structures for imaging by iPALM.  Indeed, the iPALM technique was used to 
map the FA molecular architecture, revealing that FA proteins are stratified structures
57
.  Since FAs 
assemble on the substrate, the Z-position of FAs proteins relative to the coverslip is extremely constant.  
While distance between the ventral plasma membrane and the coverslip can vary, at FAs the plasma 
membrane is a constant 25nm from the coverslip
56,57
.  This spacing is likely dictated by the size of the 
integrin extracellular domain
40
.  Thus, the coverslip can be used as a local reference point to compare the 
vertical organization of different FA proteins across multiple cells
57
.  Paxillin and FAK colocalize with 
integrin cytoplasmic tail within ~30nm of the plasma membrane in the “integrin signaling layer”.  VASP, 
zyxin, and alpha-actin colocalize with actin >50nm above the plasma membrane in the “actin regulatory 
layer”.  The talin head localizes in the integrin signaling layer while the tail localizes ~30nm higher, such 
that the majority of the talin rod domain localizes in the 30nm intermediary “force transduction layer”.   
Although iPALM is a powerful fluorescence-based technique, it requires cell fixation as it takes 
>20min to image enough single molecules to properly sample the FA structure.  Recently, scanning angle 
interference microscopy (SAIM) was applied to measure paxillin and vinculin z-position in migrating 
mammary epithelial cells and validated iPALM measurements in living cells. 
58
  SAIM measures the axial 
position of fluorescent molecules by dynamically scanning the incidence angle of the excitation beam to 
image cells plated on reflective silicon wafers 
58
.  Interference occurs between light reflected off of the 
silicon and the excitation beam, allowing the mean fluorescent molecule z position to be determined 
based on intensity fluctuations at different excitation beam incidence angles. This approach measures z-
position on a pixel-by-pixel basis, so it is diffraction limited to conventional ~200nm lateral resolution.  
However, SAIM enables measurement of axial position with nm precision.  Similar to iPALM 
measurements in fixed cells, SAIM measurements in living cells found that vinculin-mCherry was 
localized significantly higher than paxillin-mEmerald in FAs (~90nm vs 50nm above the substrate)
58
.  
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Additionally, we have reproduced the iPALM measurement of CAAX-tdEos, vinculin-tdEos, paxillin-tdEos, 
talin-tdEos, and actin-mEos2 in primary human foreskin fibroblasts (HFFs).  The FA Z-positions of these 
molecules are within a few nm of the published measurements in U2OS cells (Table 4.1).  Thus, iPALM is 
a highly reproducible technique, and FA architecture is conserved between diverse cell types.   
 
Table 4.1.  Comparison of FA protein vertical distribution in HFFs vs U2OS cells   
Vertical distributions of proteins in individual FAs in HFF cells were characterized by Zcentre (relative to the 
coverslip) and width parameter (σvert) determined from Gaussian fits of FA molecule z-coordinate 
localizations.  U2OS Zcentre and σvert were previously published
57
 and reprinted for comparison.   
 
HFF cells U2OS cells 
57
 
FA 
proteins 
Average Zcentre ± 
stdev (nm) 
Average σvert ± 
stdev (nm) 
Average Zcentre ± 
stdev (nm) 
Average σvert ± 
stdev (nm) 
Paxillin-N 48.6 ± 9 16.0 ± 6 46.2 ± 7 11.6 ± 3 
Talin-N 41.2 ± 11 14.3 ± 6 42.8 ± 4 9.8 ±2 
Talin-C 74.8 ± 11 19.6 ± 7 76.7 ± 11 15.7 ± 4 
Actin 95.7 ± 13 23.0 ± 9 96.9 ±15 31.0 ± 9 
Vinculin-N 54.0 ± 14 20.1 ± 7 53.7 ± 6 13.1 ± 4 
 
4.4 Conclusions 
 The development of superresolution light microscopy techniques has revolutionized cell biology 
and provided insight into the nanoscale molecular organization of diverse cellular structures
57,186
.  iPALM 
uses single molecule localization to achieve ~20nm resolution and interferometry to achieve ~10nm axial 
resolution.  FAs are particularly well-suited for the iPALM technique, since they are dense 
macromolecular structures that are localized within the TIRF evanescent field.  While the basic stratified 
organization of FA proteins has been determined with iPALM, it remains to be seen which proteins dictate 
the self-organization that occurs at FAs and whether this macromolecular organization regulates protein 
activity and function. 
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CHAPTER 5: MOLECULAR MECHANISM OF VINCULIN ACTIVATION AND NANO-SCALE SPATIAL 
ORGANIZATION IN FOCAL ADHESIONS  
5.1 Summary 
Focal adhesions (FAs) link the extracellular matrix (ECM) to the actin cytoskeleton to mediate cell 
adhesion, migration, mechanosensing and signaling.  While FAs have conserved nanoscale architecture, 
it is unknown how the layered organization of proteins within FAs contributes to the regulation of protein 
activity and function.  Vinculin is required for multiple FA functions, but it is unclear whether vinculin’s 
diverse protein interactions are spatiotemporally regulated.  Using superresolution microscopy to assay 
vinculin nanoscale organization and a FRET biosensor to assay vinculin conformation, we found that 
movement up the laminar FA structure during FA maturation facilitates vinculin activation and mechanical 
reinforcement of FA.  Inactive vinculin is recruited to the lower integrin signaling layer by binding to 
phospho-paxillin.  Talin and actin binding activates vinculin, and talin targets active vinculin to the higher 
FA layers where vinculin can engage retrograde actin flow.  Thus, specific protein interactions occur 
within distinct FA nano-domains to regulate vinculin recruitment, activation, and function during FA 
maturation.       
5.2 Introduction 
Integrin-mediated focal adhesions (FAs) are plasma membrane-associated organelles that 
physically connect the actin cytoskeleton to the extracellular matrix (ECM), providing specific adhesion 
between cells and their surroundings to mediate tissue formation and the immune response.  FAs also 
serve as signaling hubs where cells sense biochemical and physical cues in their environment that inform 
cell decision-making in the cell cycle, differentiation and death.  In addition, they serve as sites of force 
transmission between the cytoskeleton and the surroundings to drive tissue morphogenesis, cell 
movement, and ECM remodeling.  These diverse functions of FAs are reflected in their biochemical 
complexity.  FAs contain hundreds of different proteins and their composition can change in response to 
physical stimuli, making them important sites of mechanotransduction
47–49
.  Thus, FAs are multifaceted 
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organelles that mediate an array of functions involving biochemical and physical interactions between the 
cell and its environment. 
Although FAs are functionally and biochemically complex, they have conserved dynamics and 
structure
57
.  FAs form during protrusion of the cell edge as small (<250 nm) nascent FAs containing 
clustered integrins, FAK, and paxillin
51
.  Nascent FAs undergo a process of actomyosin-dependent 
maturation in which they grow to several microns in length and change their molecular composition
50
.  
Mature FAs exhibit variations in protein composition along their length, with phosphorylated paxillin 
concentrating at their front ends facing the cell periphery, and actin binding proteins such as vinculin, 
VASP, and α-actinin concentrating at their back ends where they attach to actin stress fibers
57,62–64
.  In 
addition, superresolution microscopy recently revealed that FAs have a stratified nano-scale architecture 
within their 200 nm thickness
57
.   This showed that proteins localize to three distinct FA nano-domains: A 
membrane-proximal integrin signaling layer (ISL) containing FAK and paxillin that is located within ~10-20 
nm of the plasma membrane; An actin regulatory layer (ARL) containing α-actinin, VASP, and zyxin that 
initiates ~50-60 nm from the membrane and extends upwards into the stress fiber; And a force 
transduction layer (FTL) containing the rod domain of talin that spans between the ISL and the ARL
57
. 
Despite these recent insights into the nano-scale configuration of molecules in FAs, the functional 
consequence of this organized structure has yet to be explored.  It is likely that the segregation of 
proteins into distinct FA layers could sterically constrain the possible protein-protein interactions, which in 
turn would dictate specific downstream functional effects.  Furthermore, whether this architecture is 
altered to mediate distinct FA functions, or if it evolves dynamically during FA maturation is not known. 
Vinculin is an essential protein that is required for multiple FA functions, including stabilizing and 
strengthening FAs and promoting their maturation
117,118,187–189
, ECM mechanosensing
97
, regulating actin 
cytoskeletal dynamics
88
, and signaling to control cell death
190
.  Vinculin has over 14 putative binding 
partners at FA including talin, actin, paxillin, PIP2, Arp2/3 and vinexin
84,191–195
. Indeed, specific vinculin-
protein interactions have been ascribed to vinculin’s distinct FA functions.  For example, vinculin 
interaction with paxillin is required for FA mechanosensing
97
, its interaction with actin is required for 
regulation of lamellipodial actin dynamics,
88
 and talin binding by vinculin mediates FA strengthening
117
. 
Thus, the spatiotemporal regulation of different vinculin interactions likely regulates cellular function.  In 
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addition, vinculin’s interaction with its binding partners is regulated by an autoinhibitory, high-affinity 
intramolecular interaction between its head and tail domains
196,197
, and release of autoinhibition is 
believed to require simultaneous binding of two ligands
116
.  However, how vinculin activation and protein 
interactions are spatiotemporally regulated during FA formation and maturation is not known.   
In this study, we sought to understand how distinct molecular interactions regulate vinculin 
recruitment and activation within the context of the three-dimensional FA architecture.  Using 
superresolution microscopy to assay vinculin nanoscale organization and a FRET biosensor to assay 
vinculin activation, we found that inactive vinculin is recruited to the lower integrin signaling layer by 
binding to phospho-paxillin.  Talin and actin binding activate vinculin, and talin targets active vinculin to 
the higher FA layers where vinculin can engage actin.  Furthermore, we show that vinculin distribution 
shifts from the ISL to the FTL and ARL as FA maturation ensues following the initiation of myosin II 
contractility. These results suggest that nanometer-scale shifts in vinculin position up the laminar FA 
structure during FA maturation facilitate vinculin activation and mechanical reinforcement of FA.    
5.3 Results 
Vinculin is distributed throughout the three focal adhesion nano-domains 
We hypothesize that the organization of vinculin into axial FA nano-domains is regulated by 
specific protein-protein interactions.  Therefore, we first sought to formalize quantitative definitions of the 
axial FA layers to serve as a framework for our analysis of vinculin distribution within the FA layers.  We 
imaged cells by iPALM using a plasma membrane marker to define the bounds of the ISL and actin to 
define the bounds of the ARL.  We then defined the intervening FTL as spanning the upper bound of the 
ISL and the lower bound of the ARL.  We transiently expressed CAAX fused to tandem Eos (CAAX-
tdEos) as a marker of the ISL or actin fused to monomeric Eos2 (actin-mEos) as a marker of the ARL in 
human foreskin fibroblasts (HFFs), plated cells on 15g/mL fibronectin for 6 hours, and fixed with 4% PFA 
for iPALM imaging.  Throughout this study, representative FA will be displayed by iPALM rendering with 
colours indicating the axial (Z) position of each localized molecule relative to the position of the coverslip 
(z=0) Figure 5.1a-b).  The Z-position of all the molecules in the rendered FA will be plotted in a 1-nm 
binned histogram (Figure 5.1a-b).  For each FA, we determine the centre of the Z distribution using a 
Guassian fit (Zcentre) as well as mean Z position of the molecules located between 25-150nm from the 
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coverslip (Zmean).  Similar to our previous study in U2OS cells
57
, this analysis showed that on average, 
CAAX-tdEos had a Zcentre of 29.9±6 and a Zmean of 50.0±9, while actin-mEos had a Zcentre of 95.7±13 and a 
Zmean of 93.3±10 (Figure 5.1c-d).  We then averaged 1nm-binned histograms of >25 FA from 5 cells to 
allow visual comparison of the mean Z-distributions of CAAX-tdEos and actin-mEos (Figure 5.1e).  Based 
on these results, we defined the ISL as 25-54nm above the coverslip, where 75% of CAAX-tdEos 
localized and only 13% of the actin-mEos localized.  We defined the ARL as 85-150nm above the 
coverslip where 64% of actin-mEos molecules localized and only 16% of CAAX-tdEos molecules 
localized. We defined the force transduction layer (FTL) as 55-84nm above the coverslip, where <25% of 
either CAAX-tdEos or actin-mEos localized (Figure 5.1f).  Thus, the ISL consists of the 30nm region 
adjacent to the inner leaflet of the plasma membrane, the ARL extends from 60nm above the membrane 
into the stress fiber, and the FTL consists of the intervening 30nm.  
We then sought to characterize the distribution of vinculin within these defined axial FA nano-
domains.  We transiently expressed full length vinculin fused to tdEos at its N-terminus (WT-vinculin-N-
tdEos) in HFFs and performed iPALM imaging and analysis (Figure5.1g). This showed that, similar to 
U2OS cells, WT-vinculin-N-tdEos had a Zcentre of 54±14nm and a Zmean of 68.0±8nm (Figure 5.1h-i).  Using 
the above definitions of the axial FA nano-domains, we found that 35% of the vinculin molecules localized 
in the ISL, 41% localized in the FTL, and 24% localized in the ARL (Figure 5.1j).  Thus, vinculin molecules 
are distributed throughout all three FA layers, with the majority of molecules residing in the ISL and 
FTL.     
Vinculin is required to stabilize talin in an extended conformation in FA 
We next sought to determine the requirement for vinculin in nano-scale organization of its binding 
partners and the molecular architecture of the FA.  We used iPALM in HFF cells in the presence (WT) 
and absence (KD) of vinculin to determine the nano-scale localization of the ISL protein paxillin, the ARL 
protein actin, and talin, an extended molecule whose head binds -integrin cytoplasmic tails
42
 in the ISL 
and whose tail binds actin
61
 in the ARL, with its -helical rod spanning the FTL
57,59
.  We utilized small 
interfering RNAs (siRNA) targeted to the 3'UTR of vinculin to knock down >95% of vinculin in HFFs 
(vinculin KD, Figure 5.2i).  We transiently expressed fluorescently labeled fusion proteins in either WT or  
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Figure 5.1.  Vinculin is distributed throughout the three focal adhesion nano-domains 
(a, b, g) Representative iPALM renderings from HFF cells expressing CAAX-tdEos to label the plasma 
membrane (a), actin-mEos2 to label actin (b), or vinculin-N-tdEos (g).  In a, b, and g) the colourscale 
represents Z-position (nm), scale bar = 2 micron.  (a’, b’, g’) Histograms of the Z-position of the 
molecules within individual focal adhesions (outlined by white boxes in a, b, and g).  N=number of 
molecules.  The measured Gaussian Z-centre and Z-mean of the distribution is shown.  (c,h) Mean of Z-
centre measurements from individual FAs from cells expressing CAAX-tdEos and actin-mEos2 (c) or 
vinculin-N-tdEos (h).  (d,i) Mean of Z-mean measurements from individual FAs in cells expressing CAAX- 
tdEos and actin-mEos2 (d) or vinculin-N-tdEos (i).  (e) Averaged normalized Z-position histograms of 
molecules within FAs from cells expressing tdEos-CAAX or actin-mEos2. (f, j) Mean fraction of molecules 
localized to each of the three focal adhesion layers in focal adhesions from cells expressing CAAX-tdEos 
and actin-mEos2 (f) or vinculin-N-tdEos (j) Colouring in (e, f, and j) is used to highlight the three focal 
adhesion layers.  ISL: integrin signaling layer (red, 25-54nm above the coverslip), FTL: force transduction 
layer (green, 55-84nm above the coverslip), ARL: actin regulatory layer (purple, 85-150nm above the 
coverslip). Graphs in c-f represent measurements of n=27 FAs from 5 CAAX-tdEos expressing cells and 
n=56 FAs from 8 actin-mEos2 expressing cells.  Graphs in h-j represent measurements of n=115 FAs 
from 8 vinculin-N-tdEos expressing cells  Data in all bar graphs are represented as mean± 95% 
confidence intervals.   
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vinculin KD background and performed iPALM analysis on >50FA from at least 5 cells per condition.  The 
measured Zcentres of paxillin-tdEos (paxillin with n-terminally fused tdEos), actin-mEos, talin-N-tdEos (talin 
with n-terminally fused tdEos) and talin-C-tdEos (talin with c-terminally fused tdEos) in WT HFFs was 
remarkably similar to results published in U2OS cells
57
, demonstrating the conserved nano-scale 
architecture of FAs and reproducibility of iPALM measurements (Table 4.1).  Comparison of WT and 
vinculin KD cells showed that vinculin had little effect on the localization of paxillin (Figure 5.2a-b, e), with 
~50% of paxillin-tdEos localized in the ISL under both conditions (WT Zcentre: 48.6±9nm, ZMean: 61.4±7nm; 
KD Zcentre: 50.1±11nm, ZMean: 64.3±11nm) (Figure 5.2e-f).  Similarly, the loss of vinculin had minimal effect 
on the localization of actin (Figure 5.2c-d) or the n-terminus of talin (Figure 5.2j-k) in FA, with ~75% of 
actin-mEos2 localized in the ARL (actin-mEos: WT Zcentre: 95.7 ± 13nm, ZMean = 93.2±10nm; KD Zcentre: 
93.2±10nm, ZMean: 94.8±8nm) and ~50% of talin-N-tdEos localized in the ISL (WT Zcentre = 41.2 ± 11nm, 
ZMean: 63.8±11; KD Zcentre: 44.4±11nm, ZMean: 62.2±8nm) (Figure 5.2g-h, n-o).  In contrast, loss of vinculin 
altered the distribution of talin-C-tdEos (Figure 5.2l-m), significantly reducing the fraction of molecules in 
the ARL and concomitantly increasing the fraction of molecules in the ISL (Figure 5.2p).  This resulted in 
a significant decrease of ~10nm in the Zcentre of talin-C-tdEos in vinculin KD compared to WT cells (WT 
Zcentre: 74.8±11nm, ZMean: 79.3±9nm;  KD Zcentre: 63.5±14nm, ZMean: 72.1±12nm) (Figure 5.2n).  Thus, in 
the presence of vinculin, the talin tail is localized ~30 nm above the head, while in the absence of vinculin, 
the tail only extends ~20nm above the head.  While talin tail extension into the ARL could result from 
increased stretching of the talin rod, as has been seen in vitro
104
, our data could also be explained by a 
more perpendicular orientation of unstretched talin relative to the coverslip.  Thus, while vinculin is not 
required for paxillin localization to the ISL or actin localization to the ARL, vinculin is likely required for 
talin to be maintained in the maximal vertically extended conformation. 
Vinculin is oriented in FA with the tail above the head 
We next sought to determine if vinculin exhibits a preferred orientation in FA.  To test this, we 
used iPALM to compare the localization of the N and C termini of WT vinculin.  WT-vinculin-N-tdEos was 
engineered with a 16AA linker between the vinculin n-terminus and the fluorophore (Figure 5.3a), and 
WT-vinculin-C-tdEos was engineered with a 21AA linker between the vinculin c-terminus and the 
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Figure 5.2.  Vinculin is required to maintain talin in an extended conformation 
(a, c, j, l): Representative iPALM renderings from wild-type (WT) HFF cells expressing paxillin-tdEos 
(Pxn, a), actin-mEos2 (c), N-terminally tagged talin-N-tdEos (Tln, j) or C-terminally tagged talin-C-tdEos 
(l).  (b, d, k, m): Representative iPALM rendering from HFF cells treated with siRNAs targeting vinculin 
(Vcl KD) and additionally expressing paxillin-tdEos (b), actin-mEos2 (d), talin-N-tdEos (k) or talin-C-tdEos 
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(l). In a-d and j-m, the colourscale represents Z-position (nm), scale bar = 1 micron.  (a’-d’, and j’-m’) 
Histograms of the Z-positions of the molecules within individual FA (outlined by white boxes in a-d, and j-
m).  N=number of molecules. Actin-mEos2 WT data is duplicated from figure 5.1 for comparison 
purposes. (e, g, n) Mean Z-mean measurements of molecules from individual FAs in cells expressing 
paxillin-tdEos in wildtype (WT) or vinculin KD cells (e); actin-mEos2 in wildtype (WT) or vinculin Vcl KD 
cells (g); or talin-N-tdEos or talin-C-tdEos in wildtype (WT) or vinculin KD) cells (n).  (f, h, o, p) Mean 
fraction of molecules localized to each of the three focal adhesion layers in focal adhesions from cells 
expressing paxillin-tdEos in wildtype (WT) or vinculin KD (f); actin-mEos2 in wildtype (WT) or vinculin KD 
(h); talin-N-tdEos in wildtype (WT) or vinculin KD (o); or talin-C-tdEos in wildtype (WT) or vinculin KD (p). 
(i) Western blot of vinculin protein in lysates of WT HFFs versus HFFs expressing vinculin siRNA for 72 
hours.  Tubulin (Tub) is shown as a loading control.  Colouring in (a’-d’, f, h, and j’-m’) is used to highlight 
the three focal adhesion layers.  red: integrin signaling layer (ISL, 25-54nm above the coverslip), green: 
force transduction layer (FTL, 55-84nm above the coverslip), purple: actin regulatory layer (ARL, 85-
150nm above the coverslip). Graphs in e-f represent measurements of n=120 FAs from 7 WT cells and 
n=117FAs from 6 Vcl KD cells. Graphs in g-h represent measurements of n=56 FAs from 8 WT cells and 
n=50 FAs from 6 Vcl KD cells. Graphs in n-p represents data from n=75 FAs from 7 TlnN WT cells, n=107 
FAs from 5 TlnN KD cells, n= 95 FAs from 5 TlnC WT cells, and n=66 FAs from 5 TlnC KD cells.  Data in 
all bargraphs are represented as mean± 95% confidence intervals. Significance tested with Wilcoxen 
rank-sum test (* p<0.05, *** p<0.0001) 
 
fluorophore (Figure 5.3b).  We performed iPALM analyses on n>100FA from at least 5 cells, transiently 
expressing each construct in a WT background.  We found that WT-vinculin-C-tdEos localized 
significantly higher than WT-vinculin-N-tdEos (Zmean = 77.8±6nm vs. 68.0± 8nm) (Figure 5.3e).  When we 
compared the relative distributions in the FA layers, we found that WT-vinculin-N-tdEos localized primarily 
in the ISL and FTL (ISL:35%, FTL:41%, ARL:24%), while WT-vinculin-C-tdEos localized primarily in the 
FTL and ARL (ISL 21%, FTL:40%, ARL:38%) (Figure 5.3f).  Since the N-terminus is adjacent to the 
vinculin head and the C-terminus is adjacent to the vinculin tail
198
, our data suggests that the majority of 
vinculin molecules are oriented in FAs with the tail above the head.   
Activation promotes association of vinculin with the FTL and ARL 
Because vinculin activation affects its ability to interact with multiple binding partners including 
talin and actin
116
, we next sought to determine if vinculin activation influences its nano-scale organization 
within FA.  We utilized iPALM analysis to measure the effect of activating point mutations on vinculin Z-
position in FA.  Mutating residues N773 and E775 to alanine permits talin binding to full length vinculin in 
vitro and increases the stability of vinculin association with FAs without altering FA assembly/disassembly 
dynamics or morphology
88,199,200
.  We introduced N773/E775A mutations into the vinculin-tdEos fusion  
constructs to create CA-vinculin-N-tdEos (Figure 5.3c) and CA-vinculin-C-tdEos (Figure 5.3d).  We  
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Figure 5.3.  Vinculin is oriented in focal adhesions with the tail above the head, and activation 
promotes association of vinculin with the actin regulatory layer 
(a-d) Representative iPALM rendering from an HFF cell expressing N-terminally tagged wild-type (WT) 
vinculin-N-tdEos (a, data duplicated from figure 5.1 for comparison purposes), WT C-terminally tagged 
vinculin-C-tdEos (b), constitutively active (CA, N773/E775A) vinculin-N-tdEos (c) or CA vinculin-C-tdEos 
(d).  In (a-d) the colourscale represents Z-position (nm), and scale bar = 1 micron.  (a’-d’) Histograms of 
the Z-position of the molecules within individual FAs (outlined by white boxes in a-d).  N=number of 
molecules. (e) Mean of Z-mean measurements of the position of molecules from individual FAs in cells 
expressing WT vinculin-N-tdEos, WT-vinculin-C-tdEos, CA-vinculin-N-tdEos or CA-vinculin-C-tdEos.  (f, 
g) Mean fraction of molecules localized to each of the three focal adhesion layers in focal adhesions from 
cells expressing WT vinculin-N-tdEos or WT-vinculin-C-tdEos (f), or CA vinculin-N-tdEos or CA-vinculin-
C-tdEos (g). Colouring in (a’-d’, f, and g) used to highlight the three focal adhesion layers.  red: integrin 
signaling layer (ISL, 25-54nm above the coverslip), green: force transduction layer (FTL, 55-84nm above 
the coverslip), purple: actin regulatory layer (ARL, 85-150nm above the coverslip).  Graphs in e-g 
represent measurements of n=115FA from 8 WT vinculin-N-tdEos expressing cells, n-137FA from 5 WT 
vinculin-C-tdEos expressing cells, n=82FA from 8 CA-vinculin-N-tdEos cells and n=110 FA from 6 CA-
vinculin-C-tdEos expressing cells.  Data in all bargraphs are represented as mean± 95% confidence 
intervals. Significance tested with ANOVA test followed by Tukey test post-hoc analysis. (* difference is 
significant at p<0.05 cutoff) 
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performed iPALM analyses on n>80FA from at least 5 cells transiently expressing each construct in a WT 
background.  We found that CA-vinculin-N-tdEos localized significantly higher in the FA than WT-vinculin-
N-tdEos (Zmean= 71.7±10nm vs 68.0± 8nm) (Figure 5.3e), and CA-vinculin-N-tdEos had significantly more 
molecules in the ARL (ISL: 30%, FTL: 41%, ARL: 29%) than WT-vinculin-N-tdEos (ISL: 35%, FTL: 41%, 
ARL: 24%) (Figure 5.3f-g).  Furthermore, CA-vinculin-C-tdEos localized significantly higher in FA than 
CA-vinculin-N-tdEos (Zmean=76.2±9nm vs 71.7±10nm), suggesting that like WT vinculin, CA-vinculin is 
also oriented in FA with the tail above the head (Figure 5.3e).  However, surprisingly, CA-vinculin-C-tdEos 
was not significantly higher in the FA than WT-vinculin-C-tdEos (Zmean=76.2±9nm vs 77.8±6nm) (Figure 
5.3e).  While this might suggest that the C-terminus does not undergo significant translocation upon 
activation, it is also possible that tagging vinculin on the C-terminus with a large (~40KDa) fluorophore 
sterically interferes with the autoinhibition of the molecule as has been reported for other molecules, such 
as kinesin
201
.  To avoid inadvertently activating the vinculin molecule, we utilized n-terminally tagged 
vinculin for all subsequent iPALM experiments in this study.  Since both CA-vinculin-N-tdEos and CA-
vinculin-C-tdEos have >70% of molecules associated with the FTL and ARL, we conclude that activation 
promotes dissociation of vinculin from the ISL and association with the FTL and ARL.    
Talin binding is required for vinculin activation in FA and promotes localization of active vinculin to the 
FTL and ARL 
 
Talin α-helical rod domain contains several mechano-sensitive vinculin binding sites spanning the 
FTL that are thought to mediate vinculin activation and strengthening of the integrin-actin link in FA
103,202
. 
We thus sought to determine the role of talin in vinculin activation and nanoscale localization in FA. To 
assay vinculin activation in cells, we utilized a vinculin activation FRET biosensor in which donor and 
acceptor  fluorophores are inserted into the vinculin protein such that FRET occurs when vinculin tail 
interacts with the head in the auto-inhibited, closed conformation, and FRET decreases when auto-
inhibition is relieved and vinculin is activated
203
.  We re-engineered the published probe using mTurquoise 
as the donor fluorophore and NeonGreen as the acceptor (WT-vinculin-FRET)
204
.  To validate WT-
vinculin-FRET, we engineered two positive control probes: one that remained cytosolic and one that was 
targeted to FA (Figure 5.4a).  The cytosolic probe consisted of mTurqouise fused to NeonGreen by a 10 
amino acid linker, while the FA-targeted probe consisted of the first 400 amino acids of vinculin followed  
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Figure 5.4.  Characterization of vinculin activation FRET bionsensor 
(a) mTurquoise (mTurq, top row:) and processed FRET ratio image (middle row) of HFF cells either 
expressing mTurqouise fused to NeonGreen by a 10 amino acid linker (Cytosolic control probe), 
expressing the first 400 amino acids of vinculin (Vcl) fused to mTurquoise and NeonGreen (FA-targeted 
control probe), co-expressing mTurquoise + NeonGreen, or co-expressing vinculin-mTurquoise  and 
vinculin-NeonGreen.  Bottom row: cartoon schematics of the different FRET probes used.  Scale bar = 5 
micron.  In a and c, The FA mask (grey lines) was created from the mTurq images and superimposed 
onto to FRET ratio images.  (b) Quantification of the mean FRET ratio value for the constructs described 
in (a) in image regions confined within focal adhesions (FA) or in non-focal adhesion cytosolic regions 
(cyto).  N = number of cells.  Significance tested with ANOVA test followed by Tukey test post-hoc 
analysis. (* difference is significant at p<0.05 cutoff, ns: not significant) (c) mTurquoise (mTurq, top row) 
and processed FRET ratio image (middle row) of HFF cells expressing wild type (WT) vinculin FRET 
biosensor (left) or constitutively active (CA, N773/E775A) vinculin FRET biosensor (right).  Scale bar = 5 
micron. Bottom row:  cartoon schematic of the WT vinculin FRET biosensor, numbers refer to amino acid 
positions in full-length vinculin. (d) Quantification of the mean FRET ratio value inside focal adhesions 
(FA) and outside focal adhesions (Cyto) from n=18 WT-vinculin FRET expressing cells and n=16 CA-
vinculin FRET expressing cells. Significance tested with ANOVA test followed by Tukey test post-hoc 
analysis. (* difference is significant at p<0.05 cutoff, ns: not significant) 
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by mTurquoise and NeonGreen.  Both of these probes exhibited a high FRET ratio of 1.5-1.6 when 
expressed in cells, independent of FA localization (Figure 5.4b).  As cytosolic and FA targeted negative 
controls, we co-expressed either mTurquoise together with NeonGreen in the cytosol or WT-vinculin-
NeonGreen together with WT-vinculin-mTurquoise in FA (Figure 5.4a).   Both of these controls resulted in 
undetectable FRET in both FA and the cytoplasm (Figure 5.4b).  In contrast, WT-vinculin-FRET probes 
exhibited localization and activation-dependent differences in FRET signal.  Indeed, WT-vinculin-FRET 
localized to both the cytoplasm and to FA, but exhibited a significantly lower FRET ratio at FA as 
compared to in the cytosol. (Figure 5.4c,d).  In contrast, when we introduced the N773/E775A activating 
mutation into WT-vinculin-FRET (CA-vinculin-FRET), CA-vinculin-FRET exhibited a FRET ratio at the 
same low level as FA-localized WT-vinculin-FRET, independent of localization.  (Figure 5.4c-d).  Thus, 
the vinculin-FRET biosensor acts as a reliable indicator of conformational change induced by reducing 
the head-tail affinity with the N773/E775A mutation.  Together, these results confirm previous reports
203
 
indicating that vinculin activation is selectively increased at FA.   
To determine the contribution of talin binding to the activation of vinculin in cells, we introduced 
the A50I mutation into the WT-vinculin-FRET biosensor (Figure 5.5a-c).  This mutation inhibits talin 
binding to the vinculin head in vitro
200
, and in cells targets to FA, but results in reduced FA number and 
decreased adhesion strength and traction force
118
.  Expression of A50I-vinculin-FRET in cells showed 
that like WT-vinculin-FRET, the talin-binding mutant was recruited to FAs (Figure 5.5b).  However, in 
contrast to WT-vinculin-FRET that exhibited reduced FRET at FA, the FRET ratio of A50I-vinculin-FRET 
was at the same high level in both the cytoplasm and FA (Figure 5.5a-c).  These results suggest that talin 
binding is required for full activation of vinculin at FA.   
To determine whether talin binding regulates vinculin nano-scale localization, we assayed the 
effects of the A50I mutation on vinculin z-distribution by iPALM.  We knocked down >95% of endogenous 
vinculin with siRNA and rescued with WT-vinculin-N-tdEos (Figure 5.5d) or A50I-vinculin-N-tdEos (Figure 
5.5e).  iPALM analysis showed that A50I-vinculin-N-tdEos localized slightly but significantly lower in FA 
than WT-vinculin-N-tdEos (Zmean = 67.2±6nm vs 71.7±10nm) (Figure 5.5f).  Furthermore, compared to 
WT-vinculin-N-tdEos (ISL:30%, FTL:44%, ARL:25%), A50I-vinculin-N-tdEos had reduced localization to 
the FTL and increased localization to the ISL (ISL:40%, FTL:35%, ARL:25%) (Figure 5.5g).  We conclude   
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Figure 5.5.  Talin binding is required for vinculin activation and localization of active vinculin to 
the force transduction and actin regulatory layers  
(a, b) mTurquoise (mTurq left) and processed mTurqouise/NeonGreen FRET ratio image (right) of an 
HFF cell expressing either a  wild-type (WT) or talin-binding mutant (A50I) vinculin (vcl) FRET biosensor.  
In (a, b) the FA mask (grey lines) was created from the mTurq image and superimposed onto to the FRET 
ratio image, scale bars = 5 micron.  (c) Quantification of the mean FRET ratio value inside focal 
adhesions (FA) and outside focal adhesions (Cyto) from n=18 WT-vinculin expressing cells and n=15 
A50I-vinculin expressing cells. Significance tested with ANOVA test followed by Tukey test post-hoc 
analysis. (* difference is significant at p<0.05 cutoff, ns: not significant) (d, e, h, i) Representative iPALM 
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renderings from HFF cells treated with siRNAs targeting vinculin (KD) and additionally expressing 
vinculin-N-tdEos (d); A50I-vinculin-tdEos (e); constitutively active (CA,  N773/E775A) CA-vinculin-tdEos 
(data duplicated from figure 5.2 for comparison purposes); or CA-A50I-vinculin-tdEos (i). In d, e, h, I) the 
colourscale represents Z-position (nm), scale bar = 1 micron.  (d’, e’, h’, I’) Histograms of the Z-positions 
of the molecules within individual focal adhesions (outlined by white boxes in d, e, h, i).  N=number of 
molecules. (f, j) Mean of Z-mean measurements of the positions of molecules in individual FAs in cells 
expressing vinculin siRNA cells and additionally expressing WT-vinculin-N-tdEos or A50I-vinculin-tdEos 
(f); or CA-vinculin-N-tdEos or CA-A50I-vinculin-tdEos (j).  (g, k) Mean fraction of molecules localized to 
each of the three focal adhesion layers in focal adhesions from vinculin siRNA cells expressing WT-
vinculin-N-tdEos or A50I-vinculin-tdEos (g) or CA-vinculin-N-tdEos or CA-A50I-vinculin-tdEos (k). 
Colouring in (d’, e’, g, h’, I’, and k) used to highlight the three focal adhesion layers.  red: integrin signaling 
layer (ISL, 25-54nm above the coverslip), green: force transduction layer (FTL, 55-84nm above the 
coverslip), purple: actin regulatory layer (ARL, 85-150nm above the coverslip). Graphs in f-g represent 
measurements of n=133 FA from 7 WT-vinculin-N-tdEos and n=102 FA from 7 A50I-Vinculin-tdEos cells.  
Graphs in j-k represent measurements of n=82 FA from 8 CA-vinculin-N-tdEos and n=129 FA from 6 CA-
A50I-Vinculin-tdEos cells.  Data in all bargraphs are represented as mean± 95% confidence intervals.  In 
f-k, significance tested with Wilcoxen rank-sum test (* p<0.05, *** p<0.0001) 
 
that talin binding is not required for vinculin localization to the ISL, but rather that talin binding promotes 
localization to the FTL.   
Since talin binding is required for vinculin activation in vitro
116
 and at FAs (Figure 5.5a-c), we next 
determined if talin binding was specifically required for vinculin localization to the FTL, or whether 
activation was sufficient to localize vinculin to the FTL independent of talin binding.  We introduced the 
A50I mutation into CA-vinculin-N-tdEos (A50I-CA-vinculin-N-tdEos) and expressed this construct in WT 
cells (Figure 5.5i).  iPALM analysis showed that compared to CA-vinculin-N-tdEos, A50I-CA-vinculin-N-
tdEos localized significantly lower in the FA (Zmean: 65.4±13nm vs 71.7±10nm) (Figure 5.5j).  Furthermore, 
A50I-CA-vinculin-N-tdEos had decreased localization to the FTL and ARL and increased localization to 
the ISL (ISL: 40%, FTL: 36%, ARL: 25%) compared to CA-vinculin-N-tdEos (ISL: 30%, FTL: 41%, ARL: 
29%)  (Figure 5.5k).  Thus, reducing the head-tail affinity is not sufficient to rescue the localization defect 
of A50I-vinculin-N-tdEos.  Together, these results show that talin binding is required for activation of 
vinculin in FA and localization of active vinculin to the FTL and ARL.   
Paxillin binding is not required for vinculin activation but promotes vinculin localization to the ISL  
 Because paxillin binding is critical to vinculin’s function in force transmission and 
mechansensation
97
, we next sought to determine the role of paxillin in vinculin activation and nanoscale 
localization in FA.  To examine the role of paxillin in vinculin activation, we used siRNA to knock down 
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>95% of endogenous paxillin and ~50% of the paxillin homologue HIC-5 (paxillin KD) (Figure 5.6a), 
expressed WT-vinculin-FRET, and performed FRET analysis in control versus paxillin KD cells (Figure 
5.6b-d).  This showed that, as reported
205
, loss of paxillin had no effect on vinculin targeting to FA, but 
additionally had no effect on the FRET ratio in either FA or the cytosol,  with WT-vinculin-FRET exhibiting 
a significantly lower FRET ratio in FA than the cytosol in both controls and paxillin KD (Figure 5.6d).  We 
conclude that vinculin activation at FA does not require paxillin.     
Published studies and the above results suggest that paxillin has no effect on vinculin activation, 
and that inactive vinculin (i.e. A50I-vinculin) can localize to FA independently of talin
188,200
.  To determine 
which binding partners might recruit inactive vinculin to FA, we next assayed the ability of talin and paxillin 
to co-immunoprecipitate (co-IP) with GFP-tagged vinculin mutants (Figure 5.6e).  We knocked down 
endogenous vinculin with siRNA and rescued with WT-vinculin-GFP, CA-vinculin-GFP, A50I-vinculin-GFP 
or the double mutant A50I-CA-vinculin-GFP.  We used a GFP antibody to immunoprecipitate vinculin and 
probed for the presence of talin or paxillin.  This showed that talin co-IPed with WT-vinculin-GFP and CA-
vinculin-GFP, but not the A50I mutants, as expected
188
.   In contrast, paxillin was able to co-IP with all 
four vinculin constructs (Figure 5.6e).  Consistent with our observation that paxillin is not required for 
vinculin activation at FA, these results show that paxillin is able to bind vinculin independently of vinculin 
activation or talin binding, and further suggest that paxillin binding could target inactive vinculin to FAs. 
To determine whether vinculin nanoscale organization required paxillin, we performed iPALM 
analysis of WT-vinculin-N-tdEos in the presence and absence of paxillin (Figure 5.6f-g).  We found that 
compared to WT (Zmean: 68.0±8nm), paxillin KD resulted in WT-vinculin-N-tdEos localizing significantly 
higher in the FA (Zmean: 75.4±9nm) with a decreased localization to the ISL (paxillin KD: 21% in ISL; 
control: 35% in ISL), suggesting that paxillin is required to efficiently target vinculin to the ISL (Figure 
5.6h-i). 
Binding to phosphorylated paxillin targets vinculin to the ISL 
We next sought to examine the role of paxillin binding and phosphorylation in vinculin nanoscale 
localization in FA.  The vinculin-paxillin interaction requires paxillin phosphorylation on Y31 and Y118 by 
FAK in response to myosin contractility
205
.  Therefore, phosphomimetic paxillin (Y31/118E-paxillin) will 
bind to vinculin, while non-phospohorylatable paxillin (Y31/118F-paxillin) does not bind to   
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Figure 5.6.  Paxillin is required for vinculin localization in the integrin signaling layer but not for 
vinculin activation  
(a) Western blots of paxillin (pax) and Hic5 protein levels in WT HFFs versus HFF treated with siRNAs 
targeting both paxillin and Hic-5 siRNA (paxillin KD) for 48 hours.  Tubulin (Tub) is shown as a loading 
control.  (b,c) mTurquoise (mTurq left) and processed mTurqouise/NeonGreen FRET ratio image (right) 
of a WT or paxillin KD HFF cell additionally expressing a vinculin (Vcl) FRET biosensor.  In (b, c) the FA 
mask (grey lines) was created from the mTurq image and superimposed onto to the FRET ratio image, 
scale bars = 5 micron.  WT-vinculin FRET data is duplicated from figure 5.5 for comparison purposes, (d) 
Quantification of the mean FRET ratio value inside focal adhesions (FA) and outside focal adhesions 
(Cyto) from n=18 WT cells and n=16 Pxn KD cells. Significance tested with ANOVA test followed by 
Tukey test post-hoc analysis. (* difference is significant at p<0.05 cutoff, ns: not significant) (e, f) 
Representative iPALM rendering from an HFF cell expressing vinculin-N-tdEos (e, data duplicated from 
figure 5.1 for comparison purposes) or expressing WT-vinculin-tdEos in a paxillin KD background (f).  In 
(e, f) the colourscale represents Z-position (nm), scale bar = 1 micron.  (e’, f’) Histograms of the Z-
positions of the molecules within individual focal adhesions (outlined by white boxes in e, f).  N=number of 
molecules. (g) Mean of Z-mean measurements of molecules in individual focal adhesions in WT or Pxn 
KD cells expressing WT-vinculin-N-tdEos.  (h) Mean fraction of molecules localized to each of the three 
focal adhesion layers in focal adhesions cells expressing vinculin-N-tdEos or WT-vinculin-tdEos in a 
paxillin KD background.  (i)  Western blots of immunoprecipitations (IP) with anti-GFP antibodies of GFP-
tagged vinculins (either wild-type (WT)), constitutively active (CA, N773/E775A), talin binding mutant 
(A50I), or CA-A50I) from HFF cells treated with siRNA targeting vinculin for 72 hours.  Input lysates and 
IP fractions were blotted for paxillin (pxn), talin (tln) and vinculin (vcl).  Colouring in (e’, f’, and h’) used to 
highlight the three focal adhesion layers.  red: integrin signaling layer (ISL, 25-54nm above the coverslip), 
green: force transduction layer (FTL, 55-84nm above the coverslip), purple: actin regulatory layer (ARL, 
85-150nm above the coverslip). Graphs in g-h represent measurements of n=115 FA from 8 WT-vinculin-
N-tdEos and n=109 FA from 6 Paxillin-Hic5 siRNA cells.   
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vinculin
205
.  Since phosphorylation of paxillin at Y31 and Y118 potentially alters other protein interactions, 
we also perturbed the paxillin-vinculin interaction using a paxillin point mutant specifically defective in 
vinculin binding (E151Q-paxillin)
97,206
.  All three paxillin-GFP mutants have been shown to co-localize with 
WT paxillin at FA and have no effect on FA size
97
.  To confirm that the vinculin-paxillin interaction did not 
affect paxillin nano-scale localization within FA, we introduced the mutations into paxillin-tdEos constructs 
and performed iPALM analysis (Figure 5.7a-d).  This showed that Y31/118E-paxillin-tdEos was localized 
slightly but significantly higher in FA than WT-paxillin-tdEos (Zmean: 64.2±8nm vs Zmean: 61.4±7nm), while 
Y31/118F-paxillin-tdEos (Zmean: 60.4±8nm) and E151Q-paxillin-tdEos (Zmean: 60.0±9) localizations were 
comparable to WT-paxillin-tdEos (Figure 5.7e).  However, all paxillin-tdEos constructs had similar 
distributions in the FA layers with >44% of molecules localized in the ISL (Figure 5.7f-h).  Therefore, 
vinculin binding and paxillin phosphoregulation is not required to target paxillin to the ISL within FAs.   To 
determine if vinculin targeting to the ISL specifically required the vinculin-paxillin interaction, we 
introduced Y31/118E, Y31/118F and E151Q mutations into paxillin-mCerulean (WT-paxillin-mCer) for co-
expression with WT-vinculin-N-tdEos (Figure 5.7i-l).  We first confirmed that over-expression of 
fluorophore-tagged paxillin did not change vinculin localization.  When WT-paxillin-mCer was co-
expressed with WT-vinculin-N-tdEos in WT HFFs, there was no significant change in vinculin Z-position 
(WT-vinculin-N-tdEos: Vinculin Zmean=68.0±8nm, WT-vinculin-N-tdEos + WT-paxillin-mCer: Vinculin 
Zmean=70.9±9nm).  Similarly, when Y31/118E-paxillin-mCer, which promotes the vinculin-paxillin 
interaction, was co-expressed with vinculin-N-tdEos in WT HFFs (Figure 5.7j), vinculin z-position did not 
significantly change (Zmean: 67.7±8nm) compared to expression of WT-paxillin-mCer (Figure 5.7m).  In 
contrast, vinculin-N-tdEos localized significantly higher in FAs when paxillin KD was rescued with either  
Y31/118F-paxillin-mCer (Zmean: 76.4±11nm) or E151Q-paxillin-mCer (Zmean: 78.3±7nm) to disrupt the 
paxillin-vinculin interaction (Figure 5.7m).  Furthermore, in the presence of either WT-paxillin-mCer or 
Y31/118F-paxillin-mCer, >30% of vinculin molecules localized to the ISL (WT-paxillin-mCer: ISL:31%, 
FTL:42%, ARL:27%; Y31/118E-paxillin-mCer: ISL:36%, FTL:42%, ARL:22%) (Figure 5.7n).  However, 
when the paxillin-vinculin interaction was disrupted by expression of either Y31/118F-paxillin-mCer or 
E151Q-paxillin-mCer in a paxillin KD background, significantly fewer vinculin molecules localized to the 
ISL (Y31/118F-paxillin-mCer: ISL:21%, FTL:44%, ARL:34%; paxillin E151Q-mCer: ISL:16%, FTL:45%,  
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Figure 5.7.  Binding to phospho-paxillin targets vinculin to the integrin signaling layer 
(a-d, i-l) Representative iPALM renderings from HFF cells expressing either wild-type (WT) paxillin-tdEos 
(a, Pxn, data duplicated from figure 5.2 for comparison purposes), paxillin Y31/118E-tdEos (b), paxillin 
Y31/118F-tdEos (c), paxillin E151Q-tdEos (d), WT-vinculin-tdEos (Vcl) and WT-paxillin-mCerulean (i); 
WT-vinculin-tdEos and paxillin Y31/118E-mCerulean (j), WT-vinculin-tdEos and paxillin Y31/118F-
mCerulean in a paxillin/hic5 siRNA (paxillin KD) background (k) or WT-vinculin-tdEos and paxillin E151Q-
mCerulean in a paxillin KD background. In (a-d, i-l) the colourscale represents Z-position (nm), scale bar 
= 1 micron.  (a’-d’, I’-l’) Histograms of the Z-positions of the molecules within an individual focal adhesion 
(outlined by white boxes in (a-d, i-l)) N=number of molecules.  (e,m) Mean of Z-mean measurements of 
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the positions of molecules of tdEos-tagged paxillins (e, WT (data duplicated from figure 5.2 for 
comparison purposes), paxillin Y31/118E-tdEos (E), paxillin Y31/118F-tdEos (F), paxillin E151Q-tdEos 
(Q)) or tdEos-tagged vinculins (m, WT-vinculin-tdEos  and WT-paxillin-mCerulean (WT), WT-vinculin-
tdEos and paxillin Y31/118E-mCerulean (E), WT-vinculin-tdEos and paxillin Y31/118F-mCerulean in a 
paxillin KD background (F) or WT-vinculin-tdEos and paxillin E151Q-mCerulean in a paxillin KD 
background (Q)). (f-h, n-p) Mean fraction of molecules localized to each of the three focal adhesion 
layers. Cells were expressing WT-paxillin-tdEos or paxillin Y31/118E-tdEos (f),WT-paxillin-tdEos or 
paxillin Y31/118F-tdEos (g), WT-paxillin-tdEos or paxillin E151Q-tdEos (h), WT-vinculin-tdEos with WT-
paxillin-mCer or paxillin Y31/118E-mCer (n), WT-vinculin-tdEos with WT-paxillin-mCer or paxillin 
Y31/118F-mCer (o) or WT-vinculin-tdEos with WT-paxillin-mCer or paxillin E151Q-mCer (p) Colouring in 
(a’-d’, f-h, I’-l’, and n-p) used to highlight the three focal adhesion layers.  red: integrin signaling layer (ISL, 
25-54nm above the coverslip), green: force transduction layer (FTL, 55-84nm above the coverslip), 
purple: actin regulatory layer (ARL, 85-150nm above the coverslip).  Graphs in e-h represent 
measurements of n=120 FA from 7 WT-paxillin-tdEos expressing cells, n=150 FA from 6 paxillin 
Y31/118E expressing cells, n=152 FA from 6 paxillin Y31/118F expressing cells, and N=79 FA from 8 
paxillin E151Q-tdEos expressing cells.  Graphs in m-p represent measurements of n=110 FA from 5 WT-
paxillin-mCer expressing cells, n=92 FA from 8 paxillin Y31/118E-mCer expressing cells, n=117 FA from 
6 paxillin Y31/118F-mCer expressing cells, and N=175 FA from 6 paxillin E151Q-mCer expressing cells.  
Data in all bar graphs are represented as mean± 95% confidence intervals. Significance tested with 
ANOVA test followed by Tukey test post-hoc analysis. (* difference is significant at p<0.05 cutoff, ns: not 
significant) 
 
ARL:40%) (Figure 5.7o-p).  We conclude that paxillin binding mediated by Y31 and Y118 phosphorylation 
promotes efficient targeting of vinculin to the ISL.  Together, these results show that the vinculin-phospho-
paxillin interaction promotes recruitment of vinculin to the ISL independent of vinculin activation.  
Actin binding is required for activation but does not regulate vinculin nanoscale localization at FA 
 Because actin binding is a critical function of vinculin in regulating actin and adhesion 
dynamics
88
, we next sought to determine the role of actin in regulating vinculin activation and nanoscale 
localization at FA.  A single amino acid point mutation (V1001A) has been shown to specifically reduce 
actin binding to the vinculin tail without affecting PIP2 binding, and results in decreased mechanical 
response to force in cells
207
.  To determine the role of actin binding in regulating vinculin activation, we 
introduced the V1001A mutation into the vinculin activation biosensor (V1001A-vinculin-FRET) and 
performed FRET imaging and analysis (Figure 5.8a-c).  This showed that unlike WT-vinculin-FRET that 
exhibited a lower FRET ratio in FA compared to the cytoplasm, V1001A-vinculin-FRET displayed a high 
FRET ratio throughout the cell with no significant difference between the FA and the cytoplasm (Figure 
5.8c).  These results show that actin binding promotes vinculin activation in FA.  To determine the effect 
of actin binding on vinculin nanoscale localization within FA, we knocked-down >95% of endogenous  
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Figure 5.8.  Actin binding is required for vinculin activation but does not regulate vinculin position 
(a, b) mTurquoise (mTurq, left) and processed mTurquoise/NeonGreen FRET ratio (right) image of a wild 
type (WT) HFF cell expressing a WT (a) or actin-binding mutant (V1001A, b) vinculin FRET biosensor.  
Scale bar = 5 micron.  The FA mask (grey lines) was created from the mTurq image and superimposed 
onto to FRET ratio image.  WT-vinculin FRET data is duplicated from figure 5.5 for comparison purposes.  
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(c) Quantification of the mean FRET ratio value inside focal adhesions (FA) and outside focal adhesions 
(Cyto) from n=18 WT-vinculin expressing cells and n=16 V1001A-vinculin expressing cells. Significance 
tested with ANOVA test followed by Tukey test post-hoc analysis. (* difference is significant at p<0.05 
cutoff, ns: not significant). (d, e, h, i) Representative iPALM renderings from HFF cell expressing vinculin-
N-tdEos (d) or V1001A-vinculin-tdEos (e) in a vinculin siRNA (vinculin KD) background or constitutively 
active (CA, N773/E775A) vinculin-tdEos (h) or CA-V1001A-vinculin-tdEos (i) in WT cells.  In (d, e, h, i), 
the colourscale represents Z-position (nm), scale bar = 1 micron.  WT-Vinculin data duplicated from figure 
5.5 for comparison pusposes.  (d’, e’, h’, I’) Histograms of the Z-positions of the molecules within 
individual focal adhesions (outlined by white boxes in d, e, h, i).  N=number of molecules. (f,j) Mean of Z-
mean measurements of molecules within individual focal adhesions in vinculin KD cells expressing WT-
vinculin-N-tdEos or V1001A-vinculin-tdEos (f) or WT cells expressing CA-vinculin-N-tdEos or CA-V1001A-
vinculin-tdEos (j).  CA-Vinculin-N-tdEos data is duplicated from figure 5.3 for comparison purposes.  (g, k) 
Mean fraction of molecules localized to each of the three focal adhesion layers in focal adhesions from 
vinculin KD cells expressing WT-vinculin-N-tdEos or V1001A-vinculin-tdEos (g) or WT cells expressing 
CA-vinculin-N-tdEos or CA-V1001A-vinculin-tdEos. Colouring in (d’, e’, g, h’, I’, and k) used to highlight 
the three focal adhesion layers.  red: integrin signaling layer (ISL, 25-54nm above the coverslip), green: 
force transduction layer (FTL, 55-84nm above the coverslip), purple: actin regulatory layer (ARL, 85-
150nm above the coverslip).  Graphs in f-g represent measurements of n=133 FA from 7 WT-vinculin-N-
tdEos and n=182 FA from 8 V1001A-Vinculin-tdEos cells.  Graphs in j-k represent measurements of n=82 
FA from 8 CA-vinculin-N-tdEos and n=132 FA from 6 CA-V1001A-Vinculin-tdEos cells.  Data in all bar 
graphs are represented as mean± 95% confidence intervals.  In f-k, significance tested with Wilcoxen 
rank-sum test (* p<0.05, *** p<0.0001) 
 
vinculin with siRNA and rescued with WT-vinculin-N-tdEos or V1001A-vinculin-N-tdEos (Figure 5.8d-e) 
and performed iPALM analysis.  Surprisingly, we found no significant difference in z-position or the 
fraction of vinculin molecules in the three layers of the FA between WT and the actin-binding mutant (WT: 
Zmean: 69.9±10nm, ISL:30%, FTL:44%, ARL:25%;  V1001A: Zmean: 69.3±10nm, ISL: 29%, FTL: 46%, ARL: 
25%) (Figure 5.8f-g).  Since actin binding contributes to vinculin activation, we examined whether actin 
binding was required for the localization of active vinculin to the FTL and ARL.  We introduced the 
V1001A mutation into CA-vinculin-N-tdEos and expressed this construct in WT cells (Figure 5.8h-i).  
iPALM analysis showed that compared to CA-vinculin-N-tdEos (ISL: 30%, FTL: 41%, ARL: 29%), there 
was no change in the proportion of V1001A-CA-vinculin-N-tdEos  localized to the ARL (ISL: 21%, FTL: 
49%, ARL: 30%) (Figure 5.8k).  However, compared to CA-vinculin-N-tdEos, there was a small but 
significantly greater proportion of V1001A-CA-vinculin-N-tdEos localized to the FTL with a concomitant 
loss of molecules from the ISL.  In spite of this shift of molecules from the ISL to the FTL, V1001A-CA-
vinculin-N-tdEos did not exhibit a significantly different mean Z-position compared with CA-vinculin-N-
tdEos (Zmean: 73.8 ± 9.8nm vs 71.7±10nm) (Figure 5.8j).  Together, these data suggest that while actin 
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binding is important for complete vinculin activation at FA, actin binding is not required for the localization 
of active vinculin to the FTL or ARL.   
Vinculin exhibits a gradient in activation and axial position across single FA 
Individual FAs vary in biochemical composition and distribution of traction forces across their 
length.  Phospho-paxillin and high traction forces are concentrated at the front of FAs near the leading 
edge, while actin-associated proteins and lower forces are located at the FA rear facing the cell 
center
53,57,62–64,97
. Therefore, we sought to determine whether vinculin activation or axial position varied 
along the length of individual FA.  To ensure that we were quantifying FAs that had recently formed and 
undergone maturation, we limited our analysis to FAs perpendicular to protruding cell edges.   
To determine if vinculin activation varied along the length of FAs, we compared the mean WT-
vinculin-FRET ratio in the front third and back third of each FA (Figure 5.9a-c).  Although both the front 
and back of FAs had lower FRET ratio values than the cytoplasm (compare Figure 5.5c and 5.9c), the 
front of FAs had consistently higher FRET ratio values than the back (Figure 5.9c, n= 17 FA in 6 cells).  
To determine if vinculin nano-scale localization varied along the length of FAs, we quantified the axial 
position of WT-vinculin-N-tdEos in the front third and back third of FAs (Figure 5.9d-f).  This analysis 
showed that in the front of FA, vinculin had a ZMean of 69.3±10, while in the back of FA vinculin was 
located significantly higher, with a ZMean of 76.4±14nm (Figure 5.9e).  Furthermore, more vinculin was 
associated with the ISL in the front of FAs while more was associated with ARL in the back of FAs (Front: 
ISL:33%, FTL:42%, ARL:24%;  Back: ISL:27%, FTL:40%, ARL:34%) (Figure 5.9f).  Together these results 
show that vinculin exhibits gradients of low-to-high activation and axial position from the front-to-back of 
single FAs.   
Because our results indicate that vinculin activation and nano-scale localization are regulated by 
interactions with phospho-paxillin and talin, we hypothesized that the observed gradient in vinculin 
activation and axial position across single FA could be mediated by these proteins.  As noted, previous 
studies identified a concentration of phospho-paxillin in the FA front
64
 that is consistent with our 
observations that vinculin is concentrated in the ISL in the front of FA. To determine if talin vertical 
extension could mediate the recruitment of vinculin to the FTL and ARL in the FA rear, we determined 
whether the position of the talin C-terminus varied along the length of FAs.  We quantified the axial 
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position of talin-C-tdEos in the front third and back third of each FA (Figure 5.9g-i).  This showed that the 
talin C-terminus was slightly but significantly higher in the FA back (Zmean = 78.4±9nm) than in the FA front 
(Zmean = 74.3±8nm) (Figure 5.9h).  This indicates that maximum talin vertical extension and higher vinculin 
axial position spatially correspond in individual FA.  These analyses, together with previous publications
64
, 
suggest that inactivated vinculin could associate with phospho-paxillin in the ISL in the FA front, and 
activation of vinculin occurs toward the rear of FA, resulting in increased association with extended talin 
molecules in the upper strata of the FA.    
Vinculin is recruited initially to the ISL and later to the FTL and ARL during myosin II-mediated FA 
maturation 
 
Previous reports showed that vinculin activation increases during FA dynamics and  growth
203
, 
which together with our current results suggest that vinculin nano-scale localization and binding partners 
may evolve during FA maturation.  Earlier measurements were performed on steady-state cells, which 
presumably contain FA at all stages of maturation.  Furthermore, iPALM measurements are limited to FAs 
that contain many more molecules than the background, making our measurements biased to larger, 
more mature FA.  To obtain a synchronized population of FAs at either an early or late stage of 
maturation, we performed washout experiments of the myosinII ATPase inhibitor, blebbistatin, and 
examined vinculin axial position during contractility-induced FA growth (Figure 5.9j-n).  We first 
characterized the kinetics of contractility-induced FA maturation.  Cells co-expressing paxillin-mCherry 
and vinculin-GFP were treated with 50M blebbistatin for 2 hours, which has previously been shown to 
inhibit FA maturation and reduce vinculin localization at FA
205,208
.  We washed out blebbistatin with drug-
free media during live-cell TIRF imaging to analyze the subsequent growth of FA and vinculin recruitment.  
We found that after blebbistatin was removed, immature FAs, seen as diffraction limited paxillin-mCherry 
punctae at the cell edge, underwent coordinated growth and maturation, with vinculin recruited to these 
maturing FA as early as 1min after washout (Figure 5.9j).  By five min post-washout, vinculin-containing 
FA were elongated and the cell edge had advanced, and by 7 min post-washout, a new row of nascent 
FA had formed at the cell edge and begun to mature.  Thus, we chose to perform iPALM analysis of 
vinculin at 1 and 5 min after blebbistatin washout to ensure that all FAs analyzed had begun maturation 
simultaneously.  To determine the nano-scale localization of vinculin during FA maturation, we expressed 
WT-vinculin-N-tdEos in WT HFF cells, treated with 50uM blebbistatin for 2hr, and fixed cells at 1min or  
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Figure 5.9.  Vinculin activation and nano-scale localization is spatio-temporally regulated 
(a)  Top: mTurquoise (mTurq, left) and processed mTurquoise/NeonGreen FRET ratio images of a 
protruding region of an HFF cell expressing the vinculin FRET biosensor.  Bottom:  Zoomed view of the 
area outlined with a red box in the panel above. The FA mask (black lines) was created from the mTurq 
image and superimposed onto to FRET ratio image.   (b) Values for mTurquoise intensity (blue line) and 
FRET ratio (red line) along the 5um long yellow line in the zoomed region in (a).  Purple shaded areas are 
in the cytosolic (cyto) regions adjacent to the focal adhesion (FA, green shaded area) (c) Quantification of 
the mean FRET ratio of the front 1/3 and back 1/3 of FA linescans. In (c-i), “front” refers to the end of the 
FA facing the leading edge, and “back refers to the end of the FA facing the cell center.  Data represents 
measurements of 17 FA from 6 cells.  (d, g)  Representative iPALM renderings of protruding regions of 
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HFF cell expressing vinculin-N-tdEos (d) or talin-C-tdEos (g). (d’, g’) Histograms of the Z-positions of the 
molecules within the front 1/3 (outlined by green box in d’, g’) or the back 1/3 (outlined by pink box in d’, 
g’) of single FA.  N=number of molecules.  (e, h) Mean of Z-mean measurements of molecules in the front 
1/3 or back 1/3 of individual focal adhesions in HFF cells expressing WT-vinculin-N-tdEos (e) or talin-C-
tdEos (h).  (f, i) Mean fraction of molecules localized to each of the three focal adhesion layers in the front 
1/3 or back 1/3 of focal adhesions in HFF cells expressing WT-vinculin-N-tdEos (f) or talin-C-tdEos (i).    
(j) Total internal reflection fluorescence microscopy images from a time-lapse series of focal adhesions 
during blebbistatin washout.  HFF cells expressing paxillin-mCherry (top row) and vinculin-EGFP (bottom 
row) were treated with 50uM blebbistatin for 2 hours.  Blebbistatin- containing media was replaced with 
blebbistatin-free media at t=0 (washout).  Time is shown in min.  Arrow points to a newly formed nascent 
adhesion. Boxed areas show time points chosen for performing iPALM analysis (1 minute: green; 5 
minutes:purple). (k, l) Representative iPALM renderings from HFF cells expressing vinculin-N-tdEos, 
treated with 50uM blebbistatin for 2hr, and then fixed and processed for iPALM imaging at 1min (k) and 5 
min (l) after blebbistatin washout.  (k’, l’) Histogram of the Z-position of the molecules within an individual 
focal adhesion (outlined by white boxes in k, l).  N=number of molecules. (m) Mean of Z-mean 
measurements of molecules in individual focal adhesions if HFF cells expressing vinculin-N-tdEos 1min or 
5min after blebbistatin washout.  (n) Mean fraction of molecules localized to each of the three focal 
adhesion layers in focal adhesions from cells expressing vinculin-N-tdEos and fixed 1min or 5min after 
blebbistatin washout. (o) Left: Representative western blots of HFF cell lysates collected after 2 hours of 
DMSO (ctr) or 50 uM blebbistatin treatment (Bleb), or 1 min and 5 min after blebbistatin washout (1’ wo, 5’ 
wo).  Immunoblots were probed with antibodies specific to paxillin or paxillin phosphorylated on tyrosine 
118 (pY118, right).  Right: Quantification of the ratio of phospho-paxillin:total paxillin, normalized to 
control.  Graphs represent the mean±SD from 3 independent experiments.  Significance was tested with 
Student’s t-test; * P<0.05, ns: not significant). In (I, j”, k, l, m”, n, and o) the FA “front” refers to the tip 
closes to the leading edge, FA “back” refers to the FA tip facing the cell center.  Graphs in e-f represent 
measurements of n=61 FA from 6 cells fixed 1min after blebbistatin washout and n=52 FA from 7 cells 
fixed 5min after blebbistatin washout.  Graphs in k-l represent measurements of n=40 FA from 10 cells. 
Graphs in n-o represent measurements of n=33 FA from 5 cells.  Colouring in (c’, d’, f, j’, l, m’ and o) used 
to highlight the three focal adhesion layers.  red: integrin signaling layer (ISL, 25-54nm above the 
coverslip), green: force transduction layer (FTL, 55-84nm above the coverslip), purple: actin regulatory 
layer (ARL, 85-150nm above the coverslip).  Data in bar graphs in e-p are represented as mean± 95% 
confidence intervals. Significance tested with Wilcoxen rank-sum test (* p<0.05, *** p<0.0001).   
 
5min after blebbistatin washout (Figure 5.9k-n).  iPALM analysis showed that at 1min after washout, 
vinculin had a Zmean of 63.4±11.9nm, with 48% of molecules localized to the ISL (Figure 5.9m,n).  In 
contrast, by 5min after blebbistatin washout, vinculin was located significantly higher, with a Zmean of 
78.8±14.6 nm (Figure 5.9m).  Furthermore, 5min after blebbistatin washout only 22% of vinculin 
molecules localized in the ISL, with the majority of molecules localizing in the FTL (39%) and ARL (40%) 
(Figure 5.9n).  Thus, vinculin localizes to the ISL at the onset of myosin II activity, and shifts to the FTL 
and ARL as FA undergo contractility-induced maturation.  To determine if paxillin phosphorylation could 
be responsible for recruitment of vinculin to the ISL in nascent FA, we characterized the dynamics of 
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paxillin phosphorylation on Y118 (pY118-paxillin) during myosin II-induced FA maturation (Figure 5.9o).  
Western blot analysis using antibodies specific to pY118 paxillin showed that, as reported
205
, 50uM 
blebbistatin treatment significantly reduced pY118 paxillin.  One minute after blebbistatin washout, pY118 
paxillin increased more than twofold, followed by a substantial but non-significant decrease at five 
minutes post-washout.  Therefore, consistent with earlier findings
151
, contractility-dependent 
phosphorylation of paxillin on Y118 occurs within the first minute of FA maturation.  These results show 
that paxillin phosphorylation mirrors the kinetics of vinculin localization to the ISL during contractility-
induced FA maturation.  Together, our findings demonstrate that vinculin nano-scale localization evolves 
during myosin II-dependent FA maturation, and suggest vinculin is recruited to the ISL by interaction with 
phospho-paxillin in nascent FA, followed by a shift to the FTL and ARL as FA grow.  
5.4 Discussion 
This study provides the first demonstration of protein activity and function regulated by the nano-
scale molecular architecture of FAs.  While vinculin has many molecular interactions characterized by 
biochemistry that have been shown to regulate distinct FA functions, it was previously unknown how 
vinculin’s protein interactions are spatiotemporally regulated within FAs during maturation.  Using 
superresolution microscopy to assay vinculin nano-scale organization and a FRET biosensor to assay 
vinculin conformational activation in combination with point mutants with well-characterized in vitro protein 
binding defects and cellular phenotypes, we dissected the roles of paxillin, talin, and actin in vinculin’s 
recruitment, activation, orientation, and nano-scale position within FA. Our work highlights the mind-
blowing power of light microscopy for probing protein activity and interactions with nanometer precision 
within organelles in intact cells.  We find that inactive vinculin is recruited to the membrane-proximal ISL 
by binding to phospho-paxillin.  Talin and actin binding promote vinculin activation, and talin targets active 
vinculin to the FTL where vinculin can engage actin in the ARL to modulate retrograde flow and 
strengthen adhesion.  Thus, the spatial segregation of paxillin to the ISL, talin to the FTL and actin to the 
ARL regulates vinculin recruitment, activation, and function during FA maturation.       
Based on our study and the work of others, we propose a model in which movement up the 
laminar FA structure during FA maturation facilitates vinculin activation and mechanical reinforcement of 
FA (Figure 5.10).  At the leading edge, integrins are activated in the protruding lamellipodium by talin-
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mediated
209
 engagement of actin retrograde flow
115,210
 to form nascent adhesions and bind ECM.  FAK 
and paxillin are quickly recruited
51
, and tension on engaged integrins
211
 promotes FAK activation
205
 and 
rapid tyrosine phosphorylation of paxillin
64,151
.  Although vinculin is absent from newly formed nascent 
adhesions
205
, paxillin phosphorylation subsequently mediates the recruitment of inactive vinculin to the 
ISL
64,205
.  This recruitment puts vinculin into proximity of a high concentration of its activating ligands, 
including PIP2 in the membrane
194
, talin
199
, and actin
116
, where it can act as a coincidence detector
116,198
.  
As tension builds, talin stretches to unmask vinculin binding sites
103
, allowing talin and a second ligand to 
mediate vinculin activation and association with the upper FA layers where it binds actin to engage 
retrograde flow
88
 and bolster the force-transmitting link between talin, integrin, and the ECM
88,117
.  Vinculin 
binding stabilizes talin in a vertically extended conformation, allowing for further extension of the talin rod, 
exposing additional cryptic vinculin binding sites
104
.  Thus, active vinculin remains associated with lower 
vinculin binding sites while higher vinculin binding sites are unmasked and become occupied, allowing for 
positive-feedback to mechanically reinforce FA.  In mature FA, inactive vinculin remains associated with 
phospho-paxillin in the ISL, and active vinculin is distributed in the FTL and ARL in the back of the FA.  
Association of vinculin with F-actin allows for maximum vinculin activation by talin and actin binding, 
supports mechanical reinforcement of FA
117
, and engages actin retrograde flow with the ECM
88
.   
 
Figure 5.10.  Model of vinculin recruitment and activation during FA maturation 
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Our results suggest that talin is a master regulator of vinculin nanoscale localization and function.  
While talin and actin were previously found to be sufficient for vinculin activation in vitro
116
, we show for 
the first time that talin binding is required for vinculin activation in vivo.  Furthermore, we show that talin 
binding, but not actin binding, is specifically required to localize active vinculin to the FTL and ARL.  
Functionally, talin binding is  critical for vinculin’s ability to strengthen FA and promote FA growth
117,188
, 
suggesting that vinculin performs these jobs in the upper layers of the FA.  Talin’s capacity to regulate 
vinculin’s association with the ARL also suggests it controls vinculin’s ability to engage retrograde actin 
flow and mechanically reinforce FAs
88
.  RIAM is a potential regulator of the talin-vinculin interaction that 
may also play into vinculin regulation.  RIAM modulates talin recruitment to nascent FA, and competes 
with vinculin for binding to talin
212,213
.  Thus, it is possible that vinculin is confined to the ISL at early 
stages of maturation due to competition with RIAM for talin binding.  Talin stretching could allow vinculin 
to displace RIAM, resulting in vinculin activation and redistribution 
103,104
.  Furthermore, while in vitro 
experiments have shown that vinculin binding prevents refolding of stretched talin,
104,202
 our results 
provide the first in vivo evidence that vinculin binding is required to maintain talin in a vertically extended 
conformation.  Thus, while talin is a master regulator of vinculin activation and localization, vinculin 
binding also regulates talin conformation in FA.     
Our data suggests that vinculin dynamics are spatiotemporally regulated by distinct protein-
interactions to mediate ECM mechanosensing.  Since the vinculin-phospho-paxilin interaction is required 
for traction force oscillations in FA that facilitate mechanosensing and durotaxis,
97
 the dynamics of 
vinculin recruitment and turnover mediated by this interaction are also likely critical for mechanosensing. 
Our results suggest that inactive vinculin may preferentially associate with paxillin in the ISL, while active 
vinculin localizes in the FTL and ARL by binding to talin.  The characterization by FRAP of the same 
vinculin point mutants used in our study suggests that the paxillin-vinculin interaction is very labile, while 
activated vinculin is more stably associated with FA.
200
  Perhaps maintaining a labile pool of inactive 
vinculin in the ISL could also allow for rapid vinculin activation upon talin stretching and minimize the 
likelihood of talin refolding.  Furthermore, paxillin and vinculin have been observed to interact in both the 
FA and the cytoplasm
72
, which could allow rapid loading of preassembled  complexes into the FA from 
the cytoplasm.  Thus, dynamic traction oscillations in FA could be mediated by rapid shift of the labile, 
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paxillin-bound pool of inactive vinculin to an active conformation in the upper FA layers where it reinforces 
FA traction.   
We have found distinct roles for paxillin, talin and actin in regulating vinculin organization and 
activation at FAs.  However, vinculin has many other binding partners at FA that could also regulate 
vinculin function.  The binding of PIP2 phospholipids to the vinculin tail has been proposed to regulate 
vinculin activation or FA turnover
194,214
.   Since PIP2 is presumably localized in the plasma membrane, it 
could be involved in recruiting or maintaining vinculin in the ISL.  Phophorylation of residues in the 
vinculin tail by Src
215
 or PKC
216
 has also been proposed to promote vinculin activation
217
.  Additionally, 
many proteins, including VASP, vinexin, and Arp2/3, can interact with proline-rich linker of vinculin,
84,218–
220
  and it is not known how binding to the vinculin proline-rich linker influences vinculin activation.       
 In conclusion, the organization of paxillin, talin and actin into distinct FA nano-domains allows for 
spatiotemporally regulated activation of vinculin and modulation of vinculin function during FA maturation.  
Paxillin maintains a labile pool of inactive vinculin in the ISL, talin and actin binding activates vinculin, and 
talin-binding promotes the stable association of active vinculin with the FTL and ARL to mechanically 
reinforce the FA and engage actin retrograde flow.  We suggest that spatial segregation of different 
protein-protein interactions into molecularly distinct nano-domains could be a broader mechanism for 
regulating the activity of FA proteins.  
5.5 Experimental Procedures 
Cell culture and transfection 
HFF cells were obtained from American Type Culture Collection (ATCC, Manassas, VA, USA) 
and maintained at 37C at 5% CO2 in DMEM supplemented with 15% FBS (Gibco, Grand Island, NY, 
USA). Transfections were performed using a Nucleofector (NHDF solution, program U-020. Lonza, Basal, 
Switzerland).  For FRET experiments, cells were plated for 6-8 hrs prior to imaging on 22 x 22mm #1.5 
coverslips pre-coated with 15g/ml fibronectin (2 hr at 37°C, Millipore, Billerica, MA, USA).  Imaging was 
performed in growth media without phenol red and supplemented with 20mM HEPES and 30 units/mL 
Oxyrase (Mansfield, OH, USA.  For iPALM experiments, fluorescent fiducials are added to the coverslip to 
provide a constant internal reference for calibration, alignment, and spatial drift correction.  Therefore, 80 
to 100 nm gold (Au) nanoparticles were sparsely adsorbed (~2,000 per mm
2
) to the coverglass surface 
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and immobilized by 30–50 nm of sputtered SiO2, as previously described
57
.  Prior to experiments, 
fiducialed coverslips were UV-sterilized for 15min, rinsed with Dulbecco’s phosphate buffered saline 
(DPBS, Invitrogen, Grand Island, NY, USA), coated with 15ug/ml fibronectin (2 hr at 37°C, Millipore, 
Billerica, MA, USA), and incubated with 1% heat-inactivated bovine serum albumin (1 h, 37°C, Sigma-
Aldrich. St. Louis, MO, USA) before a final rinse with DPBS.  For iPALM experiments, cells were 
transfected for >24 hours and then replated onto fibronectin coated coverslips for 6-8 hours, allowing time 
for cells to spread and migrate with minimal ECM fibrillogenesis.  Cells were fixed with 4% PFA in PHEM 
buffer (PIPES 60 mM, HEPES 25 mM, EGTA 10 mM, MgCl2 2 mM, pH 6.9) for 15min.  Imaging was 
performed in PHEM buffer supplemented with 2 mM Trolox (Calbiochem, Billerica, MA, USA), 0.04 
mg/mL Catalase (Sigma-Aldrich. St. Louis, MO, USA).  We imaged focal-adhesion-containing lamella 
areas, typically no greater than 20 μm from the cell edge, that also contained at least three fiducials for 
calibration and drift correction.   
Pharmacological treatments 
50µM blebbistatin was used to inhibit myosinII ATPase activity (Torronto Research Chemicals, 
North York, Ontario, Canada).   
Plasmids 
Plasmids encoding actin-mEos2, talin-N-tdEos, talin-C-tdEos, paxillin-N-tdEos, WT-vinculin-N-
tdEos, CAAX-tdEos, vinculin-EGFP and paxillin-mCherry were previously described
57,88,205
.  All 
fluorescent protein expression vectors were generated using a C1 or N1 (Clontech-style) cloning vector 
backbone.  To construct the fluorescent protein cloning vectors, the cDNA encoding mCerulean, tdEos, 
mNeonGreen, and mTurquoise was amplified with a 5’ primer encoding an AgeI site and a 3’ primer 
encoding a BspEI site (C1) or a NotI site (N1) for insertion into the corresponding vector backbone.  The 
resulting PCR products were purified, digested, and ligated into similarly treated EGFP-C1 and EGFP-N1 
vector backbones, yielding C1 and N1 cloning vectors for mCerulean, tdEos, mNeonGreen, and 
mTurquoise.   
To generate the chicken paxillin (NM_204984.1) vector, an advanced EGFP variant mEmerald 
(wtGFP + F64L, S65T, S72A, N149K, M153T, I167T, A206K), was initially used to characterize the 
fusion.  To produce a paxillin fusion with a 22 amino acid linker separating the C terminus of paxillin from 
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the fluorescent protein, paxillin cDNA was PCR amplified with a 5’ primer encoding an EcoRI site and a 3’ 
primer encoding a NotI site.  The resulting PCR product and mEmerald-N1 were both digested by the 
appropriate restriction enzymes, gel purified and ligated to yield mEmerald-Paxillin-22.  Upon sequence 
verification of the vector, mEmerald-Paxillin-22 and mCerulean-N1 were digested by EcoRI and NotI, gel 
purified, and ligated to yield mCerulean-Paxillin-22. 
To prepare the vinculin fusion, human vinculin (NM_003373.3) was PCR amplified with a 5’ 
primer encoding a NheI site and a 3’ primer encoding an EcoRI site.  The resulting PCR product and 
mEmerald-N1 were digested by the appropriate restriction enzymes, gel purified and ligated to yield 
mEmerald-Vinculin-21.  Upon sequence verification of the vector, mEmerald-Vinculin-21, tdEos-N1, 
mNeonGreen-N1, and mTurquoise-N1 were digested with NheI and EcoRI, gel purified, and ligated to 
yield tdEos-Vinculin-21 (WT-vinculin-C-tdEos), mNeonGreen-Vinculin-21, and mTurquoise-Vinculin-21. 
Dr. Susan W. Craig generously provided the initial ECFP-EYFP vinculin FRET probes (ref).  To 
generate the mTurquoise-mNeonGreen vinculin tail probe, the ECFP-EYFP vinculin tail probe was PCR 
amplified with the following primers: 
AgeI forward: GCG CTA CCG GTC GCC ACC ATG CCC GTC TTC CAC ACG CGC ACC  
BspEI reverse: TCT GAT CCG GAG CCA CTG GTA CCG TCG ACC TGA TAC CAT GGG GTC TTT 
CTG ACC CAG CGC 
The resulting PCR product was digested, gel purified, and ligated into a similarly treated C1 cloning 
vector.   Upon sequence verification, mTurquoise was PCR amplified with the following primers: 
KpnI forward: GCG CAT AGG TAC CAT GGT GAG CAA GGG CGA GGA GCT GTT CAC C 
XhoI reverse: TCT CGA CTC GAG TTA CTT GTA CAG CTC GTC CAT GCC GAG AGT GAT CCC 
The PCR fragment was digested, purified, and ligated to the similarly treated ECFP-EYFP-vinculin tail 
probe described above.  This yielded the mTurquoise-EYFP vinculin tail probe intermediate.  Following 
sequence verification, mNeonGreen was PCR amplified with the primers below: 
NotI forward: GCG CAT AGC GGC CGC ATG GTG AGC AAG GGC GAG GAG GAT AAC ATG GC  
NotI reverse: GAC AGC GCG GCC GCC CTT GTA CAG CTC GTC CAT GCC CAT CAC ATC GGT 
AAA G 
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The PCR fragment was digested, purified, and ligated to a similarly treated mTurquoise-EYFP vinculin tail 
probe intermediate.  This resulted in the mTurquoise-mNeonGreen vinculin tail probe. 
To generate the vinculin control probe, the following primers were used to PCR amplify ECFP and amino 
acids (1-419) of vinculin: 
HindIII forward: GCG CAT AAG CTT CGA TGG TGA GCA AGG GCG AGG AGC TGT TCA CC  
KpnI reverse: GGC CCG CGG TAC CTC ATG CAA CTT TCC TTG CTT CAG ACA TAA TTC CTC GA 
The resulting PCR product was purified, digested, and ligated to a similarly treated mNeonGreen C1 
cloning vector.  This resulted in an ECFP-mNeonGreen vinculin control intermediate.   Following 
sequence verification, mTurquoise was PCR amplified using the primers listed below: 
HindIII forward: GCG CAT AAG CTT CGA TGG TGA GCA AGG GCG AGG AGC TGT TCA CC  
EcoRI reverse: GAC AGC GAA TTC GAC TTG TAC AGC TCG TCC ATG CCG AGA GTG ATC CC  
The PCR fragment was digested, purified, and ligated to a similarly treated ECFP-mNeonGreen vinculin 
control probe intermediate.  This resulted in the mTurquoise-mNeonGreen vinculin control probe. 
To construct the mTurquoise-mNeonGreen-FRET-10 probe, the following primers were used to PCR 
amplify mNeonGreen: 
NheI forward: GCG AGG GCT AGC CAC CAT GGT GAG CAA GGG CGA GGA GGA TAA CAT GGC 
CTC TCT CC 
AgeI reverse: ACC GCA CCG GTG GGG ATC TGA GTC CGG ACT TGT ACA GCT CGT CCA TGC 
CCA T 
The resulting PCR product was digested, gel purified, and ligated to a similarly treated mTurquoise-N1 
cloning vector, generating a 10 amino acid linker (SGLRSPPVAT) separating the fluorescent proteins.  
This yielded mTurquoise-mNeonGreen FRET-10. 
All fusion DNA was purified using the Plasmid Maxi kit (QIAGEN, Valencia, CA, USA) and 
sequence verified (The Florida State University Bioanalytical and Molecular Cloning DNA Sequencing 
Laboratory, Tallahassee, FL, USA). To ensure proper localization, all fusion proteins were characterized 
by transfection in HeLa cells (CCL2 line; ATCC, Manassas, VA, USA) using Effectene (QIAGEN) and 
~1μg vector. Transfected cells were grown on coverglass in DMEM/F12, fixed after 48 hours, and 
mounted with Gelvatol.   
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Mutagenesis to generate vinculin and paxillin mutants 
The vinculin and paxillin point mutants were generated from the WT constructs using the Quick-
change II site-directed mutagenesis kit (Agilent Technologies, Santa Clare, CA, USA).   
Forward Primers: 
CA-Vinculin (tdEos): CTA AGA GGG AGG TGG AGG CTT CCG CGG ATC CCA AGT TCC GTG 
CA-Vinculin (FRET + GFP): GCT TGT GGC AAA ACG GGA GGT TGA AGC TTC AGC AGA CCC TAA 
ATT CAG 
A50I-Vinculin (tdEos): CGC CGT GCA GGC GAT CGT CAG CAA CCT C 
A50I-Vinculin (FRET + GFP): CGG CCG TGC AGG CCA TCG TCA GCA ACC TGG T 
V1001-Vinculin (tdEos): CAG CAT GGT GGC CTT CGC TGT GGA CAG GAT TTT 
V1001-Vinculin (FRET): CCC AGC ATG GTA GCT TTC GCT GTG GAA AGA ATT TTG A 
PaxillinY31E (tdEos + mCer): GTT TCT AAC AGA GGA AAC GCC TGA ATC CTA CCC AAC TGG AAA 
C 
PaxillinY118E (tdEos + mCer): AGT GAG GAG GAA CAC GTG GAA AGC TTC CCA AAC AAG CAG 
PaxillinY31F (tdEos + mCer): CTA ACA GAG GAA ACG CCT TTC TCC T 
PaxillinY118F (tdEos + mCer): GTG AGG AGG AAC ACG TGT TCA GCT TCC CAA ACA AGC 
PaxillnE151Q (tdEos + mCer): GGC TTC TCC TGC AAC TGA ATG CTG TTC AAC ATA ATC CCC CC 
siRNA Knockdown of endogenous protein 
To inhibit paxillin expression in HFF cells, we used the ON_TARGETplus SMART-pool for Human 
PXN, and to inhibit Hic-5 expression we used the ON_TARGETplus SMART-pool for Human 
TGFB1/1(Dharmacon, Lafayette, CO, USA).  To inhibit vinculin expression we pooled two custom siRNAs 
targeted to the 3’UTR of vinculin. (Sequence1: GGAAGAAAUCACAGAAUCAUU; Sequence 2: 
CCAGAUGAGUAAAGGAGUAUU; Dharmacon, Lafayette, CO, USA).  siRNA was transfected into cells 
using the Nucleofector and knockdown was achieved after 48hrs (paxillin and Hic5) or 72 hours (vinculin). 
Western blot 
Cells lysed in 2X SDS Protein Gel Loading Solution (Quality Biological, Gaithersburg, MD, USA) 
were separated by SDS-PAGE and transferred to Immobilon-P PVDF membrane (Millipore, Billerica, MA, 
USA). Membranes were blocked with 3% non-fat dry milk in TBS-T buffer (20 mM Tris pH 7.6, 137 mM 
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NaCl2, 0.1% (vol/vol) Tween-20) incubated with primary antibody overnight at 4˚C, washed with TBS-T, 
incubated with appropriate HRP-conjugated secondary antibodies and visualized with Immobilon 
chemiluminescent HRP Substrate (Millipore, Billerica, MA, USA). Antibodies and dilutions: mouse anti-
paxillin (1:1000, BD Transduction Labs, Franklin Lakes, NJ, USA). Mouse anti-Talin (1:1000, Abcam, 
Cambridge, MA, USA).  Mouse anti-vinculin (1:1000, Sigma-Aldrich. St. Louis, MO, USA), rabbit anti-gfp 
(1:5,000. Abcam, Cambridge, MA, USA) , rabbit anti-Y31 paxillin (1:500, BD Transduction Labs, Franklin 
Lakes, NJ, USA), rabbit anti-Y118 paxillin (1:500, BD Transduction Labs, Franklin Lakes, NJ, USA). HRP-
conjugated anti-mouse or anti-rabbit, 1:5,000 (Jackson ImmunoResearch Laboratories, Inc, West Grove, 
PA). To quantify paxillin phosphorylation levels, unsaturated exposures of the western blots were 
acquired with a myECL Imager (ThermoFischer, Waltham, MA, USA).  The background corrected mean 
intensity was measured for each band using the myECL software.  The phosphopaxillin intensity was 
divided by the total paxillin intensity, and values were normalized relative to control treatment.  
Immunoprecipitation 
HFF cells were transfected with vinculin siRNA for 60 hours.  Cells were then transfected with 
GFP (non-specific control) or vinculin-GFP constructs, plated in 10-cm tissue culture plates precoated 
with 15 µg/ml fibronectin, and supplemented with 15% FBS for 12 hours.  Cells were harvested in lysis 
buffer (50mM Trip pH 8.0, 150mM NaCl, 5mM EDTA, 5% glycerol, 1% Triton-X + complete mini-EDTA 
free protease inhibitor cocktail and PhosSTOP phosphatase inhibitor (Roche Diagnostics, Indianapolis, 
IN, USA) for 20min at 4°C.  Lysates were clarified by 20min centrifugation at 14,000rpm.  Supernatants 
were incubated with rabbit anti-GFP antibody (1:300, Abcam, Cambridge, MA, USA) and rotated 
overnight at 4°C. The following day, the solution was incubated with 30 µl proteinA Dynabeads 
(Invitrogen, Grand Island, NY) with rotation at 4°C for 1hr. Beads were washed two times with lysis buffer, 
1 time with DPBS and resuspended in 30 µl 2X SDS Protein Gel Loading Solution (Quality Biological, 
Gaithersburg, MD, USA).  Samples were boiled for 10min and analyzed by Western blotting using the 
appropriate antibodies. 
TIRF Microscopy  
Dual-color time-lapse TIRF microscopy of EGFP-Vinculin and mCherry paxillin in living cells was 
performed at 37ºC using an Apo TIRF 100x 1.49 NA oil immersion objective lens (Nikon Instruments, 
93 
 
Melville, NY, USA) on an inverted Eclipse Ti microscope system (Nikon Instruments, Melville, NY, 
USA
152
) with an evanescent field depth of ~150 nm.  Pairs of EGFP (using 488nm laser illumination, 
Coherent, Santa Clara, CA, USA) and mCherry (using 561nm laser illumination, Coherent, Santa Clara, 
CA, USA) images were captured in rapid succession at 20-sec intervals using a CCD (coolsnap HQ2; 
Photometrics, Tuscon, AZ, USA) operated in the 5 MHz readout mode using EM gain.  Drug perfusion 
during high resolution imaging was performed using an RC-30 perfusion chamber (Warner Instruments,
 
Hamden, CT, USA) as previously described 
151
.   
FRET Imaging and Analysis  
Widefield epiflourescence of FRET biosensors in living cells was performed at 37ºC using an 60x 
1.40 NA PlanApo oil immersion objective lens (Nikon Instruments, Melville, NY, USA) on an inverted 
TE2000-E microscope system (Nikon Instruments, Melville, NY, USA).  Illumination was provided by a 
solid state white light (Lumencor SOLA SE, Beaverton, OR, USA) using the CFP/YFP/HcRed-3XA Sedat 
filter set with a 444/521/608 dichroic mirror (Semrock, Rochester, NY, USA).  The following filters were 
used: mTurquoise image: Excitation 427/10, Emission 472/30; FRET image: Excitation 427/10, Emission 
542/27; NeonGreen image: Excitation 504/12, Emission 542/27.  Cells were centered and focused with 
mTurquoise filters to prevent bleaching of the acceptor fluorophore.  Images were captured in rapid 
succession (mTurquoise, then FRET, then NeonGreen) using a CCD (Coolsnap HQ2, Photometrics, 
Tuscon, AZ, USA).  For each channel, ten images are acquired in cell-free area to use for shade 
correction.  Ten darkcurrent images are acquired using mTurquoise filters without illumination.       
The raw mTurqouise, FRET and Neon Green images were aligned using rigid body method of the 
StackReg ImageJ plugin
221
.  The FRET ratio was calculated using MATLAB to run the Danuser Lab 
Biosensors processing software 2.1(available for download: http://lccb.hms.harvard.edu/software.html).  
Briefly, images were manually thresholded to create a binary mask of the cell.  Darkcurrent images are 
filtered with a 3x3 median filter, averaged, and subtracted from each raw image.  Shade correction 
images are filtered with a 3x3 median filter and averaged.  The darkcurrent-corrected images are divided 
by the averaged shade correction image.  Using the mask of the cell to define the background, the 
average background intensity is subtracted from the image.  Bleedthrough of mTurquoise and 
NeonGreen into the FRET channel was corrected with experimentally determined bleedthrough 
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coefficients.  The FRET ratio image was created by dividing the corrected FRET image by the corrected 
mTurquoise image.  The mask of the cell was applied so that the ratio value outside the cell is zero. 
For each cell, FAs were segmented using a combination of Otsu and Rosin thresholding of the 
raw mTurquoise image.  The resulting mask was applied to the processed FRET ratio image to determine 
the mean FRET ratio value at FAs (inside the masked regions) and in the cytoplasm (outside the masked 
regions).  To compare the front and back of FAs, a linescan was manually drawn along the long axis of 
individual FAs.  The FA was defined as the pixels along the linescan where the intensity was > 2*standard 
deviation of the adjacent cytoplasm intensity.  The FA linescan was divided into thirds, and the mean 
FRET value in the front 1/3 and back 1/3 were computed from the linescan of the FRET ratio image.         
iPALM imaging  
Instrumentation associated with the iPALM method has been described in detail
180
.  The sample 
is mounted between two dual-opposed infinity-corrected objectives (Nikon CFI Apochromat TIRF 60x, 
NA=1.49, Nikon Instruments Inc., Melville, NY) with index matching oil (Cargille type DF, Cargille 
Laboratories, Cedar Grove, NJ). We used light from a 50 mW 405 nm diode laser (Coherent Inc., Santa 
Clara, CA), attenuated by neutral density filters, to achieve single fluorophore-level Eos activation and a 
150mW 561nm diode pumped solid-state laser (CrystaLaser, Reno, NV) for excitation of activated 
fluorophores. Narrow bandwidth laser line filters (MaxLine©LL01-561-12.5 and MaxDiode©LD01-405/10-
12.5, Semrock Inc., Rochester, NY) were placed before the objectives to reject emission noise from the 
laser and autofluorescence generated in the optical path. The activation and excitation beams enter the 
back focal planes of the objectives through slots in custom turning mirrors, and the radial position of the 
activation and excitation beams are adjusted to produce near-total internal reflection condition.  The 
emission fluorescence signal is collected by the two objective lenses, and mirrors are used to direct the 
emitted light from the objectives into the custom designed beamsplitter (Rocky Mountain Instruments, 
Lafayette, CO).  The output beams from the 3-way beam splitter were then focused on three separate 
EMCCD cameras (Andor iXon DU-897, Andor Technology, Belfast, Northern Ireland) via achromatic 
lenses (01LAO799 , CVI Melles Griot, Albuquerque, NM). Long-pass and band-pass optical filters 
(RazorEdge©LP02-568RU-25 and BrightLine©FF01-588/21-25, Semrock Inc., Rochester, NY) are placed 
in front of the cameras to reject the excitation light.  Typical iPALM data acquisition consisted of 20,000-
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40,000 frames acquired with cameras in frame-transfer mode with a 50ms exposure per frame.  Data 
acquisition was carried out using software written in LABVIEW (National Instruments).  Data analysis, 
image processing, and rendering was performed using software written in IDL (ITT Visual Information 
Solutions) and run on a Linux computational cluster at HHMI Janelia Farm Research Campus.   
25 nm x 100 nm gold (Au) nanoparticles are used for drift correction, image registration, and 
interferometry calibration.  For each iPALM image set, the optics are aligned using localization of a single 
fiducial.  The focal plane is found with the bottom objective, which is then held constant, while the top 
objective is adjusted to the same focal plane and lateral position.  To properly align the optics for 
interference, the sample holder is continuously oscillated along the z-axis over a range of 400 nm.  The 
beam splitter is then translated up or down until the intensity of the fiducial oscillates due to the 
interferometric effect.  Finally, fine alignment of the beamsplitter is carried out by optimizing a calibration 
curve acquired by translating the sample in discrete z steps of 1 nm over a range of 250 nm.  The 
intensity of the fiducial will oscillate with a similar period but with phase differences between the cameras. 
The position and tilt of the bottom mirror in the beamsplitter are adjusted until the phase difference 
between each camera is ~120°.  Once alignment is achieved and a final calibration curve is taken, the 
acquisition of raw image sets can proceed.   
After image acquisition is complete, the raw datasets must be processed to localize individual 
molecules and extract their X, Y, and Z coordinates, as described previously
57,180
.  First the individual 
camera images were aligned and added together to form a sum image.  Individual fluorescent particles in 
the sum image are fit to a two-dimensional Gaussian by nonlinear leastsquare fitting to obtain x and y 
coordinates.  Each individual camera image in the triplicate was also fit to a two-dimensional Gaussian, to 
determine the peak amplitude.  These amplitudes were used to extract the z-coordinate of each 
fluorescent molecule from the calibration curve.  Sample drift was corrected by tracking the position of 
fiducials.  Lateral sample drift during all measurements was typically less than 5nm. The vertical (z-
coordinate) sample drift in all measurements varied between 10 nm and 60 nm over the course of the 
measurements.  iPALM images are rendered from the processed list of three-dimensional molecular 
coordinates.  The position of the xy localization is represented by a normalized two-dimensional Gaussian 
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with a width proportional to lateral localization uncertainty, while the position of the Z-coordinate is 
represented by colour.   
Analysis of processed iPALM data  
The measured molecular X, Y, and Z coordinates were exported into a .txt file for analysis in 
MATLAB.  Processed iPALM datasets include the coordinates of fluorescent molecules localized in FAs 
and the surrounding cytoplasm as well as autofluorescent molecules inside and outside the cells. To 
quantify the spatial distribution of the proteins specifically residing within individual FA regions, we 
manually segmented FAs from the top-view XY iPALM images such that each rectangular ROI contained 
a single FA and the immediately adjacent space.  For each individual FA, the vertical Z coordinates 
contained in the ROI was plotted in a 1-nm binned histogram.  As described previously, in addition to the 
main peak representing molecules in the FA, each histogram contained a smaller peak of autofluorescent 
molecules from the substrate surface.  We determined the centre vertical positions (Z-centre) and width 
parameter (σ) of each peak using a Guassian fit.  We subtract the coverslip Zcentre from the FA Zcentre, 
so that FA Z-centre measurements represent the distance from the local coverslip.  We previously found 
that integrin cytoplasmic tails are ~25-30nm above the coverslip and the FAs extend ~150nm above the 
coverslip
57
.  Therefore, molecules with X-Y coordinates within the ROI of interest and Z coordinates 
between 25-150 nm above the local coverslip Z-centre were considered “FA-associated”.   For each ROI, 
we calculated the mean Z-position of FA-associated molecules and subtracted the coverslip Z-centre from 
this value to obtain to Z-mean relative to the coverslip.  Finally, for each segmented FA we calculated the 
percent of FA-associated molecules in each of the defined FA layers (ISL:25-54nm, FTL:55-84nm, 
ARL:85-150nm).  Thus, we are able to calculate the Zcentre, Zmean, and Z-distribution for each 
individual FA in the cell.   
Statistical analysis 
Differences between two groups were determined by a Wilcoxen rank-sum test. For multiple 
comparisons the differences were determined by using an analysis of variance (ANOVA) followed by 
Tukey post-hoc anlaysis. All differences were considered significant at p<0.05. Unless otherwise stated, 
all data are presented as mean ± 95% confidence interval of the mean. 
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CHAPTER 6: CONCLUSIONS AND FUTURE PERSPECTIVES 
 Integrin-based adhesions mediate critical interactions between the cell and its external 
environment.  Integrins assemble into macromolecular “focal adhesions” (FAs) that contain hundreds of 
proteins and indirectly connect integrin cytoplasmic tails to the actin cytoskeleton.  FAs provide specific 
adhesion to the ECM allowing for the force transmission that drives tissue morphogenesis, cell 
movement, and ECM remodeling.  Additionally, FAs serve as signaling hubs where cells sense 
biochemical and physical cues in their environment that inform cell decision-making in the cell cycle, 
differentiation and death.  While the actin cytoskeleton is a major regulator of FA formation, growth and 
disassembly, the molecular mechanisms that coordinate actin polymerization and retrograde flow with 
integrin adhesion and FA formation remain unclear.  In this dissertation I have studied two examples of 
spatiotemporal coordination between the actin cytoskeleton and integrin adhesion.  I showed that Arp2/3-
mediated actin polymerization is coupled to integrin adhesion throughout the ventral cell surface in 
adhesive F-actin waves, suggesting that Arp2/3 activity, rather than the specific lamellipodium structure, 
is important for initiating integrin adhesion.  I also showed that the segregation of paxillin, talin, and actin 
to distinct FA nano-domains allows for spatiotemporal regulation of vinculin activation to engage actin 
retrograde flow and mechanically reinforce FAs during maturation.  Inactive vinculin is recruited near the 
plasma membrane, and movement up the laminar FA structure facilitates vinculin activation and 
mechanical reinforcement of FA. 
FAs form in the protruding lamellipodia, and FA formation and stability in the lamellipodia requires 
active actin polymerization
51,75
.  Additionally, loss of Arp2/3 activity reduces FA assembly and results in 
disorganized, abnormal adhesions that do not support migration up a surface-bound gradient of ECM 
82,83
.  However, since loss of Arp2/3 activity also destroys the lamellipodia, we sought to understand 
whether the lamellipodium structure was specifically required for integrin adhesion.  Arp2/3 mediates actin 
polymerization in “ventral F-actin wave” structures distinct from the lamellipodium that propagate as spots 
and wavefronts along the ventral plasma membrane.  We found that ventral F-actin waves are associated 
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with integrin-based ECM adhesion in “adhesive F-actin waves,” suggesting that Arp2/3-mediated actin 
polymerization at the plasma membrane is inherently coupled to integrin-based adhesion.  We show that 
integrin waves spatially and temporally follow Arp2/3-containing ventral F-actin waves and require actin 
polymerization, suggesting that integrin adhesion occurs downstream of Arp2/3-mediated actin 
polymerization.  Adhesive F-actin waves required actin polymerization, PI3K activity and Rac activity, but 
did not required myosinII activity.  Furthermore, inhibition of myosinII ATPase activity with blebbistatin 
resulted in an increased number of adhesive F-actin waves in U2OS cells.  Adhesive F-actin waves 
require a cycle of integrin engagement and disengagement to the ECM for their formation and 
propagation, and exhibit morphometry and a hierarchical assembly and disassembly mechanism distinct 
from other integrin-containing structures.  After Arp2/3-mediated actin polymerization, zyxin and VASP 
are co-recruited to adhesive F-actin waves, followed by paxillin and vinculin, and finally talin and integrin.   
Following our initial characterization of adhesive F-actin waves
163
, independent groups found that 
adhesive F-actn waves occurred in resting endothelial cells
121
.  Furthermore, both adhesive F-actin waves 
and ventral lamellipodia were observed to be involved in healing microwounds in the ventral endothelial 
membrane following leukocyte transmigration
121
.  Thus, we sought to further characterize endothelial 
adhesive F-actin waves.  We observed spontaneous adhesive F-actin waves containing integrin and 
paxillin in human umbilical cord endothelial cells (HUVECs).  Adhesive F-actin waves were present in 
confluent monolayers and sparsely plated cells, suggesting that they form independent of cell-cell 
contacts.  We found that thrombin inhibits endothelial adhesive F-actin waves by the ROCK-dependent 
upregulation of myosinII contractility.  Thus, in U2OS cells the pharmacological inhibition of myosin 
contractility induces adhesive F-actin waves, while in HUVECs the physiological stimulation of myosin 
contractility by thrombin inhibits adhesive F-actin waves.  Thus, we hypothesize that adhesive F-actin 
waves are a regulated by myosin II-mediated cortical tension in diverse cell types to maintain an intact, 
well-adhered actin cytoskeleton.     
In contrast to adhesive F-actin waves, the formation of mature, stress-fiber associated FAs 
requires the application of force across the FA.  During FA maturation, FAs elongate in the direction of 
actin retrograde flow and undergo compositional changes.  Vinculin is recruited during FA maturation to 
mechanically reinforce the integrin-actin linkage and engage actin retrograde flow.  Vinculin interacts with 
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over ten proteins at FAs, and different interactions regulate distinct activities.  Paxillin binding is critical for 
mechanosensing and has also been implicated in cell survival
97,190
.  Talin binding increases integrin 
adhesion and mechanically reinforces the FA structure allowing for increased traction forces
118,189
.  Actin 
binding engages actin retrograde flow to the maturing FA, slowing actin retrograde flow to establish the 
lamellipodium-lamellum border and generate high traction forces
88
.  Additionally, vinculin is regulated an 
auto-inhibatory, high-affinity intramolecular interaction between its head and tail domains
196,197
.   
However, it was previously unknown how vinculin activation and protein interactions are spatiotemporally 
regulated during FA maturation.   
Since vinculin binding partners are distributed throughout the layered FA structure
57
, we sought to 
study vinculin activation and protein interactions in the context of the three-dimensional FA architecture.  
We found that inactive vinculin is recruited to the lower integrin signaling layer (ISL) by binding to 
phospho-paxillin.  Talin and actin binding both facilitate vinculin activation at FA, and the vinculin-talin 
interaction targets vinculin to the higher FA layers and stabilizes talin in an extended conformation.  
Colocalization of vinculin with F-actin allows for maximum vinculin activation by talin and actin binding, 
supports mechanical reinforcement of FA 
117
, and engages actin retrograde flow with the ECM
88
.  
However, during myosinII mediated FA maturation, we observe a temporal lag between initial myosinII 
activation and vinculin’s nanoscale colocliazation with the actin cytoskeleton.  Vinculin is first recruited to 
the membrane-proximal ISL and only localizes to the actin regulatory layer (ARL) after ~5min of 
maturation.  Since vinculin is spatially redistributed during FA maturation, the protein organization within 
the FA is not static.  Rather, our data suggests that FA maturation not only involves a compositional 
change, but also a structural reorganization of the nanoscale protein architecture of FA.  Thus, the 
specific protein composition and the structural arrangement of proteins within FAs could both regulate FA 
function.    
We propose that while vinculin is absent from newly formed adhesions in the lamellipodia, rapid 
phosphorylation of paxillin facilitates recruitment of inactive vinculin to the ISL.  As tension builds, talin 
stretches to unmask vinculin binding sites, allowing for talin-mediated vinculin activation and association 
of vinculin with the upper FA layers.  Vinculin binding stabilizes talin in an extended conformation, 
allowing for further extension of the talin rod.  Thus, active vinculin remains associated with lower VBS 
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while higher VBS are unmasked in the FTL and ARL.  In mature FA, inactive vinculin remains associated 
with phospho-paxillin in the ISL, and active vinculin is distributed in the FTL and ARL.  Colocalization of 
vinculin with F-actin allows for maximum vinculin activation by talin and actin binding, supports 
mechanical reinforcement of FA 
117
, and engages actin retrograde flow with the ECM
88
.   
We have found distinct roles for paxillin, talin and actin in regulating vinculin organization and 
activation at FAs.  However, vinculin has many other binding partners at FA that could also contribute to 
vinculin function.  Many proteins, including VASP, vinexin, p130Cas and Arp2/3, can interact with proline-
rich linker of vinculin
84,218–220
.  VASP and Arp2/3 are both actin nucleators, and the vinculin-Arp interaction 
was shown to regulate lamellipodia protrusion, suggesting that vinculin could regulate actin 
polymerization at FA
84
.   Vinculin binding to both vinexin and p130Cas have been implicated in cell 
mechanosensing during migration and stretching
219,220
.  Thus, while we have focused our study on 
interactions in the vinculin head and tail domains, specific protein interactions with the vinculin proline-rich 
linker could also regulate distinct functions.  Furthermore, it’s not clear how binding to the vinculin proline-
rich linker would influence vinculin conformation.   
We show that both talin and actin binding were required for maximum vinculin activation at FA.  
However, talin-binding deficient vinculin had a stronger activation defect than actin-binding deficient 
vinculin.  Furthermore, actin-binding deficient vinculin had a normal distribution and was observed to 
interact with talin (data not shown).  Thus, vinculin can interact with talin independently of actin binding.  
The binding of PIP2 phospholipids to the vinculin tail has been proposed to regulate vinculin 
activation
194,214
.  Since PIP2 is presumably localized in the plasma membrane, we predict that vinculin 
interacts with PIP2 in the ISL.  Perhaps PIP2 and talin binding represents an intermediate step between 
the localization of inactive vinculin in the ISL and the localization of active vinculin in the upper FTL and 
ARL.  Further experiments are required to determine how PIP2 binding contributes to the spatiotemporal 
regulation of vinculin activation and nanoscale localization.     
Vinculin regulates the FA molecular clutch by engaging actin retrograde flow to the FA via direct 
interactions with actin and talin.  Thus, vinculin is required to slow down actin retrograde flow and to 
transmit high traction forces to the ECM
88
.  Interestingly, actin retrograde flow has been observed to be 
slowest in the back of FA
53
, consistent with our observation that vinculin colocalizes with the ARL in the 
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back of the FA.  Although actin retrograde flow is slowest in the back of FA, traction forces are observed 
to be highest toward the front of the FA
97
.  We propose that the FA acts as a three-dimensional molecular 
clutch to propagate forces diagonally through the FA (Figure 6.1).  Actin flow is engaged in the back of 
the FA >50nm above the plasma membrane, but forces propagate diagonally down and forward toward 
the membrane-proximal front of the FA.  Talin has been shown to be organized along the long axis of the 
FA such that the talin head is localized closer to the front of the adhesion while the talin tail is stretched 
rearward in the direction of F-actin flow.
65
   Thus, not only is the talin C-terminus vertically extended 
~30nm above the N-terminus, but the C-terminus can also stretch >100nm rearward relative to the N-
terminus
57,65
.  This suggests that talin is oriented diagonally and could transmit forces from the rear ARL 
to the front ISL.  Thus, the nanoscale organization of talin and vinculin could be responsible for the spatial 
distribution of traction forces and actin retrograde flow speeds at FA.   
 Efficient cell movement requires the spatiotemporal coordination of actin polymerization and 
integrin adhesion.  Additionally, the proper engagement of actin retrograde flow at FAs ensures that 
forces originating in the actin cytoskeleton are transmitted to the ECM to generate the rearward traction 
forces that propel forward cell movement.  Our work contributes to the growing body of data that the actin 
cytoskeleton is a master regulator of integrin adhesion and macromolecular FA assembly and growth.  
Arp2/3 activity is required for normal FA assembly
82,83
, and Arp2/3-mediated actin polymerization induces 
integrin adhesion in adhesive F-actin waves.  Thus, integrin activation and the initial assembly of a 
macromolecular adhesion complex is likely spatially limited to ECM-associated regions of the plasma 
membrane that have localized Arp2/3 activation.  For formation of a mature FA, tension must be applied 
across the nascent FA to induce growth and compositional change.  Vinculin is recruited during FA 
maturation to mechanically reinforce the FA and further engage actin retrograde flow.  However, the 
activation and regulation of vinculin is regulated by the three-dimensional FA architecture.  Inactive 
vinculin is initially recruited near the plasma membrane, but vinculin must be activated and redistributed 
to the upper actin-regulatory layer to engage retrograde flow and generate traction forces.  Thus, we 
observe a temporal lag between initial myosinII activation and vinculin’s colocalization with the actin 
cytoskeleton at FA.  The nanoscale organization of paxillin, talin and actin into distinct FA nano-domains 
allows for spatiotemporally regulated activation of vinculin during FA maturation.   
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Figure 6.1.  Speculative model of three-dimensional force transmission at focal adhesions 
Actin retrograde flow is engaged by talin and vinculin binding in the rear actin regulatory layer (purple).  
Forces are propagated diagonally through the force transduction layer (green) toward the front integrin 
signaling layer (red).  Thus, actin flow speeds are slowest at the proximal FA tip, but traction forces are 
highest at the distal FA tip.    
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Compartmentalization and organization of molecules is fundamental to the regulation of cellular 
processes.  As microscopy techniques improve, we are finding that cellular organization is not limited to 
the formation of membrane-bound organelles.  Nanoscale molecular organization is observed in the 
plasma membrane
222
, in mitochondria
223
, at centrosomes
186
, kinetochores
224
, chromosomes
225
, and FAs
57
.  
Here we show that not only can protein activity regulate macromolecular organization, but 
macromolecular organization can also regulate protein activity.  Thus, studying structure-function 
relationships at a macromolecular level will likely provide valuable insight into diverse cellular processes.   
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